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Abstract
A multitude of studies have revealed specific biological mechanisms that contribute to 
D-amino acid action and regulation in the mammalian central nervous system. The 
remarkable increase in our understanding of D-amino acid function and distribution in 
mammals is in many ways a result of the development of sensitive enantioselective 
separation strategies that allow for quantification in real biological samples. In capillary 
electrokinetic chromatography (cEKC) the most powerful chiral resolving agents are 
anionic cyclodextrins (CDs), yet these have not previously been investigated for chiral 
bioanalysis of amino acids. The focus of this dissertation research was to investigate for 
the first time the feasibility of and application of anionic cyclodextrins as resolving 
agents in bioanalytical chiral separations of amino acids. This dissertation encompasses 
1 ) the development of a new bioanalytical separation utilizing capillary electrophoresis 
laser induced fluorescence (CE-LIF) with sulfated-P-cyclodextrin for analysis of D- 
serine (D-ser) and L-glutamate (L-glu) in mammalian brain, 2) the first synthesis and 
characterization o f 6 members of a new family of single isomer sulfoalkyl cyclodextrins, 
3) initial studies on chiral analysis of amino acids using single isomer sulfoalkyl CDs, 
and 4) development and application of a novel microperfusion sampling approach for 
acute brain slices and coupling of this method to the developed chiral CE-LIF for 
studying magnitude and timing of D-ser and L-glu efflux from acute hippocampus in 
response to modeled cerebral ischemia. The results of these studies demonstrate that 1) 
anionic CDs are powerful chiral selectors for amino acids and can be applied for
sensitive bioanalysis of D-amino acids including D-ser, D-glu, and D-asp in brain 
samples; 2) single isomer sulfoalkyl CDs can be synthesized by regioselective reaction 
chemistry; 3) single isomer sulfoalkyl CDs are excellent resolving agents for amino acid 
analysis and may be valuable for bioanalytical chiral applications; and 4) microperfusion 
sampling coupled to CE-LIF can be used to analyze dynamic changes in the magnitude 
and timing of neurochemical efflux from single acute hippocampus slices exposed to 
modeled ischemia. Results of these latter studies suggest that D-ser and L-glu efflux 
occurs simultaneously in acute hippocampus with similar timing but differing 
magnitudes.
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1Chapter 1 
Introduction
1.1 Biological significance of D-amino acids and regulation in CNS
Chirality is a pervasive feature of biological systems. O f the 20 common a-amino acids 
found in biology, only glycine lacks a stereocenter. The 19 L-amino acids are 
widespread in nature and critical for life processes. In contrast, until recently the 
presence of D-isomers of amino acids was accepted only in lower organisms such as 
bacteria where they predominately play structural roles in peptidoglycan layers of cell 
walls (Bhattacharyya and Banerjee, 1974). Essentially all bacteria have been shown to 
produce, metabolize, and store D-amino acids; the presence of D-amino acids in 
mammalian brain and other tissue was thought to indicate bacterial contamination of 
samples (Corrigan, 1969). In 1987, Man et al. identified age dependent levels of D-asp 
in hydrolyzed protein samples from human white brain matter (Man et al., 1987). Their 
approach relied on isolating tissue samples, liberating amino acids, concentrating, 
labeling with fluorinated agents to increase volatility, and quantifying amino acid 
enantiomers by chiral gas chromatography mass spectrometry (GC-MS). Around the 
same time, Dunlop et al. identified significant levels o f free D-asp in brain and other 
tissue of mammals (Dunlop et al., 1986) using high performance liquid chromatography 
(HPLC) with fluorescence detection. This latter approach allowed for the study of free 
aspartate in newborn rat brain tissue where they found high levels of D-asp that decrease 
systematically with aging. Other related studies with chick embryos demonstrated that
free D-asp increases with development in the egg (a closed system) then decreases 
during postnatal stages (Neidle and Dunlop, 1990). Today, D-asp is known to be 
produced in mammalian brain with particular localization to glandular structures 
involved in hormone regulation including the pituitary and pineal glands (Schell et al., 
1997a). Among its effectors, D-asp may act in glandular structures in the CNS to 
regulate release of prolactin and melatonin (Furuchi and Homma, 2005; D'Aniello, 
2007).
In 1992, Hashimoto and associates utilized chiral HPLC coupled to amino acid 
derivatization and sensitive fluorescence detection and confirmed several of the earlier 
studies on D-asp localization and developmental changes. Importantly, these newer 
studies demonstrated high levels of free D-serine (D-ser) in the central nervous system 
(CNS) with particular localization in forebrain regions (Hashimoto et al., 1992b; 
Hashimoto et al., 1992a; Hashimoto et al., 1993b; Hashimoto et al., 1993a). Typical 
levels o f D-ser in the CNS are as much as one-third that o f the corresponding L 
enantiomer making free D-ser overall the most abundant D-amino acid in the brain. In 
forebrain regions the concentration of free D-ser is commonly higher then many L- 
isomers. In contrast to D-asp, Hashimoto demonstrated that free D-ser remains in high 
levels in the CNS from developmental stages throughout adulthood. The localization of 
D-ser in CNS is consistent with a regulatory role on the N-methyl-D-aspartate receptor 
(NMDAR) (Hashimoto et al., 1993a; Schell et al., 1997b).
The NMDAR is a glutamatergic ligand gated ion channel with permeability for Na+, K+, 
and Ca2+ (Hille, 2001). A functional channel is a heterodimer o f NR1 and NR2 subunits.
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NR3 subunits have also been identified and co-expressed with NR1 though their 
physiological relevance in the CNS is not well known; NR1-NR3 channels are not 
activated by glutamate (Chatterton et al., 2002; Nilsson et al., 2007; Yao et al., 2008). In 
contrast to ionotropic glutamate receptor channels, a-amino-3-hydroxyl-5-methyl-4- 
isoxazole-propionate receptors (AMPAR) and Kainate receptors (KAR), the NMDAR
9+shows greater permeability for Ca (lino et al., 1990; Jonas, 1993). It is expressed 
throughout the CNS with high levels in forebrain regions and studies demonstrate 
NMDAR plays critical roles in a variety of physiological functions and disorders ranging 
from cell excitability to learning and memory to necrotic and apoptotic cell death 
(Wolosker, 2007). The NMDAR is known to contain at least 7 distinct binding domains 
for endogenous regulators. This suggests its activity is highly controlled in the CNS. 
The receptor is unique among known neurotransmitter receptors in its requirement for 
coagonist activation. Simultaneous binding of L-glu and coagonist typically identified 
as glycine (gly) at their distinct binding domains on the NR2 and NR1 subunits 
respectively, is required for channel activation (Wroblewski et al., 1989; Dingledine et 
al., 1990).
Prior to the work of Hashimoto, the notion that D-ser can regulate the glutamatergic 
NMDAR was well established. Both D-ser and D-alanine (D-ala) bind with high affinity 
to the strychnine insensitive glycine site on the NR1 subunit with as much as 100-fold 
more potency then their corresponding L-isomers (Kleckner and Dingledine, 1988; 
McBain et al., 1989; Dingledine et al., 1990). These early studies were considered
‘nonphysiological’ responses since D-amino acids were not believed to exist in 
significant levels in the CNS.
The early work by Hashimoto and the advent o f sensitive chiral HPLC suggested a 
physiological role for D-ser and provided a common sensitive analytical tool to 
investigate D-amino acid dynamics in addition to several important L-isomers 
simultaneously. Over the next couple of years, multiple studies were undertaken that 
provided clues as to what physiological role D-ser might play in the CNS. Polyclonal 
antibodies were initially developed for D-ser allowing for selective detection and studies 
on regional localization, uptake, and release in brain tissue (Schell et al., 1995).
Dunlop and Neidle investigated the fate of L-ser in CNS and provided strong evidence 
for the endogenous origin of D-ser in mammals (Dunlop and Neidle, 1997). They 
utilized microdialysis for administering glucose, glycine, and 3H-L-ser. In addition, they 
quantified pools of free D-ser in response to administration o f these metabolites. Their 
results show that 3H-D-ser is produced in CNS after administration of the L-isomer 
providing evidence for racemization of D-ser in the CNS. In 1999, Snyder and 
colleagues provided definitive proof for D-ser regulation in the CNS by isolating its 
synthetic enzyme from glia cultures (Wolosker et al., 1999a; Wolosker et al., 1999b). 
Serine racemase (SR) selectively catalyzes the conversion of L-ser to D-ser in the 
mammalian CNS. Incubation of glial cultures with exogenous L-ser was shown to 
increase production of D-ser. The enzyme is pyridoxyl phosphate dependent and in 
addition to racemization activity, has been shown to catalyze a,(3-elimination to form 
hydroxypyruvate.
Immunohistochemistry demonstrates that SR is expressed in glia near glutamatergic 
neurons (Wolosker et al., 1999a). Initially this strict localization to glia was confirmed 
by staining techniques which did not stain neurons as determined by co-staining with 
neuronal markers. Recently however, newer antibodies and staining techniques 
demonstrate high levels of SR in neurons (Kartvelishvily et al., 2006). Purified neuron 
cultures from cortex of rat and mice were shown to contain high levels of SR and these 
cultures produce D-ser when L-ser is exogenously supplied. A recent study which 
utilized novel serine racemase knockout mice suggests that SR is primarily expressed in 
neurons in the rat CNS (Miya et al., 2008).
The regional distribution of D-ser in the CNS as determined by immunostaining and 
quantitative HPLC is consistent with the notion that D-amino acid oxidase (DAAO) is 
responsible for catabolism. DAAO was first identified in mammals in by Hans Krebs 
(Krebs, 1935) though little significance was given to the mammalian oxidase since it 
was believed that higher mammals did not utilize D-amino acids. Immunostaining 
studies suggest the enzyme is expressed exclusively in glia with a regional distribution in 
the CNS which is opposite to immunohistochemical staining for D-ser; increased 
staining of DAAO in brainstem and cerebellum is consistent with low D-ser staining in 
these regions (Horiike et al., 1994; Nagata et al., 1994).
Several studies have provided evidence for regulated release of D-ser in to extracellular 
space from both glia and neurons. A mechanism of controlled release suggests that D-ser 
dynamically regulates NMDAR function. Early work by Schell and Snyder suggested a 
glutamate receptor dependent efflux of D-ser from glial cultures (Schell et al., 1995).
Immunostaining o f glial cells loaded with 3H-D-ser decreases when cells are incubated 
with ionotropic glutamate receptor agonists kainate, AMPA, and glutamate; the effect is 
blocked by co-application o f selective antagonists o f AMPA and Kainate receptors. 
These studies were supported by Ribeiro and colleagues who demonstrated a kainate 
concentration dependent increase in 3H-D-ser efflux from glial cultures that was blocked 
with the selective antagonist DNQX (Ribeiro et al., 2002). Mothet et al. investigated 
rapid efflux o f D-ser from glial cultures using a unique luminol based double enzyme 
linked assay (Mothet et al., 2005). Application of 100 pM glutamate, AMPA, kainate, or 
metabotropic receptor nonselective agonist (lS,3R)-l-aminocyclopentane-l,3- 
dicarboxylic acid (t-ACPD) for 5 s elicited rapid efflux of D-ser over a ~10s period 
which was blocked by selective antagonists o f the ionotropic and metabotropic 
receptors. The mechanism of glu dependent release in glia was demonstrated to be Ca2+ 
dependent and apparently vesicular since various modifiers of calcium systematically 
altered release and potent blockers of vesicular loading (vesicular H+-ATPase inhibitors) 
and docking (vesicular SNARE protease tetanus neurotoxin) abolished glu receptor 
dependent D-ser release in these glia cultures.
Support for compartmentalization of D-ser into vesicles comes from two separate 
studies. Williams et al. investigated D-ser immunoreactivity in glial cells using a new 
antibody that allows for superior co-localization studies with fixation-sensitive antigens 
than previously available (Williams et al., 2006). They demonstrate that D-ser 
immunoreactivity is punctate in glial processes rather than being uniformly distributed 
throughout. They suggest that to achieve this nonuniform distribution D-ser must be
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compartmentalized. They further noted that many immunoreactive glial puncta were 
localized near cell walls suggesting the possibility o f vesicular-like storage in glia. 
Martineau et al. used confocal imaging with co-localization quantification to track 
exocytotic routes of D-ser and provide morphological evidence for Ca2+ and SNARE 
protein-dependent D-ser release from astrocytes (Martineau et al., 2008). They reveal 
that D-ser immunoreactivity in glia co-localizes with vesicular protein markers, that D- 
ser loading in to vesicles occurs directly from the cytosol, and that stimulus induced 
calcium elevation causes recruitment of labeled synaptic vesicles to the plasma 
membrane with a concomitant loss of D-ser immunoreactivity as it is released from the 
cell. Taken together, recent studies on D-ser cytochemical localization and regulated 
release provides compelling evidence that D-ser is stored in and released from glial 
secretory vesicles through calcium dependent exocytosis after ionotropic glutamate 
receptor activation.
Future studies will be required to determine definitively if D-ser can be released from 
neurons by a similar mechanism as seen in glia. Kartvelishvily and coworkers provide 
evidence that D-ser synthesized in pure cortical neuron cultures can be released by 
ionotropic glutamate receptor activation (Kartvelishvily et al., 2006). Furthermore, they 
demonstrate that release of D-ser is Ca2+ dependent in these cultures. Despite this they 
suggest that the release may not be vesicular since attempts to block release through 
blockade o f vesicle loading (vesicular H+-ATPase inhibitor) did not decrease evoked D- 
ser release. In addition, synaptic vesicles isolated from these neuron cultures did not 
take up D-ser under conditions that are optimal for L-glu uptake.
Two distinct transporters have been implicated for D-ser uptake in the CNS and while 
both operate based on heteroexchange of small neutral amino acids; they are functionally 
and structurally quite distinct. The alanine serine cysteine 1 (ASC-1) transporter was 
identified by Fukasawa and colleagues after isolation of the cDNA from mouse brain 
and shown to transport D-ser with a Km of 52 pM when expressed in Xenopus Oocytes. 
The human isoform transports D-ser with a Km of 21 pM. ASC-1 shows up to 65% 
structural homology with members of the L-amino acid transporter (LAT) family and 
requires co-expression of type II membrane glycoprotein 4F2 heavy chain for activity. 
The transporter is Na+ independent and pH independent and operates primarily by amino 
acid exchange though also to a lesser degree by facilitated diffusion. It transports small 
neutral amino acids with preference for L-isomers. Particular affinity is demonstrated 
for gly, L-ala, L-ser, L-cys, and L-thr, and D-ser. Helboe and colleagues developed a 
polyclonal antibody against ASC-1 in mouse to determine its expression in the CNS 
(Helboe et al., 2003). They found that ASC-1 is distributed throughout the CNS 
including cortex, hippocampus, striatum, thalamic structures, cerebellum, and brain 
stem. Ultrastructurally, ASC-1 appears to be expressed exclusively in neurons and 
primarily at presynaptic terminals suggesting its functional expression may allow for D- 
ser clearance from synaptic space. A similar finding at this structural level for ASC-1 in 
neurons was confirmed in rat CNS using polyclonal antibodies against the rat isoform 
(Matsuo et al., 2004).
A recent study utilizing synaptosomes isolated from ASC-1 gene knockout mice 
suggests ASC-1 is the primary transporter of D-ser in the CNS (Rutter et al., 2007). 3H-
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D-ser uptake in cerebellar and forebrain synaptosomes was reduced to -30%  of wildtype 
levels in knockout mice and further omission of Na+ reduced this to <10% of wildtype 
levels. This suggests that the Na+ independent transporter ASC-1 mediates the majority 
of D-ser uptake in the CNS. The remaining uptake in knockout mice synaptosomes is 
primarily low affinity (approaching millimolar value) Na+ dependent transport. The 
alanine serine cysteine transporter 2 (ASCT-2) is a heteroexchange neutral amino acid 
transporter with structural homology placing it in the excitatory amino acid transporter 
(EAAT) superfamily. ASCT-2 most likely mediates low affinity Na+ dependent transport 
of D-ser and other small neutral amino acids in the CNS (Utsunomiya-Tate et al., 1996; 
Broer et al., 2000). Ribeiro and colleages demonstrated that astrocyte rich primary 
cortical cultures from rat, take-up D-ser by low affinity Na+ dependent heteroexchange 
(Ribeiro et al., 2002). A low affinity component of D-ser transport was verified recently 
by studies investigated high affinity ASC-1 dependent D-ser transport (Rutter et al., 
2007).
In 2005, ASC-1 knockout mice were generated and behavioral phenotype was 
established (Xie et al., 2005). These mice displayed tremors, ataxia, seizures, and early 
postnatal death. Seizures and tremors were significantly reduced using NMDAR 
antagonist MK-801 suggesting that D-ser uptake by ASC-1 may be critical for normal 
physiological function. Studies are awaited on development of SR knockout mice which 
would be incapable of producing endogenous D-ser.
1.2 Sensitive analytical approaches for D-amino acid quantification
The discoveries of D-amino acids in biological samples and the physiological 
significance, particularly D-ser and D-asp, have stimulated new efforts to develop 
quantitative chiral selective bioanalytical techniques to measure physiological levels and 
study dynamics in brain. Sensitive approaches are either enzyme-linked assays or 
separation and detection based. Enzyme-linked assays can offer unique selectivity and 
sensitivity without the need for sample cleanup and separation. The limitation of these 
approaches is due to the fact that they are selective only as single component assays and 
in addition few enzymes for D-isomers of amino acids are available. Multiple distinct 
enzyme assays would be required in parallel preparations if multiple components were to 
be analyzed by this approach alone.
1.2.1 Enzyme linked assays
Due to the predominance o f L-amino acids in CNS, only a few select enzymes have been 
identified that show D-amino acid specificity. DAAO reacts with D-ser in the presence 
of molecular O2 to form hydroxypyruvate and H2O2. The enzyme is not selective to D- 
ser alone however, and catalyzes a-keto acids formation from many D-isomers. Despite 
this, the production of H2O2 by this enzyme has been used to estimate D-ser levels in 
mammalian brain by several approaches which indirectly detect peroxide generation. 
Enzyme assays can be adapted to study a variety of biological tissues including CNS 
tissue in vivo. Recently, Pemot et al. developed a yeast D-amino acid oxidase 
microbiosensor (enzyme microelectrode) that is highly selective for D-ser compared
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with L-amino acids and offers a mean response time of 2 s and detection limit of 16 nM 
in vivo (Pemot et al., 2008). A platinum microelectrode is initially coated with a 
membrane layer of poly-m-phenylene-diamine (PPD) that prevents oxidation of common 
metabolites such as ascorbic acid, uric acid, serotonin, and dopamine by the electrode. A 
layer o f DAAO enzyme follows the PPD coating. When a potential is applied, free D- 
ser in the vicinity o f the enzyme electrode is converted to hydroxypyruvate and H2O2 by 
DAAO with the latter product being oxidized at an applied potential o f + 500 mV verses 
the Ag/AgCl reference electrode. The current recorded from oxidation is used to 
determine [D-ser] based on calibration curves. The approach was used to assay D-ser in 
cortex o f live anesthetized rats. From a selectivity standpoint, the approach is sensitive 
only to total D-amino acids. The selectivity observed for D-ser compared to other D- 
isomers was primarily due to the apparent low abundance o f other D-amino acids in the 
CNS relative to D-ser.
DAAO enzyme linked assays have also been adapted in vitro. One approach 
investigated dynamic changes in D-ser in extracellular space from glial cells in culture 
by linking peroxide generation from DAAO to peroxide reduction through oxidation of 
luminol catalyzed by horse radish peroxidase (HRP) (Mothet et al., 2005). In this double 
enzyme linked assay, DAAO, HRP, and luminol are added to cultures and luminescence 
is quantified. The assay provides detection limits approaching 40 pM for D-ser.
1.2.2 Separation and detection of D-amino acids
The vast majority of bioanalytical approaches for chiral amino acid analysis rely on 
separation and detection strategies after derivatization of the native metabolite. 
Derivatization plays one or more functional roles depending on the analytical approach 
including 1 ) increasing detection limits by introducing chromophores and/or 
fluorophores for spectrophotometric detection, 2) increasing volatility of amino acids for 
GC based separations, and 3) conversion of enantiomers to diastereomers. High 
performance liquid chromatography (HPLC), gas chromatography (GC), and capillary 
electrophoresis (CE) have all been used to analyze derivatized DL-amino acids in the 
CNS and a multitude of approaches are available.
A fundamental distinction for chiral separation strategies in LC, GC, and CE is whether 
the chiral resolving mechanism is direct or indirect with respect to diastereomer 
formation. Direct methods for diastereomer formation are the most common approach in 
chromatographic techniques and involve chemically derivatizing the enantiomers using 
optically pure chiral reagents. Most commonly this reagent is linked to a fluorophore for 
sensitive detection though in GC it is commonly perfluorinated to alter vapor pressure. 
The derivatized pair of diastereomers can then be directly separated using standard 
separation approaches. Care must be taken with respect to optical purity and reaction 
kinetics since long reaction times can lead to differential rates of diastereomer 
production. Indirect methods for diastereomer formation (direct chiral recognition) 
involve noncovalent reversible diastereomer formation through interaction of the chiral 
solute with a chiral phase. A variety of chiral columns are commercially available for
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HPLC and GC as are chiral and achiral derivatization agents. In CE the chiral selector is 
most commonly added directly to the separation buffer (Weinberger, 2000).
GC was one of the first approaches for quantifying D-amino acids such as D-asp (Man et 
al., 1987) and D-ser (Hashimoto et al., 1992b) in the mammalian brain. It has proven 
valuable for quantitative D-isomer determinations in bulk tissue and media but is 
currently not applicable to small volume samples such as microdialysates due to sample 
preparation requirements. These generally include successive cumbersome steps after 
deproteination including sample extraction, evaporation, and re-suspension, prior to 
derivatization at high temperature (-100 °C). After derivatization samples are commonly 
extracted and dried to remove residual water which interferes with GC-MS analysis. In 
some cases amino acids are first isolated by cation exchange prior to these steps 
(Bruckner and Hausch, 1993). Ultimately, precolumn derivatization is required to 
increase volatility of amino acids. For analysis of biological samples one of the more 
successful approaches is achiral derivatization with pentafluoropropionic anhydride 
(PFPA) followed by chiral separation on a Chirasil L-valine ((N-2-methylpropionyl-L- 
valine-t-butylamide)-methylpolysiloxane immobilized) fused silica column. Separation 
is dependent on formation of multiple hydrogen bonds with the stationary phase (Gubitz 
and Schmid, 2001; Schurig, 2001). Hashimoto et al. used this approach to quantify D-ser 
distribution in mammalian neural tissue for the first time (Hashimoto et al., 1992b). 
The approach has been used to analyze D-ser and gly levels in serum with an analysis 
time of 11 min (Fuchs et al., 2008). One of the advantages of GC-MS with Chirasil L- 
valine is the high peak capacity in temperature gradient mode which under optimal
conditions allows for quantification of most DL-isomers including D-asp and D-ala in a 
single analysis. Bruckner and colleagues have extensively used this approach to 
evaluate relative and absolute levels of 13 D-isomer in mammalian tissue homogenates, 
serum, urine, and feces from a variety of species (Bruckner and Hausch, 1993; Schieber 
et al., 1997; Bruckner and Schieber, 2001; Patzold et al., 2005).
HPLC is widely used for analysis of chiral compounds though the technique has several 
limitations in this respect when applied to biological samples. Sample throughput is 
often limiting in chiral HPLC of amino acids since retention times for most typical 
bioanalytical methods are generally > 20 min and most enantioselective analysis times 
range from 20-70 min. Separation efficiency is less then GC and CE (Dong, 2006). 
Chiral HPLC columns are expensive and their selection and subsequent appropriate 
method development may not be straight forward. In addition, sample volumes are 
typically quite large (5-50 pL), which can limit the nature of the tissue samples being 
analyzed for trace metabolites. This becomes especially important with in vivo 
microdialysis studies (Benveniste et al., 1984), and especially where low volume 
sampling probes can collect extracellular neurotransmitters in a near-real time (Lada et 
al., 1997). Temporal resolution of neurochemical events such as stimulated increases or 
decreases of neurotransmitters is limited by the volume of sample that must be pooled 
for a given LC analysis. Typically microdialysis flow rates range from 0.5 to 3.0 pL/min 
for analysis of amino acid neurotransmitters, thus anywhere from 5-20 minutes may be 
required for each fraction analyzed by most HPLC approaches. Nonetheless, HPLC 
techniques are widely utilized for the separation o f D-ser and other amino acid
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neurochemicals both in vitro and in vivo. Most HPLC methods offer excellent precision 
and accuracy.
One of the first sensitive HPLC methods identifying D-ser in CNS was developed by 
Hashimoto et al. for D-ser, D-asp, and D-ala quantification in neural tissue and cerebral 
spinal fluid (Hashimoto et al., 1992a). Analysis time was optimized at 29 min for D-ser 
and ~75 min to quantify 18 amino acids (excluding column re-equilibration time). 
Derivatization using ort/zo-phthalaldehyde (OPA) and the chiral thiol N-tert- 
butyloxycarbonyl-L-cysteine (BOC-L-cys) in combination with gradient elution allowed 
for fluorescence detection of the isoindole diastereomer products with excitation at 344 
nm and emission 443 nm. Detection limits for the assay were in the low picomolar 
range per injection (~25 nM free amino acid LOD calculated based on reported injection 
and calibration curves). Due to the diastereomeric products formed in the derivatization 
step, the use of standard octadecyl silane (C-18) reversed phase column is sufficient for 
separation. This initial approach is still widely used for analysis of D-ser, D-asp and/or 
D-ala along with several L-amino acids without significant alterations (Dunlop and 
Neidle, 1997; Takahashi et al., 1997; Morikawa et al., 2001; De Miranda et al., 2002; 
Shleper et al., 2005; Panizzutti et al., 2006) despite criticism of the stability of the OPA 
derivative (Jacobs et al., 1986) as well as a prerequisite in some assays to ‘prove’ the D- 
ser peak by DAAO catabolism for each analysis. This latter prerequisite was required in 
cell culture assays where the D-ser OPA derivative partially overlapped a preceding 
major metabolite (Shleper et al., 2005).
Alternative chiral thiols have been used with OPA to alter selectivity and stability of the 
isoindole DL-amino acid derivatives (Lo et al., 1998; Grant et al., 2006). Selectivity 
appears to be the primary concern with assays being developed to allow D-ser 
quantification in neural samples in conjunction with major metabolites including L-glu, 
L-asp, L-ser, gly, taurine, and phosphoethanolamine.
Several studies utilize achiral fluorescent labeling reagents in conjunction with chiral 
bonded HPLC columns. Following deproteination o f serum and brain tissue 
homogenates, sensitive determination of D-ala, D-lys, and D-ser was obtained by HPLC 
with precolumn fluorescent labeling using 4-fluoro-7-nitro-2,l,3-benzoxadiazole (NBD- 
F) with excitation at 470 nm and emission at 530 nm and a Sumichiral OA-2500 column 
(Fukushima et al., 1995). The separation was successful for baseline resolving DL- 
isomers though in several cases the isomers partially overlapped unknown components 
when studied in serum and brain tissue. The achiral NBD-F labeling reagent displays 
superior stability compared to OPA, requires elevated temperature and longer reaction 
time compared with OPA, and offers sufficient quantum yields for fluorescence 
detection o f biological samples.
Naphthalene-2,3-dicarboxaldehye (NDA) was developed as an alternative reagent to 
OPA which offers higher quantum yields and better stability for primary amine 
derivatization (De Montigny et al., 1987). The reagent was recently reviewed (Rammouz 
et al., 2007) but significant progress in chiral amino acid bioanalytical methods 
development by HPLC is lacking. Duchateau et al. investigated enantioseparation of DL- 
amino acids by HPLC using P-cyclodextrin bonded stationary phases (Duchateau et al.,
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1992). Ammonium nitrate/methanol mobile phase compositions were studied and a 
dramatic effect of pH and buffer concentration on retention times was noted. The 
method was capable of separating several neutral NDA derivatized DL-amino acids but 
was not studied for enantioseparations in biological samples.
A column switching HPLC approach has been valuable for determining trace DL-amino 
acid levels in the CNS and was recently reviewed in part (Hamase, 2007). Column 
switching HPLC with fluorescence detection using a variety of individualized protocols 
has been successful for the quantification of trace D-isomers of amino acids in neural 
tissue, plasma, and urine. Levels of DL-ser (Fukushima et al., 2004), DL-asp (Long et 
al., 2001), DL-ala (Morikawa et al., 2003; Morikawa et al., 2008), DL-leu (Inoue et al., 
2000; Hamase et al., 2001), DL-val (Hamase et al., 2007), DL-isoleucine (Hamase et al., 
2007), DL-pro (Hamase et al., 2001; Hamase et al., 2006; Tojo et al., 2008), and DL-thr 
and D-a//o-thr (Zhao et al., 2004) have been determined in biological samples. 
Generally, precolumn derivatization with NBD-F or an alternative fluorescent reagent 
that produces stable derivatives is followed by reversed phase HPLC on C-18 column 
and fractionation of the respective mixed DL-isomer band of interest. The enantiomer 
ratio of the fractionated band is then determined subsequently by timed online post­
column switching with separation and detection using a chiral bonded column and 
fluorescence detector. The first separation step with achiral RP-HPLC is capable of 
baseline resolving a large number of amino acids which can be valuable for biological 
studies if certain amino acids are known to exist overwhelmingly in one form. The 
chiral component o f interest can then be determined through online column coupling and
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detection. When micro-RP-HPLC is used for the first separation step, optimal sensitivity 
can be obtained for the fractionated band (Hamase, 2007). Major limitation relates to 
the cost of operating the system which requires two fluorescent detectors and multiple 
LC columns as well as analysis times which generally exceed 50 min per sample. The 
system is capable of quantifying one chiral pair at a time.
Song and colleagues recently developed a micro-HPLC approach with electrospray 
ionization tandem mass spectrometry (ESI-MS/MS) to analyze DL-ser, DL-glu, and DL- 
asp in neural tissue from Aplysia ganglia (Song et al., 2006; Song et al., 2007) and rat 
(Song et al., 2006; Song et al., 2008). Detection was by selective reaction monitoring 
(SRM) for the precursor-to-product ion transitions for NBD-labeled amino acids. A 
quadrupole linear ion trap (Q-trap) MS operated in positive ion mode was used for 
detection. This was the first approach for sensitive D-amino acid analysis in biological 
samples by tandem MS techniques. Precolumn derivatization with NBD-F followed by 
sample enrichment by stacking on a C -18 extraction microcolumn was required prior to 
separation for optimal sensitivity. Samples were loaded directly by switching valve 
from the extraction column to a micro-HPLC column consisting of chiral antibiotic 
(Teicoplanin aglycon) bonded stationary phase. The use of tandem MS with SRM 
allowed for elimination of chromatographic interferences and the application of co­
eluting 3H-labeled DL-amino acid isotopes as internal standards. Detection limits for D- 
isomers were -100 ng/mL by this approach. Taking into account the microextraction 
step, an injection cycle time of -50  min was optimized for the separation. The technique 
was used to investigate differences in DL-asp, DL-glu, and DL-ser levels in total brain
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extracts from rats as well as regional variations in these D-amino acids in Aplysia 
ganglia neural processes.
Bema et al. recently developed a rapid and sensitive HPLC-ESI-MS/MS approach for 
DL-ser quantification in microdialysates after chiral derivatization using fluoro- 
dinitrophenyl-L-alanine amide (DNPA-F, “Marfey’s reagent”) and diastereomer 
separation using RP-HPLC (Bema and Ackermann, 2007). An injection cycle time of
3.5 min is reported. The approach utilized a Q-trap in negative ion mode for detection 
and a 2.1 mm I.D. C-18 column for separation. The offline derivatization step was 
carried out in microplate format and followed by evaporation of the medium to dryness 
and resuspension of the residue in separation buffer. Quantification was carried out by 
MS/MS in SRM mode with a reported 10.3 ng/mL LOD. The approach was recently 
adapted to triple quadrupole by Fuchs and colleagues in negative ion spray mode and 
selective ion monitoring (SIM) and included quantification of glycine in addition to DL- 
ser (Fuchs et al., 2008).
High Performance Capillary Electrophoresis (HPCE) coupled with laser induced 
fluorescence detection (CE-LIF) has been established as an efficient approach for D- 
amino acid analysis in biological samples. Chiral CE-LIF has many advantages over GC 
and LC approaches and can provide high sensitivity for amino acid analysis in biological 
samples. Like HPLC and GC, CE is capable of monitoring multiple components which 
is often o f significant value in biological studies. The technique is cheap to maintain, 
requiring small quantities (<60mM) of chiral selector dissolved in small volumes of 
aqueous background electrolyte (BGE). Chiral method development is, in principle,
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much simpler than HPLC since chiral selectors and various other pseudostationary 
phases can be easily adjusted. Chiral recognition by various CE approaches has recently 
been reviewed (Gubitz and Schmid, 2008). CE-LIF is especially suited for 
neurochemical studies where small sample volumes (nL-pL) are often encountered. 
Typical CE injection volumes are in the nanoliter range and attomole detection limits 
can be readily achieved with appropriate LIF detection. LIF requires derivatization of 
amino acids and several chiral and achiral reagents that have been developed for HPLC 
approaches are directly applicable to CE-LIF. Bioanalytical chiral CE-LIF approaches 
generally use either micellar electrokinetic chromatography (MEKC) as a separation 
mode or chiral capillary electrokinetic chromatography (cEKC).
Chiral amino acid separations by CE-LIF has been extensively studied and recently 
reviewed (Iadarola et al., 2008) in part. Many chiral techniques were not optimized for 
biological samples initially by their investigators. These include chiral separations of 
amino acids derivatized with OPA (Tivesten and Folestad, 1995, 1997; Yang et al., 
2001), NDA (Ueda et al., 1991; DeSilva and Kuwana, 1997), 5-dimethylamino- 
naphthalene-1-sulphonyl chloride (DNS) (Gozel et al., 1987; Yang and Yuan, 1999), 
fluorescein isothiocyanate (FITC) (Jin et al., 1999; Lu and Chen, 2002), and the achiral 
reagents such as (+)- and (-)-l-(9-anthryl)-2-propyl chloroformate (APOC) (Thorsen et 
al., 1997). Several of these methods laid the groundwork for later application to real 
samples.
OPA derivatization which continues to be popular for HPLC has been adapted for CE- 
LIF chiral analysis of D-ser. Thompson and colleagues developed a rapid CE-LIF
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approach to quantify OPA/p-mercaptoethanol derivatized DL-asp in brain homogenates 
from rats using online microdialysis CE-LIF (Thompson et al., 1999). Separation was 
accomplished using CD-cEKC at pH 10 with 7.5 mM P-CD as chiral selector. A 
separation time of ~3 s was reported. The microdialysis probe was inserted directly into 
a 50 p.L sample o f rat brain homogenate diluted 3-fold. Despite a microdialysis probe 
recovery for D-asp of only 20 %, the reported detection limit for the online microdialysis 
CE-LIF assay was 905 nM. O ’Brien et al. developed a CE-LIF approach to analyze 
OPA p-mercaptoethanol derivatized D-ser in salamander retina (O'Brien et al., 2003). 
Chiral recognition was achieved using hydroxypropyl-y-cyclodextrin (HP-y-CD) 
dissolved in a high pH BGE. Separation time using an online microdialysis CE-LIF 
approach was 9 s with a theoretical plate count per meter of 400,000. A variety of amino 
acids including DL-asp, L-glu, L-ser, GABA, and taurine could be analyzed in addition 
to D-ser. The approach was used to characterize D-ser in salamander retina (O'Brien et 
al., 2003; O'Brien et al., 2004), cortical brain slice (O'Brien and Bowser, 2006), and rat 
striatum in vivo (Ciriacks and Bowser, 2006).
Tsunoda and colleagues developed the first method of DL-amino acid bioanalysis by 
CE-LIF with precapillary derivatization using the reagent NBD-F (Tsunoda et al., 1999). 
Enantioseparation was achieved under slightly acidic conditions (pH 4) using trimethyl- 
P-cyclodextrin (TM-P-CD) as a chiral selector. DL-asp levels were investigated in 
pineal glands of rats to demonstrate application of the approach. This appears to be the 
first application of capillary electrophoresis for the analysis of D-amino acids in 
mammals. Zhao and colleagues utilized CE-LIF with NBD-F derivatization to analyze
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D-ser in rat cerebrum tissue homogenates after protein precipitation (Zhao et al., 2005b). 
Chiral separation was achieved at high pH with HP-P-CD as chiral selector. The method 
clearly separated DL-ser without interferences in 40 min. They suggested that decreasing 
capillary length and diameter could significantly increase sample throughput. Around 
the same time O ’Brien et al. developed a faster approach than Zhao with similar 
derivatization and identical BGE components though with slight differences in 
concentrations o f the components in the BGE (O'Brien et al., 2005). In addition, 
capillary length was reduced 43 % resulting in a voltage gain from 214 V/cm to 357 
V/cm (~40%). This allowed for analysis o f D-ser, L-glu, GABA, and gly in retinal 
perfusion media with a run time of 14 min. Furthermore, the approach was recently 
adapted for online microdialysis CE-LIF of D-ser (Klinker and Bowser, 2007). The final 
BGE was similar to Zhao with slight increase in pH (0.5 units) and decrease 
concentration of HP-P-CD (2-fold). Using online microdialysis CE-LIF, excellent 
resolving power was demonstrated by analyzing 16 amino acid derivatives including 
important neurochemicals L-glu, GABA, gly, D-ser, and taurine in 21.5 seconds. The 
approach was used to investigate DL-isomer changes in vivo after local K+ infusion in rat 
striatum by microdialysis.
Thorsen et al. used achiral APOC derivatization and found D-ala, D-asp, and D-gln in 
CSF and D-glu in urine (Thorsen and Bergquist, 2000). This was the first micellar 
electrokinetic chromatography (MEKC) method for analysis of D-amino acids in 
mammals.
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Precapillary derivatization with 3-(4-carboxybenzoyl)-2-quinoline-carboxaldehyde 
(CBQCA) in conjunction with chiral CD-MEKC using P-CD allowed for the separation 
of D-asp and D-ser along with 15 additional amino acids commonly found in CSF 
(Thongkhao-On et al., 2004). Quantification of D-ser along with 11 L-amino acids in rat 
brain vitreous perfusates was demonstrated with a run time o f 10 min. Detection limits 
were 0.21 pM and 0.38 pM for D-ser and D-asp, respectively.
Zhao and colleagues quantified free D-ala in human plasma using FITC labeling and 
CD-MEKC with 18 mM P-CD as chiral selector (Zhao et al., 2006). Detection was by 
optical fiber light-emitting diode-induced fluorescence. D-ala detection limit was ~8 nM 
with a separation time of < 9 min.
NDA has been extensively studied for analysis of DL-amino acids in biological fluids by 
CE-LIF using high pH BGEs. Zhao and colleagues used precapillary derivatization with 
NDA and CD-MEKC with methanol additive to analyze free DL-asp in rat brain 
homogenates at different ages of CNS development (Zhao et al., 2001). A similar 
approach without methanol was used for the analysis of DL-asp, DL-phe, DL-leu 
concentration and distribution in single cells of Aplysia californica, a sea mollusk 
commonly used in model neuronal studies (Zhao and LifuYm, 2001). The presence of 
DL-trp in human urine, CSF, rat brain homogenates, and Aplysia ganglia neurons was 
investigated using CD-MEKC with HP-y-CD in the BGE at pH 9 (Zhao and Liu, 2001). 
Quan and Liu analyzed DL-glu derivatized with NDA in rat brain, ganglia, and single 
neurons of Aplysia californica with a detection limit of 0.54 pM (Quan and Liu, 2003). 
The approach used CD-MEKC with P-CD and methanol (25%) for baseline separation
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of DL-glu in -42  min. Altering selectivity by removing micelles and using saccharide 
enhanced dual chiral selection with HP-y-CD and D-(+)-glucose allowed for separation 
and quantification of D-ser in rat brain homogenates, microdialysates, and Aplysia 
californica neuronal processes (Quan et al., 2005). D-ser analysis was optimized with a 
run time of -3 0  min and detection limit of 100 nM in this study. Zhao et al. analyzed D- 
ser labeled with NDA in homogenates of Aplysia ganglia using dual chiral selector CD- 
MEKC with sodium taurocholate and P-CD (Zhao et al., 2005a). A 30 nM detection 
limit was reported with a run time of -30  min for D-ser. Miao et al. developed NDA 
derivatization o f chiral amino acids with CD-MEKC using 15% methanol and 20 mM P- 
CD for analysis of D-asp in neural samples (Miao et al., 2005). Analysis time was 
optimized at 30 min. They investigated D-asp in neuronal processes from individual 
neurons. The approach was further used to investigate D-asp synthesis and distribution 
in specific neuronal clusters of Aplysia californica (Miao et al., 2006). Within some 
neuronal clusters of this Californian sea slug as much as 85% of the total asp levels were 
determined to be in the D-isomer form.
1.3 Cyclodextrins in electrokinetic chromatography
Cyclodextrins (CDs) are a family of naturally occurring macrocyclic oligosaccharide 
rings composed of D-glucose subunits connected by a -1,4-glycosidic linkages. The three 
most common cyclodextrins consist of 6, 7, and 8 glucose subunits and are designated a, 
P, and y-CD. A top view of the CD structures is given in Figure 1.1.
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Figure 1.1. Top view chemical structure of a-, P-, and y-CD. A top view of the CDs 
shows the linkage o f a-D-glucose subunits combined to form macrocyclic rings. Shown 
from left to right are a-, P-, and y-CD.
The result is a macrocyclic ring of toroidal shape (or truncated conical cylinder). The 
upper rim of the truncated cone (commonly referred to as CD torus) is defined by the 
secondary hydroxyls of the glucose units, while the lower rim contains primary 
hydroxyls. A side view depiction of a CD showing the toroidal structure is given in 
Figure 1.2.
n = 6, 7, 8
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R = H, (native CDs)
Figure 1.2. Side view of cyclodextrin structure illustrating toroidal shape. The 
orientation of 1,4-glycosidic linked a-D-glucose units are such that primary and 
secondary hydroxyls extend out away from CD torus at the upper (secondary) and lower 
(primary) torus rims.
The numerous hydroxyl groups on the native CDs periphery (18, 21, 24 for a, p, and y- 
CD respectively) give the exterior of the CD hydrophilic characteristics. They are also 
the site for synthetic modification. In contrast to the polar exterior, the cavity (or 
annulus) of CD is considered moderately hydrophobic, due to a high electron density 
resulting from nonbonding 7i-electrons of the glycoside linkages and the also from the 
hydrophobic backbone of the glucose units (Easton and Lincoln, 1999). The number of 
glucose subunits will determine the internal cavity volume. The combination of
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hydrophilic exterior and hydrophobic chiral interior gives rise to unique and useful host- 
guest complexation ability. An illustration of host guest complex formation through 
interaction in solution between hydrophobic guest and CD is shown in Figure 1.3.
Figure 1.3. Illustration of CD host:guest inclusion complex formation. The diagram 
illustrates the equilibrium where a hydrophobic derivatized amino acid, NDA labeled D- 
ser, forms an inclusion complex in solution with the cyclodextrin (P-CD) through 
interaction with the hydrophobic cavity.
Cyclodextrins are the most widely utilized chemicals that form host-guest inclusion 
complexes (Weinberger, 2000). Complex formation is the basis for application in 
analytical chemistry where CDs find extensive use as chiral selectors. They offer the 
broadest selectivity of any chiral selector in analytical chromatographic and 
electrophoretic separations (Juvancz et al., 2008).
The analytical separation o f enantiomers is of primary importance in pharmaceutical and 
biochemical research. Direct chiral separation (indirect diastereomer formation) is 
achieved when a pair o f enantiomers exhibit differential rates of adsorption 
(chromatography) or partitioning (capillary electrophoresis) with a chiral phase as they 
migrate through a column. CDs bonded on stationary phases act as chiral selectors in
o
Hydrophillic Exterior Inclusion Complex
GC, LC, and capillary electrochromatography (CEC) to alter enantiomer adsorption rates 
through differential chiral interactions with the solute species. Alternatively, CDs can be 
dissolved in solution and through partitioning of chiral solute into the chiral cavity from 
the bulk phase, differentially alter migration (CE) or retention (LC with CD in mobile 
phase) of enantiomers. In this latter case, the effective physiochemical properties 
(lipophilicity, effective mass/size, charge) of each enantiomer is altered as it interacts in 
the column.
CE is a powerful analytical tool originally used primarily for the separation of charged 
analytes. When coupled with the use of chiral reagents such as cyclodextrins, this 
technique is especially useful for enantiomeric separations. CE is based on the 
migration of charged analytes in solution through a small diameter liquid filled capillary 
(typically < 0.1 mm) under the influence of an electric field (typically 5-30 kV). The 
size o f the analyte and its charge are principle factors influencing migration. With an 
appropriate buffer, voltage, capillary, etc., high separation efficiencies can be realized 
(up to several hundred thousand theoretical plates/meter is common). A schematic 
illustrating the basic principle o f capillary electrophoresis separation and detection is 
shown in Figure 1.4.
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Figure 1.4. Illustration of a typical capillary electrophoresis instrument with separation 
mechanism for ionic analyte. A small diameter (< 0.1 mM) buffer filled capillary is 
immersed at either end in buffer reservoirs containing high voltage leads of opposite 
polarity. After injection o f ionic analytes, an electric field is generated by a high voltage 
power supply and ionic species migrate based on their intrinsic ionic electrophoretic 
mobilites, p,. with constant electrophoretic velocity, ve,i, proportional to the strength of 
the electric field, E, or ve>i = jqE. For the illustration shown above, cationic species 
display net mobility toward the cathode and are separated according to their size/charge 
ratios and detected in-capillary by spectrophotometric techniques. Note that the pH 
dependent electrophoretic pumping mechanism, electroosmotic flow (EOF), is not 
included in this simple illustration. A comprehensive mathematical treatment of mobility 
parameters is described elsewhere (Khaledi, 1998).
One of several distinct advantages o f CE over many chiral chromatography techniques is 
the simplicity with which the separation is carried out. Chiral secondary equilibria can 
be achieved simply by dissolving a chiral solute such as a CD at an appropriate 
concentration in an appropriate separation buffer. If a given CD proves insufficient in 
providing chiral resolution then a multitude of native and derivatized CDs are 
commercially available that can potentially alter selectivity.
Cyclodextrins are the most widely used chiral selectors in CE and a variety o f strategies 
can be employed for bioanalytical analysis o f amino acids as referenced in Section 1.1. 
Regardless of which strategy is used, the addition of CDs to electrophoretic buffers 
results in a separation mode termed cyclodextrin capillary electrokinetic chromatography 
(CD-cEKC) (Chankvetadze, 2007). In a recent 2008 CD literature review covering the 
past 8 years, it was estimated that as much as 50% of all cyclodextrin related analytical 
studies were carried out using CD-cEKC with CDs containing charged functional groups 
(Juvancz et al., 2008). Interestingly, these CDs are the least studied for DL-amino acid 
analysis in biological matrices though they are the focus o f this dissertation research. 
The most common CE-LIF approaches in bioanalytical analysis of fluorescently labeled 
amino acids as referenced in section 1.1 are illustrated mechanistically in Figure 1.5
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A.
INLET (anode) 4~  M-j.A 4—  l i i m   ► M'LOF Outlet (cathode)
B.
INLET (anode) 4~  IC .A  ^ ^  I ■.()!- Outlet (cathode)
c.
Figure 1.5. Illustration of CE modes of chiral recognition o f fluorescently labeled amino 
acids published in bioanalytical methods. These modes represent methods applied for 
chiral analysis of biological samples. Alternative modes not applied to biological 
samples are omitted here. Note that species A represents all analytes including 
enantiomers. The most common CE-LIF approaches are represented in (A) and (B). (A) 
CD-MEKC at high pH with neutral CDs. EOF drives A towards detector despite
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opposing mobility to EOF for both A and micelle. The CD is added to induce secondary 
equilibria and allow for chiral separation of A. The micelle provides additional 
hydrophobic interaction and mobilizes charged and neutral analytes increasing 
separation window. (B) CD-cEKC at high pH. Chiral separation is based on inclusion 
complex formation with CD and is applicable only to charged A species as uncharged A 
will coelute at P e o f - Separation depends on pi for each A species. (C) CD-cEKC at low 
pH. Separation is same as high pH but with reduced EOF and pH approaching pKa of 
acidic species A.
MEKC is a powerful separation approach which has been extensively used for analysis 
of small biomolecules and particularly derivatized amino acids (Figure 1.5A). The 
application to amino acid analysis was recently reviewed (Iadarola et al., 2008) in part. 
The technique operates at high pH in normal polarity mode (cathode at outlet) where 
strong electroosmotic flow (EOF) is directed toward the cathode. Anionic micelles and 
anionic solutes migrate toward the anode (inlet) based on their electrophoretic mobility, 
P i, but EOF results in bulk flow of micelles and solutes toward the detector. The interior 
of the micelle is lipophilic which results in partitioning of hydrophobic solute between 
the bulk solution and the micelle. One advantage of MEKC compared with zone 
electrophoresis is the ability to differentiate closely related species (such as fluorescently 
labeled amino acids) based on minute lipophilic differences. Furthermore, the mode is 
amenable to charged and neutral solutes. Neutral native and derivatized CDs can easily 
be added as a second pseudostationary phase for chiral resolution (CD-MEKC). In this 
case, the partitioning of solute into the chiral cavity of the CD is in competition with 
partitioning into the micelle. Typically the ratio o f the micellar agent to CD can 
dramatically influence separation and is finely tuned for a given analysis. Sodium 
dodecyl sulfate (SDS) is the most common ionic micellar agent used in conjunction with
CDs though chiral bile salts such as sodium deoxycholate also find use in bioanalytical 
DL-amino acid analysis (Zhao et al., 2005a).
CD-cEKC at high pH (>8) with neutral CDs is also a popular approach for the analysis 
of amino acids in biological samples (Figure 1.5B). In CD-cEKC migration times for a 
given set of solutes, capillary, buffer, and voltage conditions will always be less than the 
identical separation using CD-MEKC. The exception is the use of multiply charged CDs 
in high pH CD-cEKC which has not been used for bioanalytical approaches of amino 
acids. Derivatized amino acids migrate based on unique electrophoretic mobility for 
each analyte. Chiral resolution is achieved through differential partitioning into the CD 
cavity. Strong EOF opposing anionic analyte migration results in bulk mobility toward 
the detector. A variety of native and neutral CDs have been utilized for high pH cEKC. 
When the pH of the BGE approaches the pKa of the charged solute, enantioresolution 
can often be obtained (Weinberger, 2000). Low pH CD-cEKC (Figure 1.5C) with 
neutral CDs is not well studied for chiral amino acid analysis in biological samples. 
Low pH would be required to approach the pKa region o f several derivatized amino 
acids, either the a-COOH and/or the terminal -COOH (aspartate and glutamate). One 
study by Tsunoda et al. investigated NBD-DL-asp enantioseparation in biological 
samples in the pH range of 2.5-4.7 (Tsunoda et al., 1999). A variety of native and 
derivatized neutral CDs were tested. Separation was achieved with neutral trimethyl-P- 
CD at pH 4.0 and the approach was applied to study D-asp in CNS. This is the only low 
pH normal polarity (cathode at outlet) approach that has been applied to DL-amino acids 
in biological samples.
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An alternative to the modes described above is the use of anionic cyclodextrins at low 
pH (minimal EOF) under reversed polarity (RP, anode at detector) to sweep neutral and 
weakly ionic species towards the detector as represented in Figure 1.6 below.
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Figure 1.6. Illustration of reversed polarity CD-cEKC with anionic CDs. The anionic 
CDs possess strong p i  towards the anode which exceeds that o f p e o f - Significant 
inclusion complex formation results in sweeping of ionic and neutral A toward the 
detector. While weakly acidic analytes approach their pKa in this pH range, cationic 
analytes are capable o f forming additional interactions (electrostatic).
With this approach an anionic CD would migrate toward the detector while the 
derivatized amino acids (protonated carboxylic acid at low pH, derivatized on amine) 
will be swept toward the detector based upon the strength o f their interaction with the 
cyclodextrin as well as any inherent electrophoretic mobility o f the weakly acidic 
analyte. Cationic amino acids derivatives such as those produced from lys, his, and arg 
may additionally exhibit electrostatic interactions with anionic CDs.
This approach is referred to as RP-CD-cEKC and, as of the writing o f this dissertation, 
only Piehl and coworkers have used it for fluorescently labeled amino acids (Piehl et al.,
2004). With microchip electrophoresis and fluorescence detection, they achieved 
subsecond chiral separations o f dansylated amino acids (DNS-AA) by utilizing highly 
sulfated y-CD at pH 2.5. They did not report on the separation of DNS-ser nor was the 
approach applied to biological samples or complex multicomponent mixtures.
1.4 Summary of research aims
The focus of this dissertation was to demonstrate for the first time the capabilities of 
anionic CDs in cEKC bioanalysis of amino acids and take advantage o f sensitive 
bioanalytical approaches with these chiral selectors for quantifying D-amino acids in the 
CNS. Selective separation and sensitive detection of D-ser, the dominant coagonist of 
the NMDAR, in CNS samples, was a central focus of this work. This research 
represents the first application of an ionic CD for bioanalysis o f a chiral amino acid. 
Because of this there is particular emphasis placed on developing an understanding of 
the advantages and disadvantages of using this type of chiral selector in cEKC 
bioanalysis. Studies over the past few years stress the importance of single isomer CDs 
for robust chiral separations; this thesis research also focuses on design and synthesis of 
a new family o f single isomer selectively modified sulfoalkyl anionic CDs and 
investigations on their application for D-amino acid analysis. Sensitive separation and 
quantification is only one aspect of bioanalytical chemistry. This dissertation 
additionally includes the development of a novel microperfusion brain slice chamber for 
rapid sampling of neurochemical efflux dynamics including D-ser and L-glu from single 
acute hippocampus slices. Studies with this approach coupled to anionic CD based
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chiral separations are carried out for investigating timing and magnitude of D-ser and L- 
glu efflux in response to modeled cerebral ischemia.
Chapter 2
Development and application of S-P-CD cEKC for D-ser and L-glu 
analysis in microdialysates
2.1 Overview of study
Research in amino acid neurochemistry reveals that D-ser is an important 
neuromodulator responsible for coagonist regulation o f the glutamatergic NMDA 
receptor. Therefore the ability to monitor D-ser and L-glu dynamics simultaneously is an 
important attribute in a bioanalytical technique used to study NMDA receptor function. 
Sensitive amino acid analysis requires derivatization. Naphthalene-2,3- 
dicarboxaldehyde (NDA) is an efficient fluorogenic reagent for amino acids which reacts 
with primary amines in the presence of sodium cyanide in a condensation reaction to 
form fluorescent cyanobenz(f)isoindole (CBI) derivatives, according the reaction scheme 
and proposed mechanism given in Figure 2 .1 .
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H,N OH 
+ H
D-serine
NDA
NaCN
pH >9
CN-
H,0
COO-
Figure 2.1. Reaction scheme for fluorescent labeling of amino acids with NDA. NDA 
reacts with primary amines in the presence of cyanide to form highly fluorescent 
cyanobenz[f]isoindoles. The possible key intermediates in mechanism for condensation 
of NDA and a-amino is also illustrated. Mechanism is adapted and modified from the 
scheme proposed by De Montigny et al. for key intermediates in the analogous OPA 
reaction (De Montigny et al., 1987).
Few CE-LIF approaches have been successful resolving CBI-DL-ser. There are currently 
no reports for the development of a bioanalytical method utilizing anionic sulfated 
cyclodextrins for quantification of fluorescently labeled amino acids in complex 
biological matrices. This is perhaps surprising considering this class of chiral selectors 
is considered one of the more powerful resolving agents available in CE.
This dissertation research describes the development of the first bioanalytical method 
utilizing anionic cyclodextrins for sensitive chiral analysis of amino acids in a biological 
matrix. We (Kirschner et al., 2007) utilized commercially available S-P-CD in reversed 
polarity CD-cEKC for the quantification of D-ser, L-glu, and L-asp in microdialysates
obtained from hippocampus of arctic ground squirrel. The chiral separation was 
optimized for CBI-DL-ser and then applied to other CBI-amino acids. Baseline 
resolution of 13 CBI-amino acids was achieved using a single buffer formulation. We 
demonstrate an important dependence o f chiral separation on buffer pH. At 2 wt % S-P- 
CD, CBI-ser enantiomers are baseline-resolved at pH 2.00 but no resolution is obtained 
at pH 3.00. Furthermore, we demonstrate that dilute solutions o f CBI-amino acids can be 
stacked by hydrodynamic injection with a 100-fold improvement in signal-to-noise ratio 
without loss o f chiral resolution. The mechanism proposed for stacking is described.
2.2 Methods
2.2.1. Chemicals and reagents.
All chemicals were analytical reagent grade unless otherwise stated. NDA and sodium 
cyanide were purchased from Sigma-Aldrich. All amino acids were purchased from 
Aldrich Chemical Company unless otherwise noted. Water was prepared from a 
Millipore Milli Q ultrapure water purification system with 18 M'D-cm resistivity. 
Sulfated-P-CD was purchased from Fluka (Lot # 1148973, reported as 7-11 moles per 
mol P-CD). Phosphoric acid and sodium monohydrogen phosphate were obtained from 
Fisher Scientific. Background electrolytes (BGEs) typically consisted of 25 mM 
phosphate adjusted to a desired pH by mixing equal concentrations o f aqueous 25 mM 
sodium monophosphate and 25 mM phosphoric acid solutions.
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2.2.2. Capillary electrophoresis apparatus.
The capillary electrophoresis instrument was in-house built using an Olympus BH2 
microscope (Olympus, Center Valley, PA, USA). A high-voltage power supply (0-30 
kV, Spellman CZE 1000R) was used to drive the electrophoresis. The bare silica 
capillary (Polymicro Technologies Inc., Phoenix, AZ, USA) was focused with an oil 
immersion lOOx 1.3 na, 0.17 working distance Olympus UVFL fluorite microscope 
objective. A 420-nm blue diode laser (Power Technology Inc., Little Rock, AR, USA), 
adjusted to 5 mW power, was used for excitation. The laser beam passed initially 
through a D425, 40x bandpass exciter filter (Chroma Technologies Corp., Rockingham, 
VT, USA) followed by reflection of 90° by a dichroic filter (460DCLP, Chroma 
Technologies) prior to focusing on the capillary. Fluorescent emission passed back 
through the dichroic filter and then through a bandpass emission filter (D490/40m) to a 
photomultiplier tube (PMT) (R1527, Hamamatsu Photonics, Hamamatsu City, Shizuoka, 
JAP) housed in a Photon Technology Instrument DB104 photometer. The analog signal 
was converted to digital signal, stored, and processed using LabView software (National 
Instruments Corp., Austin, TX, USA). The signal was collected at 200 Hz and signal 
averaged to 20 Hz. Injection was accomplished by computer-controlled application of 
vacuum at the outlet side o f the capillary for a specified time. Applied vacuum injection 
ranged from 300-400 Torr as measured with Baratron® Type 221 AD pressure transducer 
(MKS Instruments Inc., Andover, MA, USA). PeakFit® software (SeaSolve Software 
Inc., Framingham, MA, USA) was used to fit the peaks to a Gaussian line shape to 
determine resolution values, Rs, and noise levels to the 95% confidence interval.
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Furthermore, Peakfit® was valuable for determining the separation efficiency of an 
analyte for a given electrophoretic condition. The efficiency of a separation is an 
indication of the sharpness of the peaks relative to the separation time; an efficient 
separation produces sharp peaks in a short amount of time. Separation efficiency is 
defined as the number of theoretical plates or plate number (N) for a given 
electrophoretic condition. The number of theoretical plates can be calculated as the 
square of the ratio of migration time (tm) divided by the standard deviation (o) of the 
peak (Dong, 2006). For Gaussian peaks, width at base (wb) is approximately 4o, so 
N=16(tm/wb)2.
2.2.3. Derivatization procedure for separation and stacking studies.
CBI-amino acids were prepared for separation and stacking studies by reacting equal 
volumes of amino acid (1 mM), NDA (1 mM in methanol), and NaCN (1 mM in 60 mM 
borate buffer, pH 9.3) and allowed to react for a minimum of 15 min. CBI-amino acids 
were diluted to 10 pM with water. The use of equal molar quantities of amino acid, 
NDA, and NaCN were used to minimize NDA side products for the separation and 
stacking studies. For derivatization of microdialysates and standards for calibration 
curves, see below. CBI-amino acids absorb strongly in the visible region at 405, 422, 
and 442 nm with a broad emission band at 490-530 nm. The absorption and emission 
spectra of CBI-tyrosine in water is shown in Figure 2.2.
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Figure 2.2. Absorbance and emission spectrum of CBI-tyr in water. Absorbance 
spectrum is shown in blue (360-480 nm) and emission spectrum in red (430-600 nm) for 
a 10 pM solution o f CBI-tyr. The characteristic absorbance wavelength, Xabs, of 405, 
420, 442 nm demonstrate that the 420 nm blue diode laser maximally excites CBI-tyr. 
The emission spectrum scanned after excitation at 420 nm demonstrates that maximum 
emission is collected at 490 nm corresponding to the selected bandpass filter for the 
above described CE instrumentation. Absorption/fluorescence instrumentation: Perkin 
Elmer LS-50B Spectrofluorimeter with 4-sided 1-cm quartz cuvettes. Sample was 
prepared according to Section 2.23.
2.2.4. Capillary electrophoresis and enantioseparation studies.
All electrophoresis experiments were operated with reverse polarity (anode at detector). 
For separation studies, the capillary was bare fused-silica of dimensions 70 x 45.0 cm x 
25 pm. Injection was accomplished by vacuum injection at the detector end. Typical
currents ranged from 20 to 60 fxA. Typical injection times were 1 s, but ranged from 2 to 
180 s for stacking experiments. Injection vacuum was 380 mbar, which gave an injection 
plug of 19.5 cm for 180-s injection. New capillaries were conditioned once for 8 min 
with 1 M NaOH, then for 2 min with 0.1 M NaOH, and 2 min with BGE between each 
experiment. Resolution (Rs) of CBI-amino acid enantiomers was calculated by dividing 
the difference in migration times (Atm) of eluting peaks by the average peak width at 
base (wb). An Ohm’s law plot for the capillary (70 cm x 25 pm) with the optimized BGE 
consisting of 25 mM phosphate adjusted to pH 2.0 and containing 2 wt % S-p-CD gave a 
linear relationship (Correlation coefficient, R2 = 0.991) in the region of 5-30 kV 
suggesting maximum voltage (30kV) could be used without loss of resolution through 
joule heating (Weinberger, 2000).
2.2.5. Construction of standard curves and analysis of microdialysates.
All biological samples and standards were analyzed using a bare fused-silica capillary of 
dimensions 48 x 45 cm x 25 pm. Voltage was reduced to 21 kV to allow for similar 
applied field conditions as described for separation studies. Five standards were prepared 
for CBI-D-ser, CBI-DL-asp, and CBI-DL-glu with concentrations of 0.3, 0.8, 1.4, 2.4, 
and 5.0 pM by dilution of a 2 mM stock amino acid solution with artificial cerebral 
spinal fluid (aCSF, containing in mM; 124 NaCl, 2.7 KC1, 1 CaCL, 0.85 MgCL, 24 
NaHCCL, 1.4 D-glucose, pH 7.4). Standards and samples were reacted by equal volume 
dilutions with NDA (1 mM in methanol) and NaCN (1 mM in 60 mM tetraborate with 9 
pM L-homoarginine as the internal standard). Capillary was preconditioned and the
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standards/samples were injected using 1-s vacuum injection (380 mbar). Using peak 
areas, the CBI-amino acid/internal standard ratio was plotted versus [CBI-amino acid]. A 
five-point calibration curve was constructed for each amino acid (n > 4 at each 
concentration) using a weighted least-squares analysis. For microdialysis, typically 1-2 
pL of dialysate was reacted. Samples and standards were reacted a minimum of 15 min 
prior to analysis. Identities of CBI-amino acids in the microdialysates were confirmed by 
spiking with known CBI-amino acids. Triplicate analyses were conducted on all 
microdialysates. Concentrations o f amino acids were determined from calibration curves 
using a weighted least-squares analysis, with uncertainty reported as ± s, where s is the 
standard deviation. The average and standard deviation in peak area ratios (CBI-amino 
acid/ internal standard) for nine injections of 2.4 pM CBI-amino acid were as follows; 
CBI-L-glu, 0.461 ± 0.070; CBI-D-ser, 0.400 ± 0.085, CBI-L-asp, 0.358 ± 0.036.
2 .2 .6 .13C NMR titration of ser and CBI-ser.
All l3C NMR measurements were made with a Varian Mercury FT-NMR at 75 MHz. 
Ser titration: 15 mL of 60 mM borate buffer, pH 9.3, was mixed with 5 mL of methanol- 
d4 and then 0.50 g o f L-ser in 15 mL of D2O. The pH was 8.70 using a H20-calibrated 
pH meter. The solution was titrated incrementally with 1.0 mM HC1 followed by 
measurement of the 13C NMR chemical shift o f the carboxyl carbon referenced to 
methanol-d4 (49.9 ppm). CBI-ser titration: The same procedure was used except 15 mL 
of 60 mM borate buffer, pH 9.3, containing 15 mM NaCN was mixed with 15 mM NDA 
in 15 mL o f methanol and then with 15 mL of (C 1)-I3C enriched L-ser in D2O. The pKa
H*, which was determined in D2O using an H20-calibrated pH meter, was determined 
by plotting the first derivative of the chemical shift in ppm against pH*.
2.3 Results
2.3.1. Chiral separation of CBI-derivatives
Literature suggests that CBI-ser enantiomers are difficult to resolve at high pH using 
conventional neutral chiral selectors. Therefore we chose reverse polarity CD-cEKC 
with commercially available Sulfated-P-CD (S-P-CD) at low pH. Stalcup and Gahm 
have demonstrated excellent resolving power of this chiral selector for a variety of chiral 
analytes (Stalcup and Gahm, 1996). Conditions are typically carried out under reversed 
polarity (anode at detector) in a pH range of 2.00-3.50. Under these conditions, EOF 
would be minimized and the highly charged anionic S-P-CD would migrate toward the 
detector. CBI-amino acids could interact with S-P-CD through their hydrophobic 
naphthalene group to form inclusion complexes in solution with S-P-CD. Strong 
complex formation would result in sweeping of the CBI-amino acid solute toward the 
detector.
We find pH to be the most critical factor controlling chiral resolution of CBI-ser 
enantiomers using S-p-CD in the range of 2-6 wt % as shown in Figure 2.3.
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Figure 2.3. Dependence of chiral resolution of CBI-ser on pH o f the BGE. A) BGE: 6 
wt % S-P-CD, 25 mM phosphate, B) 2 wt % S-P-CD, 25 mM phosphate.
Resolution dramatically decreases as the pH of the BGE is raised from 2 to 3 irrespective 
of the concentration of CD. Indeed, CBI-ser enantiomers are baseline resolved at pH
2.00 (Rs = 1.62, 1.72 for 6 and 2 wt % respectively), but resolution completely vanishes 
at pH 3.00. Additionally, migration time is not significantly altered by BGE pH; an 
observation not altogether surprising given the reduced EOF over this range.
Studies on resolution verses pH were also conducted on CBI-ala, CBI-glu, and CBI-arg 
and a plot is given in Figure 2.4.
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Figure 2.4. Effect of BGE pH on chiral resolution of CBI-amino acids. BGE: 2 wt % S- 
P-CD, 25 mM phosphate. Each Rs value represents an average (n = 3).
CBI-glu and CBI-ala show a similar pH dependent response as seen for CBI-ser with a 
linear decrease in resolution with increasing pH. This suggests a similar mechanism of 
chiral recognition between these analytes and S-P-CD. In contrast, CBI-arg resolution 
increases linearly with increasing pH.
CBI-amino acids possess carboxylic functional groups that may influence chiral 
recognition and migration time by interacting with S-P-CD during inclusion complex 
formation. The degree of ionization could play an important role by influencing 
electrostatic, hydrogen bonding, and/or hydrophobic interactions with the anionic CD. It 
has been demonstrated that anionic CDs are poor chiral resolving agents for anionic 
substrates due to electrostatic repulsion. The lower pH (2.00) in our study may minimize 
these undesirable interactions. To our knowledge, the pKa values of CBI-amino acids 
have not been determined. To investigate the nature of the interaction of CBI-amino 
acids with S-P-CD, we utilized 13C NMR titration to determine the pKa value of CBI-ser. 
The chemical shift of the carboxyl carbon of 13C-enriched CBI-L-ser (99.0 atom % at C- 
1) was determined over the pH* range 1-6 as shown in Figure 2.5.
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Figure 2.5. I3C NMR titration of L-ser and CBI-L-ser. (A) 13C NMR titration of L-ser 
and CBI-L-ser. 13C chemical shift of carboxyl group monitored. (B) First derivative of 
titration curve. Peak maximums for (B) yield pKaH* which is used to determine pKaH for 
L-ser and CBI-L-ser.
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pH* is the direct reading o f the D20/methanol solution used in the titration with an H2O 
calibrated pH meter. The titration curves are shown in Figure 2.5A, along with results on 
L-ser. The first-derivative curves for these titrations are shown in Figure 2.5B. The 
pKaH* values for L-ser and CBI-L-ser are determined to be 1.9 and 2.8, respectively, 
according to the peak maxima in Figure 2.5B. A recently published equation allows for 
converting these pKaH* values determined in D2O into an H2O equivalent, thus yielding 
pKaH of 2.2 for L-ser and 3.0 for CBI-L-ser. The accepted pKa o f L-ser is 2.2. These 
results demonstrate that incorporation of the amino function into the NDA molecule 
substantially decreases the acidity o f the carboxyl group o f L-ser.
At pH 3 when enantioresolution is lost (Figure 2.3), CBI-ser is substantially ionized 
(50%, see Figure 2.5) and thus likely exhibits significant electrostatic repulsion with S- 
P-CD. It is possible that at pH 3 chiral resolution is lost for the weakly acidic CBI-ser 
due significant lack o f interaction with the anionic CD at this pH. A comparison of 
migration times for CBI-L-ser in the presence and absence of S-P-CD at pH 3 is shown 
in Figure 2.6.
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Figure 2.6. Comparison o f electropherograms o f CBI-L-ser in the presence and absence 
of S-P-CD at pH 3. BGE: 25 mM phosphate pH 3.00 with and without 2 wt % S-P-CD.
It is apparent that CBI-ser migrates with its own electrophoretic mobility in the absence 
of S-P-CD at pH 3. This is in agreement with the pKa data demonstrating its ionization 
at this pH. Addition of 2 wt % S-P-CD then results in a > 2-fold decrease in CBI-ser 
migration time. Thus, despite repulsion, CBI-ser continues to show a strong interaction 
at pH 3 with S-P-CD. This suggests that the loss of chiral recognition at this pH is more 
probably related to a change in the nature of interaction with the chiral resolving agent. 
The anionic moiety o f CBI-ser may be positioned above the CD cavity and exhibit 
electrostatic repulsion which limits the depth of penetration into the hydrophobic CD 
cavity. In contrast, the more protonated CBI-ser at pH 2 (10% ionized) may exhibit 
greater depth of penetration of the naphthyl group into the CD cavity. This effect could 
allow for greater enantioselectivity by bringing the chiral a-carbon of CBI-ser in closer
proximity to the chiral cavity. It is also plausible that hydrogen bonding interactions 
between the carboxyl group of CBI-ser and the hydroxyl and sulfato groups of S-P-CD 
becomes more important for the more protonated CBI derivative. A similar explanation 
may likely explain the parallel linear decreases in resolution with pH shown in Figure
2.4 for CBI-ala and CBI-glu.
CBI-arg resolution increases with increasing pH (positive slope) with nearly 2-fold 
resolution improvement when pH is increased from 2.0 to 3.5 as shown in Figure 2.4. 
The guanidine R-group of CBI-arg is fully protonated over the pH range investigated 
here. At low pH (2.00), CBI-arg would be expected to be significantly cationic, due to 
protonation of both the a-COOH and guanidine R-group. Electrostatic attraction of the 
CBI-arg and S-p-CD would be expected and is likely the primary cause of the fast 
electromigration of CBI-arg relative to other amino acids at pH 2.0, as shown in Figure 
2.7.
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Figure 2.7. Electropherogram of a mixture of CBI-DL-amino acids arg, ala, ser, and glu 
at 2 wt % S-P-CD. BGE: 25 mM phosphate pH 2.00 with 2 wt % S-p-CD. The cationic 
CBI-arg displays the fastest migration time in the presence of S-p-CD.
Strong interaction must play an important role for CBI-arg since in the absence of S-p- 
CD migration would be directed toward the inlet (cathode). Evidence further implicating 
an electrostatic interaction for CBI-arg is shown when plotting concentration of S-P-CD 
as a function of the average chiral pair migration time as shown in Figure 2.8.
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Figure 2.8. Effect o f S-P-CD concentration on the migration time of CBI-amino acids. 
BGE: 25 mM phosphate pH 2.00. Each chiral pair migration time represents an average 
(n=3).
CBI-arg electromigration does not appreciably change over the S-P-CD concentration 
investigated whereas CBI-ser, CBI-glu, and CBI-ala all show appreciable change. 
Finally, as pH is increased, CBI-arg migration time dramatically increases, in contrast to 
the nonbasic CBI-amino acids (Figure 2.9).
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Figure 2.9. CBI-DL-arg migration time as a function of buffer pH at 2 wt % S-P-CD. 
BGE: 25 mM phosphate with 2 wt % S-P-CD.
This increase in migration time with pH can be attributed to changes in the degree of 
ionization of the CBI-arg carboxylic acid group with increasing pH. Indeed, at pH 3.5, 
CBI-arg is approaching a neutral, zwitterionic form with decreased electrostatic 
interaction with S-P-CD, and its migration time approaches that of nonbasic CBI-amino 
acids at pH 2.00.
The impact of phosphate buffer concentration on resolution of a series of CBI-amino 
acids is shown in Figure 2.10.
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Figure 2.10. Influence o f phosphate buffer concentration on chiral resolution of a series 
of CBI-amino acids. BGE: 2 wt % S-P-CD, pH 2.00. Each resolution value is an 
average (n=3).
Optimal chiral resolution is found for CBI-ser, CBI-glu, and CBI-ala at low phosphate 
concentration. While phosphate plays a lesser role then other variables investigated, 
increasing phosphate beyond 25 mM appears detrimental for resolution of CBI-ser, CBI- 
glu, and CBI-ala.
The chiral resolution of a larger group of CBI-amino acids is shown in Figure 2.11 and 
represented numerically in Table 2.1. An optimized buffer consisting o f 25 mM 
phosphate at pH 2.00 with 2 wt % S-P-CD was used to investigate these chiral 
separations. Table 2.1 additionally contains numeric data for the same analytes except 
using 6 wt % S-P-CD for comparison.
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Figure 2.11. Chiral separation of 14 CBI-amino acids with 2 wt % S-|3-CD in 25 mM 
phosphate, pH 2.00. Peak identities: (1) CBI-DL-arg; (2) CBI-DL-his; (3) CBI-DL-phe; 
(4) CBI-DL-ile; (5) CBI-DL-asg; (6) CBI-DL-tyr; (7) CBI-DL-met; (8) CBI-DL-ala; (9) 
CBI-DL-trp; (10) CBI-DL-thr; (11) CBI-DL-ser; (12) CBI-DL-gln; (13) CBI-DL-asp; 
(14) CBI-DL-glu. Migration times for a given analyte varied by as much as 5% per run 
(Table 2.1) and thus this illustration does not absolutely represent positions of CBI- 
amino acids relative to one another.
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Table 2.1. Migration and Rs values for CBI-DL-amino acids at 2 and 6% wt % S-P-CD"
CBI-amino acid
Migration time (s)  
2 wt %  S -p -C D  
D / L
Resoiution 
2 wt %  S -p -C D
Rs
tyrosine 636 / 509 15.74threonine 639 / 704 8.89
asparagine 512 /549 7.15
phenylalanine 504 /460 3.95histidine 325 / 336 4.88glutamatic acid 690 /677  ± 3 9 /3 7 3.29 ± 0.08
methionine 545 / 527 3.02
alanine 525 /539  ± 2 4 /2 5 2.79 ± 0.11arginine 307 /312  ± 8 / 8 2.37 ± 0.15aspartic acid 637 / 648 1.79
isoleucine 485 /506 3.16serine 621 / 632 ± 3 1 / 3 2 1.69 ± 0.05tryptophan 576 /513 2.74glutamine 580/571 1.45valine 492 0
leucine 462 0
lysine 289 0
6 wt %  S -p -C D 6 wt %  S -p -C D
CBI-amino acid D / L Rs
tyrosine 411 /361 17.66threonine 402 /428 8.2asparagine 358 / 374 6.02
phenylalanine 347 / 328 5.17histidine 306 /313 3.22glutamatic acid 421 / 413 2.67methionine 367 / 360 2.55alanine 353 /358 1.92arginine 287 /290 1.89aspartic acid 403 /408 1.86isoleucine 331 /341 1.77serine 392 / 397 1.58tryptophan 392 / 366 1.91glutamine 371 0valine 334 /335 0.51leucine 344 0lysine 291 0
a BGE: 25 mM phosphate, pH 2.00. All CBI-amino acids pairs were diluted 10 uM total (1:2 D/L).
6 wt % S-P-CD, n = 1; 2 wt %, n =3 except for CBI-glu, CBI-arg, CBI-ala, and CBI-ser where n=9.
It is apparent from Table 2.1 that the concentration of S-p-CD plays a lesser role than pH 
on chiral resolution for CBI-amino acids. In fact, with the exception of CBI-phe, CBI- 
tyr, and CBI-val, all CBI-amino acids show either no change or a slight decrease in 
resolution at high concentration of S-P-CD. Nearly half the CBI-amino acids (6 of 14 at 
2 wt % S-p-CD) demonstrate a reversed migration order compared to CBI-ser with the 
L-isomer exhibiting the greater electrophoretic mobility. These include CBI-met, CBI- 
gln, and CBI-glu in addition to all 3 of the aromatic side chain CBI-amino acids. These 
latter aromatic amino acid derivatives all show excellent enantioresolution (Rs > 2.5) at 2 
wt % S-p-CD. CBI-tyr demonstrated remarkable enantioresolution using S-P-CD with 
the L-isomer eluting >2 min prior to D-isomer over the course of an 11 min separation.
2.4 Stacking of dilute amino acid solutions with S-P-CD
Stacking is an important feature of CE which under the proper conditions allows for 
enhanced detection of trace analytes through substantial increase in volume and/or mass 
injected into the capillary. For hydrodynamic injection, stacking mechanisms are 
important for injections > 2 % of the capillary volume (Weinberger, 2000).
We found that CBI-ser and CBI-glu standards diluted in water could be substantially 
stacked using vacuum injection as demonstrated in Figure 2.12, where injection time 
ranges from 2 to 120 s (380 mbar) for a 0.05 gM solution of each enantiomer.
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Figure 2.12. Stacking of dilute solutions of CBI-DL-ser and CBI-DL-glu using S-P-CD. 
CBI-amino acids were prepared at 0.05 pM in water. Stacking is demonstrated by 
comparison o f separate electropherograms obtained from vacuum injections ranging 
from 2-120 s (380 mbar). BGE: 25 mM phosphate pH 2.00 with 3 wt % S-P-CD.
An enhancement o f signal-to-noise of ~100-fold for a 120 s versus 2s injection is 
realized without substantial loss of chiral resolution, as shown numerically in Table 2.2.
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Table 2.2. Signal to Noise (S/N) Ratio, Resolution (Rs), and Estimated Concentration 
Limits of Detection (CLOD) for CBI-Ser and CBI-Glu.
SW  CLO D  (nM)c Rs
CBI-ser, CBI-ser, CBI-ser,
Injection, sa CBI-glu CBI-glu CBI-glu
2 2.6, 2.3 57.4, 65.7 1.92, 3.26
5 17.0, 15.8 8.8, 9.5 1.77, 3.32
10 31.4, 27.2 4.8, 5.5 1.78, 3.41
20 60.9, 51.9 2.5, 2.9 1.91, 3.38
60 135, 130 1.1, 1.2 1.57, 2.82
120 226, 186 0.66, 0.81 1.34, 2.46
180 14.9, 10.2 0.20, 0.30 1.72, 2.20
a50 nM of each enantiomer hydrodynamically vacuum injected except 180-s 
injection, which was 1 nM each enantiomer (see Figure 2.13). b Noise was estimated 
at the 95% Cl by PeakFit. cCLOD were estimated at S/N = 3.
Furthermore, good signal-to-noise was achieved for a 180 s injection of 1 nM of each 
enantiomer of CBI-ser and CBI-glu as shown in Figure 2.13.
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Figure 2.13. Detection by hydrodynamic stacking of 1 nM each of CBI-DL-ser and 
CBI-DL-glu using S-p-CD BGE. Stacking is represented by an electropherogram 
showing typical S/N obtained for low ionic strength solutions of racemic CBI-ser and 
CBI-glu. Injection was 180 s (capillary filled 19.5 cm). BGE: 25 mM phosphate pH 2.00 
with 3 wt % S-p-CD. Estimated LOD; CBI-ser, 0.20 nM; CBI-glu, 0.30 nM (S/N =3).
The baseline resolution of CBI-ser and CBI-glu enantiomers at 1 nM each demonstrates 
that significant stacking occurs in addition to chiral separation without significant 
resolution loss. A detection limit of 0.2 nM of CBI-ser and 0.3 nM CBI-glu is calculated 
(S/N = 3) from this electropherogram. The volume injected was determined using long 
injections of Brilliant Blue dye (FD&C Blue No. 1) solution. This dye was visible under 
10X microscope without removal of capillary polyimide coating. This approach gives a
19.5 cm injection (-28%  o f capillary volume) for a 180 s vacuum injection (380 mbar) 
which corresponds to -96  nL of solute. Hydrodynamic vacuum injection can also be 
used for stacking more complex samples, as shown in Figure 2.14, for a mixture of 11 
amino acids (including 4 chiral pairs).
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Figure 2.14. Stacking of a complex dilute sample of 11 CBI-amino acids with S-P-CD. 
Injection time corresponds to 380 mbar vacuum. Amino acids were prepared at -0.5 pM 
each. Peak identities: (1) CBI-D-arg; (2) CBI-L-arg; (3) CBI-D-his; (4) CBI-L-his; (5) 
CBI-gly; (6) CBI-L-tyr; (7) CBI-L-gln; (8) CBI-D-ser; (9) CBI-L-ser; (10) CBI-L-glu; 
(11) CBI-D-glu. BGE: 25 mM phosphate, pH 2.00 with 2 wt % S-P-CD.
The mechanism for stacking is proposed herein to involve a combination of field 
amplified stacking, pH mediated stacking, and sweeping by S-P-CD. A schematic of 
this proposed mechanism is given in Figure 2.15.
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Figure 2.15. Schematic diagram of the pH-mediated stacking/ sweeping-S-J3-CD of 
chiral CBI-amino acids. '
The dilute CBI-amino acids are anionic when initially injected at -1/3 of the capillary 
volume due to the carboxylic acid groups which are substantially ionized when dissolved 
in water at pH 6. The exceptions are CBI-amino acids with basic side chains as 
mentioned above for CBI-arg. When a negative potential o f -30 kV is applied (B), the 
current initially starts out at zero (observed) and the dilute anionic CBI-amino acids 
experience field amplified migration, with mobility toward the anode. This mobility is 
ultimately interrupted by a pH junction formed by the boundary between the injection 
plug and BGE at pH 2. At the pH junction (C), the dilute injection plug is substantially
stacked as CBI-amino acids are neutralized  by the low pH BGE. This stops their 
electromigration. Around the same time, (D) an EOF is generated in the aqueous plug 
that drives the pH 6 solution out of the capillary via the inlet. Eventually the current 
increases as anionic S-P-CD migrates into the stacked plug and sweeps the CBI-amino 
acids toward the detector. It is important to note that under this mechanism, S-P-CD 
must enter the capillary prior to ejection of the aqueous plug or else the CBI-amino acids 
would be expelled from the capillary. Thus it appears there is a combination of field 
amplified migration, pH mediated stacking, and sweeping o f the ~ neutralized CBI- 
amino acid toward the detector that is responsible for the overall stacking effect.
Support for the mechanism was obtained from 2 experiments using a capillary in which 
the detector window was placed 3 cm from the capillary inlet as shown in Figure 2.16.
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Figure 2.16. Electropherograms from experiment demonstrating both pH mediated 
stacking and sweeping mechanisms for S-P-CD. Lower trace: Electropherogram 
illustrating stacking when operating BGE without S-P-CD at low-pH reversed polarity. 
The capillary (70 x 3 cm x 25 pm) was filled 19.5 cm with 0.10 pM CBI-L-ser in water 
(pH 5.2), and a voltage (-30 kV) was applied. The dilute CBI-ser is stacked at the pH 
boundary and driven toward the inlet vial and detected prior to exiting the capillary. 
Upper trace: electropherogram illustrating stacking/sweeping when operating BGE with 
S-P-CD. Once the stacked zone nears the inlet (peak 1), it reverses direction as S-P-CD 
enters the capillary and sweeps the stacked CBI-ser toward the outlet vial (peak 2).
In both experiments CBI-L-ser was injected for 180 s (380 mbar) corresponding to a
19.5 cm injection. In the lower trace, a peak is observed in the absence of S-P-CD 
represents the field amplified, and pH mediated stacked band passing by the detector due 
to the EOF driving the aqueous plug back toward the inlet. Since S-P-CD is absent from 
the BGE, the stacked band is expelled from the capillary. In comparison, the upper trace 
shows an identical experiment conducted in the presence of S-P-CD. A similar pH 
mediated stacked band is observed from EOF driven migration back toward the inlet. In
contrast however, the upper trace demonstrates that S-p-CD enters the capillary prior to 
sample expulsion and sweeps the analyte back toward the detector prior to sample 
expulsion as represented by a second band shown at ~ 100 s. Interestingly, the pH 
mediated band is significantly narrower then the sweeping band suggesting some 
destacking occurs during migration reversal at the sweeping step (D). The cause of 
destacking during sweeping is currently unknown but it suggests that pH mediated 
stacking may be the primary mechanism responsible for stacking observed in Figures 
2.12-2.16.
The proposed mechanism is similar to that proposed by Lin and Shih for CBI-amino 
acids using anionic SDS and low pH BGE (Shih and Lin, 2005), except their 
stacking/sweeping-MEKC apparently requires that initial BGE contain no SDS. After 
migration o f the stacked analyte to nearly the inlet, the vials at both inlet and outlet are 
replaced to contain BGE-SDS. SDS then sweeps the stacked analyte toward the detector. 
Comparison o f the techniques can be made and is shown in Table 2.3.
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Table 2.3. Comparison of full-capillary sample stacking / sweeping-MEKC and pH 
mediated stacking/sweeping-S-P-CD of dilute CBI-amino acids.
Method
FCSS / sweeping 
MEKCa
pH stacking/ 
sweeping S-p-CD6
analyte CBI-lle CBI-DL-ser
injection lenth, cm 60 (full capillary) 19.5 (28% of length)
capillary i.d., pm 75 25
injection volume, pL 2.65 0.096
CLOD, M 1.1 x 10'9 0.3 x 10'9
mole detection limit, 2900 29
fmol
switching of BGE Yes No
migration time, min -30 -11
chiral separation no yes
plate number, N 1.2 x 105 1.8 x 105
aTotal and effective length of capillary 60/54 cm, violet LED 410 nm, 2 mW.bTotal and effective length of capillary 75/45 cm, violet diode laser, 420 nm, 5 mW.
The concentration detection limits are similar for dramatically different injection 
volumes, with the molar detection limit for pH-mediated stacking/sweeping-S-P-CD 
being ~ 100-fold more sensitive. Given the similar separation efficiencies (N) of the two 
methods, it is difficult to reconcile the different molar detection limits for the two 
methods. The application of this stacking technique to brain microdialysates discussed 
below was not possible due to the high ionic strength o f the sample, as discussed by 
Gillogly et al. (Gillogly and Lunte, 2005). Injection time of microdialysates greater than 
5 s (380 mbar) results in significantly broader peaks with loss o f resolution. We believe 
pretreatment of the sample, such as desalting, will be necessary for successful
application o f this stacking technique to brain microdialysates. The promise of the 
technique may lie in its ability to provide low detection limits for evaluation of 
enantiopurity o f amino acids and other chiral molecules, using either UV or fluorescence 
detection.
2.5 Analysis of D-ser, DL-asp, and DL-glu in the hippocampus of arctic ground 
squirrel.
To demonstrate application of S-P-CD at low pH reversed polarity for amino acid 
analysis, we chose to quantify levels of CBI-DL amino acids sampled from the brain of 
live arctic ground squirrels (AGS). Using a standard mixture of 22 primary amines 
commonly found in brain microdialysates, no interfering species were identified for 
CBI-D-ser, CBI-DL-asp, and CBI-DL-glu. Calibration curves were constructed for low- 
micromolar detection. L-homoarginine was chosen as internal standard to minimize error 
in quantitative analysis. The calibration curves are given in Figure 2.17.
69
70
concentration, pM
concentration, pM
concentration. pM
concentration, pM
concentration, pM
Figure 2.17. Linear regression calibration curves for CBI-amino acid standards for 
bioanalysis with S-P-CD. Curves were generated using an internal standard and are 
represented as the concentration of CBI-amino acid verses the peak area ratio of the 
internal standard (9 pM CBI-L-homoarginine) to CBI-amino acid. Error bars represent 
the standard deviation of the average I.S./CBI-amino acid peak area for the represented
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concentration. Data points were constructed from at least n > 4 separate determinations 
at each known concentration.
A typical electropherogram of a microdialysate from an AGS hippocampus is illustrated 
in Figure 2.18.
Figure 2.18. Typical electropherogram of a microdialysate from the hippocampus of an 
arctic ground squirrel. (A) Standard amino acid mixture including (1) CBI-D-ser; (2) 
CBI-L-ser + NDA side product; (3) CBI-D-asp; (4) CBI-L-asp; (5) CBI-L-glu; (6) CBI- 
D-glu. (B) Microdialysate from AGS obtained 40 min after probe insertion at flow rate 
of 0.6 pL/min. The internal standard is labeled as peak (0). Identities of CBI-amino acids 
in microdialysates were determined by spiking with known CBI-amino acids.
Appreciable levels of D-ser, L-asp, and L-glu were observed, while D-asp and D-glu are 
found only as trace components below the limit of quantification (LOQ). Quantitative 
analysis of CBI-amino acid concentrations is shown in Table 2.4, along with equations 
of the weighted linear regression standard curves used for analysis.
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Table 2.4. Quantitative analysis of amino acids in microdialysate from hippocampus of 
arctic ground squirrel.
CBI-amino acid standard curve3 R2 CLOD, nM6 [dlalysate], uMc [dialysate], uMtf
CBI-D-ser Y = 0.171x - 0.005 0.996 43.8 ±0.4 0.25 ±0.09 0.23 ±0.09
CBI-L-asp Y = 0.145x + 0.005 0.998 40.3 ±0.4 1.54 ±0.23 0.43 ±0.11
CBI-L-glu Y = 0.203x-0.013 0.998 32.3 ±0.3 0.86 ± 0.06 0.57 ±0.15
CBI-D-asp Y = 0.130x-0.004 0.991 57.1 ±0.1 trace -
CBI-D-glu Y = 0.203x + 0.004 0.997 41.2 ±0.4 trace -
ay = mx + b. (CBI-aa/internal std) = m[CBI-aa] + b. 6Concentration limits of detection (CLOD) 
calculated from response of low-concentration standard of 0.3 pM (n=4) assuming S/N = 3. c20 min after 
probe insertion. a 110 min after probe insertion.
2.6 Summary of S-p-CD as chiral selector for CBI-amino acids
Commercially available S-P-CD is found to be an excellent chiral selector for CBI- 
amino acids using low-pH reverse polarity CD-cEKC. The strength of this CE technique 
lies in its ability to baseline resolve a large number of CBI-DL-amino acids with a single 
buffer formulation. This separation occurs best at BGE pH levels below the pKa of the 
weakly acidic a-COOH of CBI-amino acids. Significant electrostatic interactions 
(favorable and unfavorable) were demonstrated between this CD and CBI-amino acids. 
D-asp, D-ser, and D-glu can all be potentially quantified in neuronal samples, if present. 
In our study, basal levels of D-ser, L-glu, and L-asp, all important 
neurotransmitters/neuromodulators, were quantified in microdialysates from the 
hippocampus of an arctic ground squirrel. Stacking with enantioseparation of low ionic 
strength solutions of CBI-amino acids was demonstrated with detection limits of 0.20 
and 0.30 nM for CBI-ser and CBI-glu, respectively.
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Chapter 3
Synthesis and characterization of single isomer sulfoalkyl cyclodextrins
3.1 Overview of study
Single isomer highly charged sulfated cyclodextrins have emerged as some of the most 
powerful chiral selectors in capillary electrophoresis. Currently the only single isomer 
highly charged anionic cyclodextrins are substituted with sulfato functional groups. Vigh 
and colleagues have designed an entire family of single isomer sulfato a-, P-, and y-CDs 
for enantioresolution in CE (Vincent et al., 1997a; Vincent et al., 1997b; Cai et al., 1998; 
Zhu and Vigh, 2000; Maynard and Vigh, 2001; Busby et al., 2003; Li and Vigh, 2003; 
Zhu and Vigh, 2003; Li and Vigh, 2004b, a; Busby and Vigh, 2005a, b; North and Vigh, 
2008). As of the writing of this dissertation thesis, many of these are now commercially 
available, offer a range of functional modifications on the primary and secondary CD 
rim offering alternative selectivity for chiral guests, and are thoroughly investigated for a 
wide range of chiral pharmaceutical compounds. The strength of the single isomer 
sulfato CDs as chiral selectors arises from several important structural features. Firstly, 
charged chiral selectors are capable o f resolving charged as well as neutral chiral 
analytes (Chankvetadze et al., 1995). All of the anionic P-CDs synthesized by Vigh and 
coworkers bear at least 7 charged sulfato groups on the primary or secondary rim (a-CDs 
have at least 6). High charge can maximize the difference in electrophoretic mobility of 
free and complexed analytes, increasing resolution and separation efficiency (Skanchy 
et al., 1999). Secondly, CDs synthesized by Vigh and coworkers are isomerically pure
through the use of selective reaction chemistry. In contrast, nonselective synthesis of 
CDs often results in a wide range of regional and positional isomers with a wide range of 
degrees of substitution, often leading to poor batch to batch reproducibility. While they 
may be excellent resolving agents as isomeric mixtures for certain compounds, this 
heterogeneity limits robustness of developed assays. For example, the separation of CBI- 
ser, CBI-glu, and CBI-asp optimized in Chapter 2 is shown in Figure 3.1 below for 
separate synthetic batches of S-P-CD obtained from the same commercial supplier.
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Figure 3.1. Comparison of the chiral separation of a mixture of CBI-DL-ser, CBI-DL- 
glu, CBI-L-asp using different synthetic batches of S-P-CD. (A) 2 wt % S-P-CD, Fluka 
Lot # LI 148973 as optimized in Chapter 2. B) 2 wt % S-P-CD, Fluka Lot # L 1348154. 
Separations were carried by CE-LIF as described in Chapter 2. A bare fused silica of 
dimensions 48 x 45 cm x 25 pm was used in reversed polarity (21 kV). BGE was 25 
mM phosphate adjusted to pH 2.15. Samples were prepared at 5 pm each amino acid in 
water and injected by vacuum (380 mbar) for Is.
While CBI-DL-glu is baseline resolved with both S-P-CD batches, CBI-DL-ser is not. 
Furthermore, the relative mobility of the various CBI-amino acids varies with different 
synthetic batches. The longer migration times shown in Figure 3 .IB would additionally 
suggest a lower average degree of substation (DS) of the sulfated CD mixture in this
particular synthetic batch since, under the conditions used, the migration time is related 
to the strength of interaction. This latter point is an important structural limitation of 
randomly substituted CDs since it drastically limits robustness of an analytical assay. 
Thirdly, CDs composed of isomeric mixtures can demonstrate marked reduction in 
overall resolving power since different cyclodextrin isomers within a given mixture may 
possess finite differences in complexation rates resulting in unavoidable kinetic band 
broadening (Vincent et al., 1997a). These numerous inconsistencies are entirely avoided 
with single isomer CDs.
Interestingly, CDs bearing sulfato groups on their primary and or secondary rim like 
those produced by Vigh and coworkers are not without some theoretical inclusion 
complexation limitations. For sulfato CDs the high charge density is in close proximity 
to the hydrophobic CD torus. It is reasonable that this could significantly limit the 
strength o f interactions with hydrophobic guest molecules especially for highly charged 
(> hepta-sulfato) CDs. CDs bearing sulfoalkyl groups on the primary and secondary rim 
have been produced through nonselective reaction chemistry (Rajewski, 1990). These 
highly charged sulfoethyl, sulfopropyl, and sulfobutyl CDs are isomeric mixtures 
characterized by an average degree of substitution (DS) (Rajewski, 1990; Tait et al., 
1992; Luna et al., 1996; Luna et al., 1997b). Zia et al. have proposed that an increase in 
binding potential can be realized for charged selectors by increasing the distance of the 
sulfonate groups from the CD torus (Zia et al., 1997). Thus for inclusion complex studies 
of progesterone and testosterone, a reduction o f the CD alkyl chain length from 
sulfobutyl ether to sulfopropyl ether decreased the complexation potential. It is quite
possible therefore that single isomer sulfoalkyl CDs may exhibit enhanced complexation 
potential compared to single isomer sulfato CDs, and this enhancement may be 
important for analytical chiral separations since increased selectivity may be realized. 
Despite advantages, selective sulfoalkylation to produce single isomer sulfoalkylated 
CDs has never been achieved.
This dissertation research describes the first synthesis and characterization for an entirely 
new family of single isomer cyclodextrins; heptasubstituted (3-CDs and hexasubstituted 
a-CDs with sulfoalkyl functional groups (Kirschner and Green, 2005; Kirschner et al., 
2008). New single isomer (3-CDs include heptakis(2,3-di-0-methyl-6-0- 
sulfopropyl)cyclomaltoheptaose potassium salt (KSPDM-(3-CD), heptakis(2,3-di-0- 
methyl-6-0-sulfobutyl)cyclomaltoheptaose potassium salt (KSBDM-(3-CD), and 
heptakis(2,3-di-0-ethyl-6-0-sulfopropyl)cyclomaltoheptaose potassium salt (KSPDE-(3- 
CD). The single isomer sulfoalkyl derivatives of (3-CD have been initially investigated as 
chiral resolving agents herein for CBI-amino acids including CBI-ser, CBI-asp, CBI-glu, 
and CBI-ala (see Chapter 4). New single isomer a-CDs include hexakis(2,3-di-0- 
methyl-6-0-sulfopropyl)cyclomaltohexaose potassium salt (KSPDM-a-CD), 
hexakis(2,3-di-0-methyl-6-0-sulfobutyl)cyclomaltohexaose potassium salt (KSBDM-a- 
CD), and hexakis(2,3-di-0-ethyl-6-0-sulfopropyl)cyclomaltohexaose potassium salt 
(KSPDE-a-CD).
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3.2 Materials and methods
3.2.1. General methods
All chemicals were purchased from Aldrich Chemical Co. (Milwaukee, WI) and were of 
the highest purity unless otherwise noted. Native P-CD, 18-crown-6, potassium hydride, 
and tert-butyldimethylsilyl chloride were purchased from Alfa Aesar (Ward Hill, MA). 
All native and derivatized CD intermediates were dried under reduced pressure in a 
vacuum oven at 70 °C for a minimum of 24 h before subsequent reaction. THF was 
freshly distilled from potassium metal in the presence of benzophenone. N-N- 
dimethylformamide (DMF) was stirred over CaH2, filtered, and distilled under reduced 
pressure (20 torr) at 57 °C onto activated 4 A 8-12  mesh sieves. Aluminum backed 
silica-60 TLC plates were used to monitor reaction products and chromatography 
eluents. Cyclodextrin spots were imaged by charring on TLC plates after dipping plate 
in a solution o f 2-5% concentrated sulfuric acid in ethanol and heating on a hot plate to 
>180 °C.
3.2.2. NMR spectral analysis
'H, 13C, gCOSY, gHSQC, and ROESY NMR spectra were acquired with a Varian 
Mercury 300 MHz FT-NMR instrument. The ROESY spectra were acquired with 16 
acquisitions in f2 and 200 increments in fl with a mixing time of 300 ms. Assignments 
were made by gCOSY and gHSQC techniques. Chemical shifts are reported relative to 
internal sodium 3-(trimethylsilyl)-l-propanesulfonic acid (TSP) for single isomer CDs 
and relative to solvent peaks for CD intermediates.
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3.2.3. Indirect UV detection CE
Indirect UV detection CE electropherograms of anionic cyclodextrins were obtained 
with an Agilent 3D CE system with diode array UV detector and with a Beckman 
P/ACE 2000 instrument as indicated. Separation buffer was 30 mM benzoic acid titrated 
to pH 6.0 with 0.1 M Tris base. CE conditions for P/ACE 2000 are as follows: 
wavelength, 254 nm; applied potential, 25 kV; injection, 22 mg/mL, 0.5 psi, 6 s 
injection. The analyses were performed in a bare, fused-silica capillary (Polymicro 
Technologies, Phoenix, AZ) o f 50 x 59.5 cm x 50 pm. CE conditions for Agilent were as 
follows: wavelength, 214nm; applied potential, 25 kV; injection 10 mg/mL, 0.5 psi 6 s 
injection. Capillary: 41.5 x 50.0 cm x 50 pm bare fused silica.
3.3 Synthesis and characterization
A general reaction scheme for the selective synthesis of sulfoalkylated cyclodextrins is 
given in Figure 3.2.
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X = 7. beta CD (1A) 
X = 6, alpha CD (IB)
Dry Pyridine (for I A) 
Dry DMF (for 1B)
H 6 / OSi(CH3)2C(CH3)3
H.O
CH jI or CH3CH2I 
NaH
Dry THF(CH 3I rxn) 
Dry DMF(CH3CH2I rxn)
X = 7. (2A) 
X = 6, (2B)
excess KH
excess 1,3-propane sultone (4A, 4B, 4C,4D) 
or
excess 1,4-butane sultone (4A, 4B)
3.6 equiv./hydroxyl 18-crown-6
Dry THF
X = 7, R = CH, 
X = 7, R = CHj, 
X = 6, R = CHj,
. R' = (CH2)3S03K+(5A) X = 6, R = C ^, R' = (C H ^ O jK *  (5D)
R' = (CH^SO j' K* (5B) X = 7, R= C^CH,, R' = (C ^ )3S 03K* (5E)
R' = (Cht)3SO,' K* (5C) X = 6, R = ChJCH,, R' = (CH2) 3SO,' K+ (5F)
OSi(CH3)2C(CH3)3V «/ H-0
X = 7. R = CH3 (3A)
X = 6, R = CH3 (3B)
X = 7, R = CH2CH3 (3C) 
X = 6, R = CH2CHa (3D)
methanol, reflux
X = 6, R = CH  (4B)
X = 7, R = CHCHa (4C) 
X = 6, R = CHCH (4D)
Figure 3.2. General reaction scheme for the selective synthesis of single isomer 
sulfoalkylated cyclodextrins. The final products are potassium salts and are labeled 
(5A)-(5F) depending on sulfoalkylation reagent, alkylation reagent, and a- verses P-CD.
A protection/deprotection strategy was required for regioselective synthesis of the 
primary (C-6) and secondary (C-2, C-3) hydroxyls to give single isomer selectively 
sulfoalkylated CDs. References for published procedures are given appropriately in 
sections 3.31-3.35 after a brief overview of the synthesis. After regioselective protection 
of the primary hydroxyls, the secondary hydroxyls were alkylated with either methyl 
iodide or ethyl iodide. The protected alkylated CDs were deprotected to give 2,3-di-O- 
alkyl-CDs. These CDs were then fully sulfoalkylated on the primary hydroxyl rim using 
the method developed and optimized as given in section 5.26.
Excess NH4F
3.3.1 Heptakis(6-0-te/*M)utyldimethylsilyl)cyclomaltoheptaose (2A) and Hexakis(6- 
0-terf-butyldimethylsilyl)cyclomaltohexaose (2B)
The C-6 primary hydroxyls of a-CD (1A) and P-CD (IB) were protected using tert- 
butyldimethylsilyl chloride (TBDMSiCl) according to a slight modification of the 
procedure described by Takeo for a-CD (Takeo et al., 1988) and P-CD (Takeo et al., 
1989). For P-CD derivatives the C-6 hydroxyls were reacted under N2 (g) with 1.5 
equiv./hydroxyl TBDMSiCl in anhydrous pyridine cooled to -  0 °C. The silylation 
reagent was added slowly and solution was kept at ~ 0 °C for 2 h then at room 
temperature overnight. For a-CD derivatives, the same procedure was used with the 
exception that anhydrous DMF replaced pyridine as reaction solvent. After 24 h the 
reaction was poured over ice water and the white precipitate that formed was filtered, 
washed successively with ice water, and dried in vacuo. The protected P-CD derivative 
could often be used without further purification. The nearly pure (based on TLC and 'H 
NMR) protected a-CD could be recrystallized from hot methanol/water (-95 %). A
I 1 1
similar recrystallization is possible for protected P-CD. H and C NMR spectra of the 
purified product are shown in Figure 3.3 and 3.4 for 2A and Figure 3.5 and 3.6 for 2B.
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Figure 3.3. 'H NMR of heptakis(6-0-tert-butyldimethylsilyl)cyclomaltoheptaose (2A)
in CDCI3.
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Figure 3.4. I3C NMR of heptakis(6-0-ter?-butyldimethylsilyl)cyclomaltoheptaose (2A) 
in CDC13.
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Figure 3.5. 'H NMR of hexakis(6-0-tert-butyldimethylsilyl)cyclomaltohexaose (2B) in
CDCI3.
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Figure 3.6. 13C NMR of hexakis(6-0-tert-butyldimethylsilyl)cyclomaltohexaose (2B) in 
CDCI3.
Full assignments o f 2A and of 2B were made based on comparison to literature values 
(Takeo et al., 1988; Takeo et al., 1989). The product NMR spectra matched well with 
literature and were utilized without further purification.
3.3.2 Heptakis(2,3-di-0-methyl-6-0-te/'/-butyldimethylsilyl)cyclomaltoheptaose 
(3A) and Hexakis(2,3-di-0-methyl-6-0-te/'f-butyldimethylsilyl)cyclomaltohexaose 
(3B).
The C-2 and C-3 secondary hydroxyls of 2A and 2B were methylated using excess 
methyl iodide and NaH according the procedure described by Takeo and colleagues 
(Takeo et al., 1988; Takeo et al., 1989). Conditions were the same for P-CD and a-CD 
derivatives. Briefly, regioselective methylation was achieved by dissolving 2A or 2B in
anhydrous THF under N2 and slowly adding 3 equiv./hydroxyl NaH (60 % dispersion in 
mineral oil, previously washed with hexane and dried under N2) followed by 5 
equiv./hydroxyl methyl iodide. The reaction was stirred for 24 h at RT. Excess NaH 
was quenched with methanol after 24 h and THF was removed by rotovaporization. The 
resultant material was partitioned between CH2CI2 and water, extracted 3X, dried over 
Na2SC>4, and concentrated. 'H and 13C NMR analysis is shown in Figures 3.7 and 3.8 for 
3A and 3.9 and 3.10 for 3B.
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Figure 3.7. ’H NMR of heptakis(2,3-di-0-methyl-6-0-tert-butyldimethylsilyl)- 
cyclomaltoheptaose (3A) in acetone-d6.
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Figure 3.8. 13C NMR of heptakis(2,3-di-0-methyl-6-0-fert-butyldimethylsilyl)- 
cyclomaltoheptaose (3 A) in acetone-d6.
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Figure 3.9. ‘H NMR of hexakis(2,3-di-0-methyl-6-0-ter/-butyldirnethylsilyl)- 
cyclomaltohexaose (3B) in acetone-d6.
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Figure 3.10. 13C NMR of hexakis(2,3-di-0-methyl-6-0-tert-butyldimethylsilyl)- 
cyclomaltohexaose (3B) in acetone-d6.
Full assignments o f 3A and of 3B were made based on comparison to literature values. 
The product spectra matched literature and were utilized without further purification.
3.3.3 Heptakis(2,3-di-0-ethyl-6-0-tert-butyldimethylsilyl)cyclomaltoheptaose (3C) 
and Hexakis(2,3-di-0-ethyl-6-0-ter/-butyldimethylsilyl)cyclomaltohexaose (3D)
The C-2 and C-3 secondary hydroxyls of 2C and 2D were ethylated using excess ethyl 
iodide and NaH according to an adaptation of the procedure described by Takeo and 
colleagues (Takeo et al., 1988; Takeo et al., 1989). Conditions were the same for P-CD 
and a-CD derivatives. An identical synthetic procedure was used as for methylation
with the exception that anhydrous DMF was used instead of THF. After reaction for 24 
h, the excess hydride was quenched and the product was poured over ice water and the 
white precipitate that formed was filtered, washed successively with ice water, and dried
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in vacuo. TLC of the resultant product indicated a mixture of products which was 
verified by ’H NMR.
The product was purified by normal phase chromatography using a mobile phase 
consisting of hexane and ethyl acetate (7:1). 'H NMR analysis of the purified material is 
shown in Figure 3.11 for 3C and Figure 3.12 for 3D.
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Figure 3.11. 'H NMR of heptakis(2,3-di-0-ethyl-6-0-/er/-butyldimethylsilyl)- 
cyclomaltoheptaose (3C) in CDCI3.
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Figure 3.12. H NMR of hexakis(2,3-di-0-ethyl-6-0-ter/-butyldimethylsilyl)- 
cyclomaltohexaose (3D) in CDCI3.
In 3C the presence o f mineral oil contaminant from the NaH dispersion was apparent in 
the purified product even after chromatography. The mineral oil was noninvasive for the 
follow up reaction and thus not removed from 3C. The Assignments of the 'H NMR 
spectrum for CD peaks of 3C and 3D were made based on comparison to literature 
values. The materials were used without further purification.
3.3.4 Heptakis(2,3-di-0-methyl)cyclomaltoheptaose (4A) and Hexakis(2,3-di-0- 
methyl)cyclomaltohexaose (4B)
O-desilylation of the C-6 protecting group of 3A and 3B was accomplished using a 
modification o f the approach described by Takeo and colleagues (Takeo et al., 1988; 
Takeo et al., 1989). Briefly, the CD derivative was dissolved in methanol with 7 
equiv./hydroxyl NH4F instead of tetrabutylammonium fluoride. The reaction was 
refluxed for at least 48 h until TLC (4:1 Chloroform: methanol) indicated successful O- 
desilylation as indicated by a significant decrease in the retention factor compared to 
starting material. The reaction was stopped by cooling to room temperature and 
rotovaporizing methanol. The product was partitioned between CH2CI2 and water, and 
then extracted 3X, and concentrated. 'H NMR of the crude product suggested that 
nearly complete O-desilylation was achieved. The crude material was purified by flash 
chromatography using 4:1 chloroform methanol mobile phase. 'H and l3C NMR 
analysis o f the purified material is shown in Figure 3.13 and 3.14 for 4A and Figure 3.15 
and 3.16 for 4B.
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Figure 3.13. 'H NMR of heptakis(2,3-di-0-methyl)cyclomaltoheptaose (4A) in acetone-
d6.
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Figure 3.14. 13C NMR of heptakis(2,3-di-0-methyl)cyclomaltoheptaose (4A) in
acetone-d6.
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Figure 3.15. 'H NMR of hexakis(2,3-di-0-methyl)cyclomaltohexaose (4B) in acetone- 
d6.
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1 TFigure 3.16. C NMR of hexakis(2,3-di-0-methyl)cyclomaltohexaose (4B) in acetone- 
d6.
Full assignments of 4A and 4B could be made and are consistent with literature values. 
The product was used without further purification.
3.3.5 Heptakis(2,3-di-0-ethyl)cyclomaltoheptaose (4C) and Hexakis(2,3-di-0- 
ethyl)cyclomaltohexaose (4D)
O-desilylation of the C-6 protecting group of 3C and 3D was accomplished using an 
identical approach as indicated for the synthesis o f 4A and 4B. 'H  NMR of the crude 
product suggested that nearly complete O-desilylation. The crude material was purified 
by flash chromatography using chloroform and methanol (8:1 —> 4:1
chloroforrmmethanol). ]H and l3C NMR analysis o f the purified material is shown in 
Figure 3.17 and 3.18 for 4C and Figure 3.19 and 3.20 for 4D.
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Figure 3.17. 'H NMR of heptakis(2,3-di-0-ethyl)cyclomaltoheptaose (4C) in CDCI3.
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Figure 3.18. I3C NMR of heptakis(2,3-di-0-ethyl)cyclomaltoheptaose (4C) in CDCI3 .
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Figure 3.19. 'H NMR of hexakis(2,3-di-0-ethyl)cyclomaltohexaose (4D) in CDCI3 .
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Figure 3.20. 13C NMR of hexakis(2,3-di-0-ethyl)cyclomaltohexaose (4D) in CDCI3.
Full assignments o f 4C and 4D were made and are consistent with literature values. The 
product was used without further purification.
3.3.6 Heptakis(2,3-di-0-methyl-6-0-sulfopropyl)cyclomaltoheptaose (5A) and (5A’)
Full regioselective sulfopropylation of the C-6 primary hydroxyls of 4A was 
accomplished using 1,3-propanesultone in THF with KH/18-crown-6 as base. The 
reaction was carried out on mg and gram scales with a typical scaled down example 
given here.
Compound 4A (0.200 g, 0.152 mmol) was added to 35 mL o f anhydrous THF under 
nitrogen, followed by the slow addition o f 0.300 g (7.48 mmol) o f KH. After stirring at 
room temperature for 15 min, 1.02 g (3.86 mmol) o f 18-crown-6 was slowly added, and
the reaction was allowed to stir for 30 min. 1,3-Propanesultone (0.520 g, 4.26 mmol) 
was dissolved in 4 mL of anhydrous THF and introduced dropwise over 30 min. The 
reaction was stirred at room temperature for 24 h. Excess KH was decomposed by 
cooling the reaction to 0 °C and slowly adding methanol. The solvents were removed by 
rotary evaporation at 70 °C, and the brown oil was dried in a vacuum oven at 70 °C for 1
h. Dry acetone (80 mL) was added to the oil, and the precipitate that formed was 
transferred to centrifuge tubes where successive acetone washes, followed by 
centrifugation removed all 18-crown-6 yielding an off-white solid. The solid was blown 
dry with N2 gas, dissolved in water, and neutralized with 1 M HC1. Compound 5A was 
purified by ultrafiltration through an Amicon Model 8310 Stirred Cell Ultrafiltration 
Unit (Millipore Corp., Billerica, MA) with a 1000 MWCO regenerate cellulose (RC) 
membrane to give, after concentration, 0.24 g (0.098 mmol, 61%). 'H NMR (300 MHz, 
D20): 8 5.27 (H -l), 3.85 (H-4), 3.71 (H-3), 3.36 (H-2), 3.85 (H-5), 3.66 (OCH2), 3.95,
3.73 (H-6), 3.63 (OCH3), 3.53 (OCH3), 2.99 (CH2S), 2.05 (C //2CH2S). 13C NMR (75 
MHz, D20): 5 100.5 (C-l), 80.7 (C-4), 83.6 (C-3), 83.0 (C-2), 73.6 (C-5), 72.4 (OCH2),
71.6 (C-6), 62.7 (OCH3), 60.9 (OCH3), 51.1 (CH2S), 27.5 (C //2CH2S). Anal. Calcd for 
K7C77Hi33 056S7-7H20 : C, 35.86; H, 5.74; S, 8.70. Found: C, 36.08; H, 5.45; S, 8.52. 
Inverse detection CE: Mean DS (6.9).
Partial regioselective sulfopropylation of C-6 primary hydroxyls of 4A was 
accomplished to give 5A’ by following the same procedure as described above with 
omission of 18-crown-6. The product was worked up in an identical fashion. Yield 69%.
1 0 1
Inverse detection CE was employed to monitor the reaction as well as assess the 
average degree o f substitution of the final product (Tait et al., 1992). This has become a 
popular approach for analysis of isomeric purity o f sulfated CDs (Tait et al., 1992; Luna 
et al., 1996; Luna et al., 1997a; Cai and Vigh, 1998; Maynard and Vigh, 2000; Zhu and 
Vigh, 2000; Chen et al., 2001; Maynard and Vigh, 2001; Busby et al., 2003; Li and 
Vigh, 2003; Zhu and Vigh, 2003; Li and Vigh, 2004b, a; Busby and Vigh, 2005a, b). 
Using this method, however, Luna et al. have demonstrated that the molar response 
factor o f sulfobutyl ether-P-CDs (SBE-P-CDs) increases with degree of substitution 
( D S c e ) (Luna et al., 1997a). Uncorrected integration of the CD bands will overestimate 
DS for an SBE-P-CD ( D S c e  4.7 from CE compared to D S ea  3.6 from elemental 
analysis). However, the results presented here show much better agreement between 
D S ce  and D S ea  for these selectively modified cyclodextrins (vide infra). Typical inverse 
detection CE electropherograms of the purified reaction product 5A’ obtained without 
18-crown-6 show a mixture of multiply charged derivatives centered on DS 4 ( D S ce  4.1) 
with 8% of the product containing CDs with DS 5 (Figure 3.21).
103
T im e  (s)
Figure 3.21. Indirect UV detection of heptakis(2,3-di-0-methyl-6-0- 
sulfopropyl)cyclomaltoheptaose (KSPDM-P-CD). The upper inverse detection 
electropherogram shows the product from the reaction without 18-crown-6 while the 
bottom electropherogram is the product from the reaction using 18-crown-6. The 
positive peak in both electropherograms is potassium ion from the CD-potassium salt. 
The inverse band at -180 s represents electroosmotic flow. The numbers beside the top 
electropherogram are the different CD charged isomers which are separated uniformly 
due to a systematic change in their size/charge with increasing degree of substitution. 
BGE: 30 mM benzoic acid titrated to pH 6.0 with 0.1 M Tris base. For additional 
conditions see Section 3.23
Elemental analyses (C, H, S) are consistent with a DSea of 3.8. In comparison, the 
electropherogram of the product 5A from the reaction incorporating 18-crown-6 
indicates a predominance of DS 7 (DSce 6.9), with less than 10% of the mixture 
containing DS <7 (Figure 3.21). Elemental analysis is consistent with a DSea of 6.7 in 
comparison.
The 'H NMR spectrum of the purified 5A’ for the reaction omitting 18-crown-6 is 
shown in Figure 3.22.
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Figure 3.22. 'H NMR spectrum of KSPDM-P-CD (5A’), DSCe 4.1 in D20 .
Poorly resolved H -l anomeric signals typical of heterogeneous CD mixtures are 
observed. A fully substituted symmetric CD should show 'H NMR integration ratio of 
1:2 for the anomeric H -l to sulfopropyl methylene protons, respectively. Integration of 
methylene units o f the sulfopropyl chain (2.02, 2.97 ppm) in comparison to the anomeric 
signal (5.18-5.38 ppm) suggests a low DS. The poor resolution in this spectrum is 
undoubtedly due to the mixture of multiply charged anionic cyclodextrins that result 
from incomplete substitution of the primary hydroxyl groups. Additionally, a variety of
positional isomers are possible for degrees of substitution 2-5, which further adds to the 
heterogeneity of the product.
Due to the poor resolution of the 'H NMR of 5A’, the progress o f the reaction under 
alternative conditions was monitored by 'H NMR in addition to inverse detection CE. 
An aliquot o f reaction mixture (-0.5% by volume) was added to 1 mL D2O to 
decompose hydride. THF was removed by drying in vacuo at 70 °C for 15 min.
O f particular note in the development of the synthesis using 18-crown-6 was the 
generation of a viscous layer in the reaction vessel that immediately deposited after a 
threshold level o f propane sultone was added to the reaction mixture. This gummy layer 
only formed when the reaction was carried out in the presence o f 18-crown-6. Using *H 
NMR reaction monitoring and slowly adding sultone, the NMR of the gummy layer 
washed with THF immediately after it formed is shown in Figure 3.23 prior to addition 
of a molar excess o f sultone.
105
106
f l  (ppm)
Figure 3.23. 'H NMR reaction monitoring spectrum of (5A) from reaction using 18- 
crown-6 immediately after formation of gummy layer but prior to addition of excess 
propane sultone. The spectrum is representative of a sample obtained from the gummy 
layer formed in THF after rinsing with fresh THF, briefly drying, and decomposing 
hydride with NMR solvent.
Clearly based on resolved coupling the degree of substitution is approaching that of the 
single isomer (DS 7) product. Notably, the peak at 5.27 ppm is characteristic of the fully 
substituted Heptakis product 5A whereas the peak at 5.23 ppm may be due to the 
hexakis (DS 6) product (latter not verified). This substitution pattern does not appear to 
have changed significantly after further reaction (data not shown). The lack of excess 
sultone is apparent in this spectrum due to a lack of sultone byproduct peaks. An obvious
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impurity in the reaction mixture is 18-crown-6 represented by a singlet at 3.52 ppm and 
residual THF at 1.83 ppm.
One clear conclusion from comparison o f Figure 3.23 with Figure 3.22 is that the 
reaction in the presence o f 18-crown-6 is very rapid, since the sample from Figure 30 
was obtained during the course of adding the final reagent. After 3 h following addition 
of 3 equiv./ hydroxyl excess sultone in this reaction, an additional aliquot of the gummy 
layer was obtained and a single peak showing typical well resolved coupling was noted 
(Figure 3.24).
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Figure 3.24. ’H NMR reaction monitoring spectrum of (5A) from reaction using 18- 
crown-6 after addition o f excess 1,3-propane sultone. The spectrum is representative of 
a sample obtained from the gummy layer formed in THF.
Clearly excess sultone pushed the reaction to completion. It is possible that this approach 
could be used to optimize a minimum amount of excess sultone required for full
sulfoalkylation. This would simplify sample workup. .............. ....  .. ............... ........
Acetone extraction and ultrafiltration steps were required for impurity removal and 
representative 'H NMR spectra of the extract and ultrafiltrate eluent are shown in Figure 
3.25.
108
A)
JJ
Acetone Extract of (5A)
5.4 4.9
B)
4.4 3.9 3.4 2.9 2.4 1.9
f l  (ppm)
Ultrafiltration Eluent of (5A)
UL
5.4 4.9 4.4 3.9 3.4 2.9 2.4 1.9
f l (ppm)
Figure 3.25. 'H NMR spectra of acetone and ultrafiltration waste showing selective 
removal of impurities. A) Acetone extract and B) Ultrafiltrate eluent for the purification 
of heptakis(2,3-di-0-methyl-6-0-sulfopropyl)cyclomaltoheptaose (5A). The NMR of the 
acetone extract shows the characteristic 18-crown-6 singlet while the ultrafiltration 
waste shows predominately sultone byproducts. Careful examination of the baseline in 
the region of 3.3-5.3 ppm did not reveal the presence of any characteristic cyclodextrin 
peaks in either spectrum.
It is clear that acetone extraction primarily removes 18-crown-6 without concomitant 
loss of CD as indicated by a lack of CD signal in the 'H  NMR spectrum. In addition, 
ultrafiltration removes sultone products and possibly some 18-crown-6 without loss of 
CD. It should be mentioned that higher levels of 18-crown-6 (>2.4 equiv./hydroxyl) 
during the reaction make purification more difficult by simple acetone extraction. 
Indeed, when 3.6 equiv./hydroxyl of 18-crown-6 is used during reaction, acetone 
extraction resulted in a significant loss of anionic CD into the acetone supernatant. 
Ultrafiltration is additionally a poor choice for removal of 18-crown-6 as attempts at 
extensive ultrafiltration without acetone extraction still resulted in the characteristic 18- 
crown-6 signal in the 'H  spectrum. For this reason 18-crown-6 was removed by an 
alternative procedure for other single isomer CDs during product workup.
In contrast to the poorly resolved 'H  signals for the spectrum of 5A’ shown in Figure 
3.22, the 'if  NMR spectrum of purified 5A from the reaction in the presence of 18- 
crown-6 ( D S ce  6.9) reveals a high degree of symmetry; especially sharp peaks with 
well-defined couplings for H-l at 5.27 ppm (d, J 3.3 Hz) and H-2 at 3.36 ppm (dd J 3.3,
9.9 Hz) are observed (Figure 3.26).
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Figure 3.26. 'H  NMR spectrum of pure heptakis(2,3-di-0-methyl-6-0-sulfopropyl)- 
cyclomaltoheptaose (5A), DSce 6.9 in D2O.
In addition, integration of the sulfopropyl methylene proton signals is in better 
agreement with full substitution at the C-6 primary hydroxyl sites (ratio -1:2 for H-l at 
5.27 ppm and -C //2S at 2.98 ppm). From CE analysis, this product consists of -93%  of 
the highly symmetric heptakis-(KSPDM)-P-CD (5A) and -7%  of hexakis product 
(Figure 3.21). The 13C NMR spectrum is given in Figure 3.27.
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Figure 3.27. I3C NMR spectrum of pure heptakis(2,3-di-0-methyl-6-0-sulfopropyl)- 
cyclomaltoheptaose (5A), D S ce  6.9 in D2O.
The use of DMSO-d6 as solvent can provide additional lH NMR diagnostic information 
on the degree of sulfoalkylation of the C-6 primary hydroxyls. 'H NMR spectroscopy 
with DMSO-d6 can be used for detecting the presence o f unreacted primary hydroxyl 
groups. This is due to the ability of DMSO to significantly reduce the rate of exchange 
of hydroxyl protons. The spectrum of a sulfopropylated product obtained with 1.2 
equivalents/ hydroxyl 18-crown-6 ( D S ce  6.7) is shown in Figure 3.28.
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Figure 3.28. 'H NMR spectrum in DMS0-d6 of heptakis(2,3-di-0-methyl-6-0- 
sulfopropyl)cyclomaltoheptaose (5A). Product is from reaction using 1.2 equiv./ 
hydroxyl 18-crown-6. The triplet at 4.34 ppm is representative o f unreacted C-6 primary 
hydroxyl.
This spectrum reveals well-resolved H-l and H-2 resonances, but the weak triplet at 4.36 
ppm is indicative of the presence of unsubstituted primary hydroxyl. This triplet 
remained undetected in the product with D S ce  6.9.
Increasing amounts of 18-crown-6 were required to achieve a high degree of substitution 
as shown in Table 3.1.
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Table 3.1. Effect of 18-crown-6 in reaction medium on the average degree of 
substitution of KSPDM-P-CD, (5A). Percent in mixture and average DS was determined 
by inverse detection CE.
mmol 18-crown-6 IUO
COQ No. of added Percent in
mmol OH of (4A) sulfopropyl groups mixture
0 4.1 1 0.1
2 3.9
3 21.6
4 37.8
5 28.6
6 7.1
7 0.9
1.2 6.5 5 6.5
6 40.5
7 53
2.4 6.7 5 1
6 28.9
7 70.1
3.6 6.9 6 7
7 93
More than 3.5 equivalents of 18-crown-6, based on the number OH groups, is required to 
achieve a DSce of 6.9 in 24 h at room temperature. From a practical standpoint, this 
amount o f 18-crown-6 seems excessive, but the crown ether is recovered from the 
acetone wash (Figure 3.25), and can possibly be purified and reused if necessary. It is 
noteworthy that 18-crown-6 seems to be much more critical than time to the success of 
the reaction. CE and NMR of aliquots taken during the course of the reaction indicates 
the reaction is essentially complete within 1 h reaction time, with no detectable change 
during the next 23 h. Addition of more crown ether after 24 h then results in a rapid 
increase in the degree o f substitution. 18-Crown-6 is known to effectively complex to 
potassium ion in THF. By doing so, the solubility o f the increasingly anionic KSPDM-P-
CD 5A’ species (DS 1-7) in THF may be enhanced during the course of the reaction, 
leading to a more substituted product. The 18-crown-6-potassium complex may also 
result in a more reactive cyclodextrin oxyanion, especially if the crown ether induces 
some degree of potassium cation-oxyanion separation in THF. For some nucleophilic 
ring-opening reactions, crown ether-metal complexes also stabilize the developing 
negative charge on departing leaving group (Gobbi et al., 1995; Albanese et al., 2001). 
The precise role of the 18-crown- 6 in our reaction requires further investigation.
During the development o f the sulfoalkylation reaction, several alternative approaches to 
18-crown-6 were investigated but not successful. The avoidance o f 18-crown-6 would be 
beneficial by minimizing product workup and thus maximizing recovery of KSPDM-P- 
CD. Polar aprotic solvents are beneficial for SN2 reactions. Reactions carried out in the 
absence of 18-crown-6 in anhydrous DMF did not provide a highly substituted product 
based on 'H NMR despite the increased polarity of DMF compared with THF. 
Alternatively, Monflier et al. demonstrated that repetitive additions of excess 1,3- 
propane sultone and KH over several days was necessary for significant sulfoalkylation 
of calixerene derivatives (Hapiot et al., 2004). Attempts at repetitive additions of these 
reagents in THF, however, did not yield highly substituted products.
3.3.7 General procedure for the synthesis of potassium salts of (5B), (5C), (5D), 
(5E), (5F)
Full regioselective sulfopropylation of the C-6 primary hydroxyls o f 4B, 4C, and 4D and 
sulfobutylation of 4A and 4B was accomplished using 1,3-propane sultone and 1,4-
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butane sultone respectively in THF with KH/18-crown-6 as base. These reactions were 
scaled at 1-2 g of CD starting material. The same procedure as described above for the 
synthesis of 5A was used. An alternative product purification strategy is described for 
these CDs and is recommended over the approach described above. After reaction for 
24 h, the excess KH was reacted with methanol to quench reaction, and the mixture was 
transferred to a round bottom flask for rotary evaporization of methanol and THF. The 
solid was dissolved in 30 mL of water. The aqueous solution was then passed through a 
column o f acidic cation exchange resin (Dowex 50W-X8, 25 mm dia x 350 mm length). 
After ion exchange, the acid form of the CD in water was extracted three times with 
methylene chloride, discarding the methylene chloride layer which contains almost 
exclusively 18-crown-6. The use of acidic ion exchange to form the CD-persulfonic acid 
allowed for maximal recovery of the CD as compared to acetone extraction when crown 
ether is in high molar excess. A 'H NMR spectrum of the acid form of SPDE-P-CD (5E) 
after methylene chloride extraction but prior to further workup is shown in Figure 3.29.
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Figure 3.29. !H NMR spectrum obtained for the crude acid o f heptakis(2,3-di-0-ethyl- 
6-0-sulfopropyl)cyclomaltoheptaose (5E) in D2O. The spectrum demonstrates that ion 
exchange successfully removes 18-crown-6 (absence of a singlet, 3.52 ppm). The H-l 
anomeric proton shows especially sharp coupling when the CD-acid is dissolved in D2O.
While sultone byproduct peaks are abundant in this spectrum, a well resolved H-l 
anomeric doublet is observed for the acid form of the CD. Furthermore, a lack of 
significant signal at 3.52 ppm demonstrates that 18-crown-6 was successfully removed. 
Caution is recommended during ion exchange against prolonged formation of the acid 
form of the CD which may irreversibly decompose in solution if kept for an extended 
period. The acid form seems sufficiently stable for at least 3 h, however. After acid ion 
exchange, the CDs were neutralized with excess KHCO3 (~10 g). The aqueous solution 
was rotary evaporated to remove trace amounts of methylene chloride, and then
subjected to continuous ultrafiltration using an Amicon Model 8400 Stirred Cell 
Ultrafiltration Unit. The purified CD concentrate was rotary evaporated to remove most 
of the water. The resulting solid was then dried in a vacuum oven (70 °C) to a constant 
mass. In the case o f 5C and 5D, the purification was performed with Regenerated 
Cellulose 1000 MWCO ultrafiltration membranes. Lower yields obtained for these 
cyclodextrins were typical using these membranes compared with cellulose acetate 500 
MWCO membranes used for 5B, 5E, and 5F. Samples were analyzed by 'H ,13C, 
gCOSY, and gHSQC NMR spectroscopy, elemental analysis, inverse detection capillary 
electrophoresis and, for some CDs, matrix-assisted laser desorption ionization/time of 
flight mass spectrometry (MALDI/TOF MS). Yields are given for last step in synthesis.
3.3.8 Characterization of heptakis(2,3-di-0-methyl-6-0-sulfobutyl)cyclomaltohep- 
taose (5B).
Yield, 98%; 'H  NMR (300 MHz, D20): 5 5.19 (H-l), 3.70 (H-4), 3.57 (H-3), 3.26 (H- 
2), 3.73, (H-5), 3.49 (OCH2), 3.83, 3.61 (H-6), 3.53 (OCH3), 3.43 (OCH3), 2.85 (CH2S), 
1.65 (C //2CH20 ), 1.72 (C //2CH2S). 13C NMR (75 MHz, D20 ): 6 101.8 (C-l), 85.0 (C-4),
84.2 (C-3), 82.3 (C-2), 74.8 (C-5), 74.8 (OCH2), 73.0 (C-6), 64.1 (OCH3), 62.1 (OCH3),
54.9 (CH2S), 31.9 (C //2CH20 ), 25.3 (Cif2CH2S). Anal. Calcd for K yC g^uyO seS y^O : 
C, 37.68; H, 6.06; S, 8.38. Found C, 37.42; H, 6.06; S, 8.86. Inverse detection CE: Mean 
ds (6.8).
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Figure 3.30. 'H  NMR spectrum of heptakis(2,3-di-0-methyl-6-0-sulfobutyl)- 
cyclomaltoheptaose (5B), D S ce  6.8 in D2O.
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Figure 3.31. 13C NMR spectrum of heptakis(2,3-di-0-methyl-6-0-sulfobutyl)-
cyclomaltoheptaose (5B), D S c e  6.8 in D 2O.
Figure 3.32. gCOSY NMR spectrum of heptakis(2,3-di-0-methyl-6-0-sulfobutyl)- 
cyclomaltoheptaose (5B), DSCe 6.8 in D20 .
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Figure 3.33. gHSQC NMR spectrum of heptakis(2,3-di-0-methyl-6-0-sulfobutyl)- 
cyclomaltoheptaose (5B), D S ce  6.8 in D2O.
3.3.9 Characterization of hexakis(2,3-di-0-methyl-6-0-sulfopropyl)cyclomaltohex- 
aose (5C)
Yield, 55.0%; 'H N M R  (300 MHz, D20): 5 5.10 (H-l), 3.69 (H-4), 3.50 (H-3), 3.19 (H- 
2), 3.74 (H-5), 3.53 (OCH2), 3.84, 3.61 (H-6), 3.54 (OCH3), 3.42 (OCH3), 2.92 (CH2S), 
1.97 (C772CH2S). I3C NMR (75 MHz, D20): 5 101.5 (C-l), 83.4 (C-4), 83.1 (C-3), 82.8 
(C-2), 72.9 (C-5), 71.6 (OCH2), 70.8 (C-6), 62.9 (OCH3), 59.5 (OCH3), 50.3 (CH2S),
26.6 (C //2CH2S). Anal. Calcd for KeQeHmCUgSe- 6H20 : C, 35.86; H, 5.74; S, 8.70.
Found C, 35.98; H, 5.63; S, 8.71. Inverse detection CE: Mean ds (6.0). MS: Calcd for 
K7C66H 114O48S6 + 2142, Found 2141.
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Figure 3.34. !H NMR spectrum of hexakis(2,3-di-0-methyl-6-0-sulfopropyl)
cyclomaltohexaose (5C), D S c e  6.0 in D2O.
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Figure 3.35. 13C NMR spectrum of hexakis(2,3-di-0-methyl-6-0-sulfopropyl)
cyclomaltohexaose (5C), D S ce  6.0 in D2O.
Figure 3.36. gCOSY NMR spectrum of hexakis(2,3-di-0-methyl-6-0-sulfopropyl) 
cyclomaltohexaose (5C), D S ce  6.0 in D20 .
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Figure 3.37. gHSQC NMR spectrum of hexakis(2,3-di-0-methyl-6-0-sulfopropyl) 
cyclomaltohexaose (5C), D S ce  6.0 in D2O.
3.3.10 Characterization of hexakis(2,3-di-0-methyl-6-0-sulfobutyl)cyclomalto- 
hexaose (5D)
Yield, 54.6%; 'H NMR (300 MHz, D20): 5 5.12 (H-l), 3.72 (H-4), 3.52 (H-3), 3.22 (H- 
2), 3.75, (H-5), 3.59, 3.49 (OCH2), 3.87, 3.61 (H-6), 3.57 (OCH3), 3.43 (OCH3), 2.88 
(CH2S), 1.68 {CH2CH20 ), 1.75 (C //2CH2S). 13C NMR (75 MHz, D20): 5 101.6 (C-l),
83.5 (C-4), 83.1 (C-3), 82.8 (C-2), 73.0 (C-5), 72.8 (OCH2), 70.9 (C-6), 62.8 (OCH3),
59.6 (OCH3), 52.9 (CH2S), 29.8 (CH2CH20 ), 23.3 (CH2CH2S). Anal. Calcd for 
K6C72H 126 0  48S6- 6H20 : C, 37.68; H, 6.06; S, 8.38. Found C, 38.18; H, 6.21; S, 8.98. 
Inverse detection CE: Mean ds (5.8).
Figure 3.38. 'H  NMR spectrum of hexakis(2,3-di-0-methyl-6-0-sulfobutyl) 
cyclomaltohexaose (5D), D S ce  5.8 in D2O.
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Figure 3.39. I3C NMR spectrum of hexakis(2,3-di-0-methyl-6-0-sulfobutyl) 
cyclomaltohexaose (5D), D S c e  5.8 in D2O.
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Figure 3.40. gCOSY NMR spectrum of hexakis(2,3-di-0-methyl-6-0-sulfobutyl)
cyclomaltohexaose (5D), DSce 5.8 in D2O.
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Figure 3.41. gHSQC NMR spectrum of hexakis(2,3-di-0-methyl-6-0-sulfobutyl) 
cyclomaltohexaose (5D), D S ce  5.8 in D2O.
3.3.11 Characterization of hexakis(2,3-di-0-ethyl-6-0-sulfopropyl)cyclomalto- 
hexaose(5E)
Yield, 86.5%; ‘H NMR (300 MHz, D20): 5 5.03 (H-l), 3.85, 3.68 (OC//2CH3), 3.57 
(OC//2CH3), 3.83, 3.45 (H-6), 3.65 (H-5), 3.42, 3.54 (OCH2), 3.67 (H-3, H4), 3.24 (H- 
2), 2.82 ( CH2S), 1.88 (C //2CH2S). 1.08 (2 C //2CH20). 13C NMR (75 MHz, D20): 8 
100.0 (C-l), 82.0 (C-4), 80.5 (C-3), 79.8 (C-2), 73.4 (C-5), 72.0 (OCH2), 71.5 (C-6),
70.8 (OC//2CH3), 69.3 (OC//2CH3), 50.5 (CH2S), 26.9 (C //2CH2S), 17.2 (CH3), 17.1 
(CH3). Anal. Calcd for K ^ H ^ C ^ S e -  6H20 : C, 39.38; H, 6.36; S, 8.09. Found C,
38.93; H, 6.27; S, 7.88. Inverse detection CE: Mean ds (6.0). MS Calcd for 
K7C78H 138O48S6 + 2310 Found 2309.
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Figure 3.42. ’H NMR spectrum of hexakis(2,3-di-0-ethyl-6-0-sulfopropyl)
cyclomaltohexaose (5E), D S c e  6.0 in D2O.
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Figure 3.43. I3C NMR spectrum of hexakis(2,3-di-0-ethyl-6-0-sulfopropyl)
cyclomaltohexaose (5E), D S ce  6.0 in D2O.
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Figure 3.44. gCOSY NMR spectrum of hexakis(2,3-di-0-ethyl-6-0-sulfopropyl)
cyclomaltohexaose (5E), D S c e  6.0 in D2O.
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Figure 3.45. gHSQC NM R spectrum o f hexakis(2,3-di-0-ethyl-6-0-sulfopropyl) 
cyclomaltohexaose (5E), D S c e  6 .0  in D2O.
3.3.12 Characterization of heptakis(2,3-di-0-ethyl-6-0-sulfopropyl)cyclomaltohep- 
taose(5F)
Yield, 95.4%; 'H NM R (300 MHz, D20): 5 5.27 (H-l), 3.85, 3.89, 4.04 (OC//2CH3), 
3.80 (OC//2CH3), 4.04, 3.70 (H-6), 3.86 (H-5), 3.64, 3.74 (OCH2), 3.85 (H-3), 3.78 (H- 
4), 3.44 (H-2), 3.03 ( CH2S), 2.09 (C//2CH2S). 1.29 (2 CH3). 13C NM R (75 MHz, D20): 
□  100.8 (C-l), 82.5 (C-4), 81.4 (C-3), 80.1 (C-2), 73.9 (C-5),' 72.5 (OCH2), 71.6  (C-6),
7 1.5  (OC//2CH3), 69.8 (OC//2CH3), 51 . 1  (CH2S), 27.4 (CH2CH2S), 17.8, 17.6 (2 CH3). 
Anal. Calcd for K 7C9iHi6i056Sr7H20 : C, 39.38; H, 6.36; S, 8.09. Found C, 39.33; H,
6.23; S, 8.28. Inverse detection CE: Mean ds (6.8). MS: Calcd for K.8C91H 161O56S7 + 
2688, Found 2688.
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Figure 3.46. ’H NMR spectrum of heptakis(2,3-di-0-ethyl-6-0-sulfopropyl)
cyclomaltoheptaose (5F), DSce 6.8 in D2O.
135
~i--- 1--- 1--- '--- r~
84 82 80 78 76 74 72 70 68f l  (ppm)
18 17,f l  (ppm).
105 95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0 -5f l  (ppm)
Figure 3.47. 13C NMR spectrum of heptakis(2,3-di-0-ethyl-6-0-sulfopropyl)
cyclomaltoheptaose (5F), D S ce  6.8 in D2O.
Figure 3.48. gCOSY NMR spectrum of heptakis(2,3-di-0-ethyl-6-0-sulfopropyl) 
cyclomaltoheptaose (5F), DSce 6.8 in D20 .
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Figure 3.49. gHSQC NMR spectrum of heptakis(2,3-di-0-ethyl-6-0-sulfopropyl) 
cyclomaltoheptaose (5F), D S ce  6.8 in D2O.
3.4 Investigation of inclusion complex formation
One o f the advantages of single isomer cyclodextrins like those produced here is that the 
'H resonances in the NMR spectrum are confidently assigned which allows for detailed 
study on the inclusion complex formed in solution between a hydrophobic guest and the 
CD. Upon binding, complex induced chemical shifts (CICS) can be pronounced for both 
guest and host 'H resonances. Of particular note for CD inclusion complex studies are 
the H-3 and H-5 hydrogens on the glucose units which are directed facing the interior of 
the CD cavity and can show significant through space interactions (Nuclear Overhauser 
Effects, NOEs) with nearby hydrogens on the included guest molecule. Inclusion 
complex NMR data can be important for determining the orientation as well as the 
direction of approach of a guest molecule with the CD host. For large molecular weight 
(>2000 Da) species, the 2-D rotating frame NOE or ROESY experiment can be valuable 
for determining the orientation of the guest species. Kahle et al. were able to correlate 
CICS and ROESY NMR data with capillary electrophoresis chiral separation studies to 
provide a mechanistic explanation for pH dependent reversal of migration order of chiral 
dipeptides possessing aromatic amino acid side chains (Kahle et al., 2005). 
Chankvedetski et al. used ROESY NMR to study the inclusion complexes of the drug 
clenbuterol with p-CD and heptakis(2,3-diacetyl-6-0-sulfo)cyclomaltoheptaose (HDAS- 
P-CD) in order to investigate the mechanism of the opposite order of migration of 
enantiomers by CE (Chankvetadze et al., 2001). They observed significant differences 
in the structure of the complexes of p-CD/clenbuterol and HDAS-P-CD/clenbuterol.
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As an initial study, the inclusion complex of CBI-ser with the new single isomer 
KSPDM-P-CD was investigated using ROESY NMR. The partial 2D-ROESY spectrum 
showing relevant cross peaks between CBI-ser and H3 and H5 of KSPDM-P-CD is 
given in Figure 3.50.
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Figure 3.50. 2D ROESY spectrum of inclusion complex of KSPDM-P-CD:CBI-ser 
(molar ratio 2:1). Mixing time 300 ms.
Assignments of the 'H resonances of CBI-ser were made by a combination of *H, 
gCOSY, and ID NOE experiments and are given in Figure 3.51 for the proposed 
complex orientation.
140
Figure 3.51. Inclusion Complex of KSPDM-P-CD with CBI-ser in D2O.
A strong NOE crosspeak between the overlapped resonances of H io\ H n ’ of CBI-ser 
and H5 of KSPDM-p-CD suggest penetration of CBI-ser deep into the cavity of the 
sulfoalkylated CD as represented in Figure 3.51. A weaker interaction is also observed 
for H3 of KSPDM-p-CD with H 10’ and H 13’ of CBI-ser. Furthermore, H5 of KSPDM-P-
CD shows a weak NOE crosspeak with the overlapped resonances of H u ’, H 12’ of CBI- 
ser which is not observed for H3. Finally, H3 of KSPDM-P-CD shows NOE crosspeaks 
with both H9’ and He’ of CBI-ser with the latter being slightly greater in magnitude 
suggesting a tilt in orientation of CBI-ser within the cavity. In contrast, very weak 
interactions between H5 of the CD and He’ and H9’ of CBI-ser are observed suggesting 
these protons on CBI-ser lie closer to the secondary rim of the CD. No interactions 
between H2’ of CBI-ser and H3 and H5 of KSPDM-P-CD are observed. Taken together, 
the data suggests complexation occurs by inclusion of CBI-ser from the secondary rim 
with the naphthalene group inserted deep into the cavity and the polar groups of CBI-ser 
oriented towards the wider secondary rim. This deep insertion into the cavity is evident 
despite the pH of the solution being ~ 6 which results in full ionization of CBI-ser a- 
COOH group (pKa 3.0, Chapter 3). It is quite possible that at lower pH when the acid is 
significantly protonated (pH < 3), any electrostatic repulsion would be minimized 
resulting in deeper penetration of CBI-ser into the hydrophobic cavity.
3.5. Summary of findings on single isomer sulfoalkyl CD synthesis
The first members of a family of selectively modified single isomer sulfoalkylated a- 
and P-CDs have been synthesized through regioselective reaction chemistry. 
Additionally the P-derivatives have been initially investigated as chiral resolving agents 
for fluorescently labeled amino acids (vide infra). The primary challenge in the 
synthesis was full sulfoalkylation of the primary rim of the 2,3-di-O-alkylated (methyl or 
ethyl)-CD derivative. Successful sulfoalkylation was accomplished for all the derivatives
using sultone in THF with KH/18-crown-6 as base. The crown ether was demonstrated 
to be essential for producing the single isomer CD and was required in high molar excess 
compared to the CD derivative. Two steps were required to purify single isomer CDs by 
removing small molecule impurities. In the first step, 18-crown-6 was optimally 
removed by converting the CD-potassium salt to a CD-acid form, extracting away crown 
ether with organic solvent, and neutralizing the resultant product. In the second step 
sultone byproducts as well as excess salts were removed by continuous ultrafiltration 
using 500 MWCO membranes. All CDs were successfully characterized by NMR 
spectroscopy, inverse detection capillary electrophoresis, elemental analyses and, in 
some cases, matrix-assisted laser desorption ionization mass spectrometry (MALDI).
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Chapter 4
Chiral Separations of CBI-amino acids with single isomer 
  ...........  sulfoalkyl p -C D s   ................. ........... ......
4.1 Overview of study
Single isomer sulfoalkyl CDs developed in Chapter 3 were investigated for their ability 
to analytically resolve CBI-amino acid enantiomers, with a particular emphasis on 
biologically significant separations o f the enantiomers o f CBI-ser, CBI-asp, CBI-glu, 
and CBI-ala. Separation conditions mimicked the optimized neurochemical analysis 
conditions described in Chapter 2 and 5, in order to make comparisons with the 
commercially-available S-p-CD. Briefly, separation was carried out using reversed 
polarity with the following p-CDs synthesized in Chapter 3: 5A, 5B, and 5E. To more 
clearly establish nomenclature with CD structure, anionic sulfoalkyl derivatives are 
considered here as KSPDM-p-CD (5A), KSBDM-p-CD (5B), and KSBDE-P-CD (5E) 
according to alkyl and sulfoalkyl substituents reported in Figure 3.2 o f Chapter 3. The 
smaller a-CD analogs were not used in any of these studies. The concentration of CD in 
the BGE ranged from 0.05-10 mM (-0.01-2 wt %). As mentioned in Chapter 2, under 
reverse polarity low pH conditions with anionic CD chiral selectors, the effective 
mobility of CBI-amino acids is, to a first approximation, a measure o f the strength of the 
interaction o f the analyte with the anionic CD.
4.2 General methods
All chemicals were analytical reagent grade unless otherwise stated. Reagents were 
described in Section 2.21 of Chapter 2. Capillary electrophoresis was performed on the 
instrument described in Section 2.22 of Chapter 2 using a bare fused silica capillary of 
dimensions 48 x 45 cm x 25 pm. CBI-amino acids were prepared for separation studies 
by reacting equal volumes of amino acid (1 mM), NDA (1 mM in methanol), and NaCN 
(5.5 mM in 60 mM borate buffer, pH 9.3) and allowed to react for a minimum of 15 min. 
CBI-amino acids were diluted to 5-10 pM with water. The use o f equal molar quantities 
of amino acid, NDA, and NaCN were used to minimize NDA side products for the 
separation studies. The BGE was 25 mM phosphate adjusted to pH (typically 2.15) by 
adding appropriate volume ratios of equal molar H3PO4 and NaH2P04 solutions. 
Resolution (Rs) and plate count (N) were calculated using PeakFit® software as 
described in Chapter 2.22.
4.3 Results with single isomer sulfoalkyl CDs for chiral analysis
Single isomer sulfoalkyl CDs interacted strongly with CBI-amino acids and could be 
utilized at much lower concentrations compared with S-P-CD as optimized in Chapter 2. 
A comparison of CBI-ser mobility and selectivity in the presence of ~0.2 wt % S-P-CD 
verses -0 .2  wt % KSPDM-P-CD demonstrates the significantly increased interaction of 
CBI-ser with the single isomer sulfopropyl CD (Figure 4.1).
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Figure 4.1. Comparison of mobility and selectivity of KSPDM-P-CD and S-P-CD at low 
pH reverse polarity. Both CDs were prepared to -0 .2  wt %. (A) CBI-DL-ser (-22:78 
D:L) with KSPDM-P-CD in BGE, (B) CBI-DL-ser with commercially available S-P-CD 
in BGE, C) CBI-DL-ser in the absence o f CD.
Despite its low charge at pH 2.15, the weakly acidic CBI-ser does migrate with its own 
electrophoretic mobility in 25 mM phosphate with a migration time of -25 min (Figure 
4.1C). A theoretical plate count, N = 41,000, is calculated. Addition o f 0.2 wt % S-P-
CD then reduces migration time ~ 32% (Figure 4 .IB) indicating that despite low 
concentration, S-P-CD does interact with CBI-ser. This interaction results in enhanced 
separation efficiency which approaches 78,000 plates. Additionally, partial resolution of 
CBI-ser enantiomers is achieved with 0.2 wt % S-P-CD. The addition of 0.2 wt % 
KSPDM-P-CD into the BGE results in dramatic -75%  reduction in CBI-ser migration 
time and additionally allows for near baseline resolution of the enantiomeric pair (Figure
4.1 A). The separation efficiency reaches 328,000 plates using the single isomer 
KSPDM-P-CD. Thus it is apparent that the single isomer sulfoalkyl derivative, KSPDM- 
P-CD, forms very strong interactions with CBI-amino acids at pH 2.15 which surpass 
that of S-P-CD, enhances separation efficiency, and through selective chiral recognition 
additionally allows for analysis of CBI-amino acid enantiomers at reduced 
concentrations of chiral selector.
The separation o f a variety o f CBI-amino acids under the same conditions with KSPDM- 
P-CD is demonstrated in Figure 4.2.
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Figure 4.2. Chiral separation of 9 CBI-amino acids using KSPDM-P-CD. Conditions: 25 
mM phosphate, pH 2.15 with 0.8 mM (~ 0.20 wt %) KSPDM-P-CD.
KSPDM-P-CD resolves a large number of CBI-amino acids in less than 7 min at low pH 
reverse polarity despite [KSPDM-P-CD] being < ImM in the BGE. In fact, a
concentration ~ 10-fold less than that optimized for CBI-amino acids with S-P-CD is 
used here with KSPDM-P-CD. Several important conclusions can be drawn from these 
separations. Firstly, KSPDM-P-CD appears to be an excellent new chiral resolving agent 
for capillary electrophoresis which forms strong interactions with hydrophobic species 
like CBI-amino acids. Importantly, Figure 4.2 demonstrates that several D-amino acids 
o f biological significance can easily be resolved with KSPDM-P-CD. This result is 
significant in consideration of future application of this new resolving agent for 
bioanalytical separations of amino acids. While separation efficiency remains high with 
this CD (>300,000 plates) despite low concentrations, chiral recognition is a result of 
enhanced selective chiral interaction rather then simply increased plate counts. However, 
while CBI-glu, CBI-asp, and CBI-ala are all baseline resolved, complete baseline 
resolution is not achieved for CBI-ser at the concentration used above (Rs = 1.19). An 
investigation of the role o f concentration o f KSPDM-P-CD on chiral separation of CBI- 
glu, CBI-asp, CBI-ala, CBI-thr, CBI-his, and CBI-ser is summarized in Figure 4.3.
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Figure 4.3. Effect o f KSPDM-P-CD concentration on chiral resolution of CBI-amino 
acids at low pH reversed polarity.
Increasing KSPDM-p-CD concentration in the BGE beyond 0.8 mM results in decreased 
resolution o f CBI-amino acids, in spite of a slight increase in separation efficiency 
(328,000 theoretical plates for CBI-ser at 0.8 mM verses 355,000 plates at 10 mM). It is 
apparent from the trend in this data that a chiral selector concentration below 0.8 mM 
may indeed continue to improve resolution o f CBI-amino acids. The optimum 
concentration was not pursued in the current study with KSPDM-p-CD but may be 
between 0.1-0.8 mM for the CBI-amino acids investigated. Eventually it is expected that 
migration times will significantly increase with attendant peak broadening with
decreasing KSPDM-P-CD concentration, thus reducing overall resolution and separation 
efficiency. CBI-ser alone was investigated beyond concentrations used in Figure 4.3 and 
an electropherogram for the separation carried out at 0.20 mM KSPDM-P-CD is given in 
Figure 4.4.
150
T i m e ,  s
Figure 4.4. Chiral separation of CBI-ser at 0.2 mM (-0.05 wt %) KSPDM-P-CD in the 
BGE.
A 4-fold decrease o f KSPDM-P-CD from the minimum in Figure 4.3 still allows for 
excellent resolution of CBI-ser enantiomers in < 10 min with no loss in resolution. 
Indeed, CBI-DL-ser separation may be slightly better (Rs 1.26 verses 1.19) at 0.2 mM 
though statistical analysis o f a larger data set was not examined. Either way, the 
migration time of CBI-ser enantiomers is increased at 0.2 mM KSPDM-P-CD (-588 s 
enantiomeric pair migration time) compared with higher concentrations (384 s 
enantiomeric pair migration time for 0.8 mM CD) suggesting that further decreases in 
chiral selector will continue to result in longer migration eventually leading to a decrease 
in resolution. In comparison to S-P-CD optimized in Chapter 3, the data shown here 
suggests CBI-ser can be resolved with KSPDM-P-CD using -  40-fold reduction (-0.5 
mg/mL verses 20 mg/mL) in mass per volume of chiral selector.
A qualitative comparison of migration times for amino acids in Figure 4.2 reveals that 
the cationic CBI-his does not have a unique migration time compared to other CBI- 
amino acids. This result is in contrast to that using S-P-CD (Chapter 2) for the cationic 
CBI-amino acids arginine and histidine, which form strong electrostatic interactions with 
S-p-CD and result in drastically reduced migration times (see Figures 2.7, 2.8, and 2.11 
in Chapter 2). Indeed, it appears that, based on migration times in Figure 4.2, CBI-his 
does not display significant electrostatic interactions with KSPDM-P-CD. This suggests 
that the mechanism of chiral resolution for CBI-his is different for KSPDM-P-CD 
compared to S-P-CD. From a structure activity relationship, this has important 
implications. The sulfoalkyl groups on KSPDM-P-CD are selectively positioned on the 
primary face of the cavity and extend away from the CD torus by 3 methylene units.
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Inclusion complex formation of CBI-amino acids with KSPDM-P-CD demonstrated by 
ROESY NMR (Chapter 3.5) provides evidence that the naphthalene inserts into the CD 
annulus from the secondary methylated face. Taken together, the data suggests that the 
cationic CBI-his imidazole group is too far extended from anionic sulfates during 
inclusion complexation to allow for any significant electrostatic interaction. In contrast, 
the sulfato groups of S-P-CD are positioned on both primary and secondary hydroxyl 
faces allowing for significant electrostatic interaction with cationic substrates. The 
results of future investigation on additional cationic species will have important 
implications in potential application of KSPDM-P-CD to chiral separation under 
reversed polarity o f cationic drugs and metabolites which are widely analyzed with 
sulfato CDs (Stalcup and Gahm, 1996; Vincent et al., 1997b).
The second structural analog to KSPDM-P-CD, KSBDM-P-CD has also been 
investigated initially for chiral separation of CBI-amino acids and the results for the 
series of analytes investigated above are summarized in Figure 4.5 for 0.8 mM KSBDM- 
P-CD.
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Figure 4.5. Chiral separation of 9 CBI-amino acids using KSBDM-p-CD. Conditions: 
25 mM phosphate, pH 2.15 with 0.8 mM (~ 0.20 wt %) KSBDM-P-CD.
The sulfobutyl single isomer derivative is an excellent new chiral resolving agent for 
amino acids. In fact, KSBDM-p-CD offers significantly better resolution compared to
KSPDM-P-CD for the most biologically relevant DL-amino acids which are baseline 
resolved including CBI-ser (Rs 1.71 verses 1.19), CBI-glu (Rs 4.80 verses 4.10), and 
CBI-asp (Rs 3.25 verses 2.64) with no change in resolution o f CBI-ala (Rs 2.95 verses 
2.93) compared to KSPDM-P-CD. Interestingly, CBI-thr demonstrates greater than 2­
fold increase in resolution with this chiral selector (Rs 3.38 verses 1.48). Furthermore, 
the average chiral pair migration time is significantly reduced for KSBDM-P-CD 
separations compared to KSPDM-P-CD for all CBI-amino acids at 0.8 mM CD except 
CBI-his which is unchanged. The reduced migration time suggests that a significant 
increase in the binding potential occurs when increasing the alkyl spacer group from 
sulfopropyl to sulfobutyl. This could be explained mechanistically by extension of 
sulfate charge density further from the CD torus with sulfobutyl CDs compared to 
sulfopropyl resulting in deeper penetration of the hydrophobic naphthalene group into 
the hydrophobic cavity. The resolution of CBI-tyr and CBI-his decreased for this CD 
though it is of note that CBI-his is still well resolved (Rs 3.59). Due to the near identical 
structural features o f KSPDM-P-CD and KSBDM-P-CD, it is expected that increased 
KSBDM-P-CD concentration in the BGE beyond 0.8 mM will result in reduced chiral 
resolution as demonstrated for KSPDM-P-CD in Figure 4.3 above. Overall, it would 
appear that KSBDM-P-CD may be the better choice for development of a CE 
bioanalytical separation using charged chiral selectors that emphasizes separation of 
CBI-ser enantiomers since CBI-ser is well resolved.
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While the concentration of KSBDM-P-CD was not investigated above 0.8 mM, the 
effect of reduced concentration o f this chiral selector in the BGE on resolution of CBI- 
amino acids was deemed important to determine the minimum concentration of this new 
chiral selector capable of offering maximal resolution o f biologically relevant amino 
acid enantiomers. The results are summarized in Figure 4.6 for concentrations ranging 
from 0.05-0.8 mM KSBDM-P-CD.
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Figure 4.6. Effect of decreasing concentration o f KSBDM-P-CD in the BGE on chiral 
resolution o f CBI-amino acids at low pH reversed polarity.
Decreasing concentrations of KSBDM-P-CD below 0.8 mM results in enhanced 
enantioresolution of all CBI-amino acids investigated. Resolution reached a plateau for 
CBI-amino acid in the range of 0.10-0.40 mM CD. At concentrations of CD below -0.10 
mM, CBI-amino acid resolution rapidly decreases. Despite the -16-fold reduction in 
BGE CD concentration compared to the 0.8 mM used for separations in Figure 4.5, all 
CBI-amino acids (except CBI-his) were baseline resolved at 50 pM (-0.013 wt %) 
KSBDM-p-CD in <17 min. A summary of the enhanced enantioresolution of CBI- 
amino acids demonstrated in Figure 4.6 is given in Table 4.1.
Table 4.1. Summary o f enhanced enantioresolution of CBI-amino acids at low (< 0.8 
mM) concentrations of KSBDM-P-CD in the BGE.
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CBI-glu CBI-ser CBI-ala CBI-asp CBI-thr CBI-his
% max Rs enhancement (from 0.8 mM) 74.7 40 76.9 87 83.1 65.9
Rs at optimal [KSBDM-b-CD] 8.37 2.38 5.22 4.65 6.17 5.92
[KSBDM] at max Rs, mM 0.1 0.4 0.1 0.2 0.1 0.2
D-isomer mobility at 50 pM CD, min 15.35 15.53 14.99 13.77 14.26 34.05
All CBI-amino acids exhibit a >60 % increase in resolution when decreasing KSBDM-P- 
CD below 0.8 mM except CBI-ser which shows a 40 % increase. The best resolution for 
this series of CBI-amino acids is realized for CBI-glu enantiomers at 0.10 mM KSBDM- 
P-CD (Rs = 8.37). Despite this low concentration, CBI-D-glu has an apparent mobility 
of 15.35 min with 50 pM KSBDM-P-CD, which, according to Figure 4.7 below, 
indicates significant interaction o f KSBDM-P-CD with CBI-glu.
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Figure 4.7. Comparison o f CBI-glu enantioseparation in the presence and absence <100 
pM KSBDM-P-CD in the BGE. (A) CBI-DL-glu separation with 100 pM KSBDM-P- 
CD; Rs = 8.37. (B) CBI-DL-glu separation with 50 pM KSBDM-p-CD. Rs = 6.9 (C) 
CBI-DL-glu without CD in the BGE. The comparison demonstrates that 50 pM CD 
dramatically alters CBI-glu mobility. Conditions: 25 mM phosphate, pH 2.15. The slight 
tailing for CBI-glu is an instrumental artifact caused by unequal buffer reservoirs.
A comparison o f the migration time of the cationic CBI-his with the weakly acidic CBI- 
amino acids is shown in Figure 4.8 using 50 pM KSBDM-P-CD in the BGE.
158
T im e , m in
Figure 4.8. Comparison of cationic CBI-his migration time with weakly acidic anionic 
CBI-amino acids. BGE: 25 mM phosphate, pH 2.15 with 50 pM KSBDM-P-CD in the 
BGE. For Rs values for acidic CBI-amino acids see Figure 4.6.
A ~2-fold difference in migration time is observed between weakly acidic CBI-amino 
acids and the cationic CBI-his. The cationic CBI-his has a net mobility in the absence of 
CD directed toward the cathode; it is likely that the longer migration time is a result of a 
greater proportion of free/bound CBI-his in solution. Importantly, it can be concluded
from Figure 4.8 that CBI-his does not form any significant electrostatic interaction with 
KSBDM-P-CD since the apparent mobility o f CBI-his is greater than (Figure 4.8) or 
equivalent to (Figure 4.5) other derivatives which do not possess cationic functional 
groups capable of forming positive charge interactions. Overall, the comparison in 
Figure 4.8 strongly argues that electrostatic interaction between cationic analytes and the 
selectively modified single isomer anionic sulfobutyl CD is insignificant. Interestingly, 
the data presented in Figure 4.8 for KSBDM-P-CD interaction with CBI-his is nearly 
opposite to that presented for commercial S-P-CD in Figure 2.11 of Chapter 2 which 
illustrated strong electrostatic interactions between CBI-amino acids and S-P-CD. 
Another important factor affecting resolution of CBI-amino acids is the BGE pH as 
mentioned in Chapter 2. Therein it was demonstrated that CBI-ser is significantly 
ionized when pH is raised from 2 to 3, leading to a loss of chiral resolution due to 
electrostatic repulsion with the S-P-CD. We speculated that this loss of resolution was 
likely due to reduced depth of penetration of the CBI-amino acid into the hydrophobic 
cavity of the anionic CD because of charge repulsion.
A comparison of chiral resolution of CBI-ser using 2 wt % S-P-CD and -0.2 wt % 
KSBDM-P-CD in nearly identical conditions for the pH range of 2-3 is given in Figure 
4.9 below.
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Figure 4.9. Effect o f pH and anionic chiral selector on resolution of CBI-ser 
enantiomers. BGE is 25 mM phosphate with either 0.2 wt % KSBDM-p-CD or 2 wt % 
S-p-CD adjusted to pH through appropriate volume additions o f equal molar NaH2P04 
and H3PO4 solutions. The separation shown in C and D are reproduced from Figure 2.3B 
in Chapter 2. The electric field was maintained at 430 V/cm in all separations.
As mentioned in Chapter 2, a change in the pH of the BGE from 2 to 3 for S-P-CD
BGEs results in a complete loss of resolution of CBI-ser (Rs = 1.72 at pH 2.00, Rs = 0 at
pH 3.00) under reversed polarity. In comparison, a much more modest loss of chiral 
resolution is observed for similar pH changes with KSBDM-P-CD (Rs = 1.70 at pH 2.15, 
Rs = 1.36 at pH 3.00). Thus, it is apparent that chiral separation of CBI-ser with 
KSBDM-P-CD is much less dependent on the degree of ionization of the a-COOH of 
CBI-ser. From a mechanistic standpoint, and in concert with data presented above on 
CBI-his, this result is compelling evidence that the ionic sulfates of KSBDM-P-CD are 
significantly separated away from the hydrophobic CD torus such that charge interaction 
(positive or negative) does not dramatically alter binding affinity of guest molecules. 
Further studies on additional ionic guest species will be required to determine 
definitively if this is more or less a universal phenomenon with this new chiral selector. 
It is of note that the result for CBI-ser shown in Figure 4.8A,C was also reproduced in an 
identical experiment for CBI-glu enantiomers though, interestingly, CBI-glu 
enantiomers are better resolved with KSBDM-P-CD at higher pH (S-P-CD; Rs = 3.26 at 
pH 2.00, Rs = 1.46 at pH 3.00. KSBDM-P-CD; Rs = 4.79 at pH 2.15, Rs = 5.37 at pH 
3.00).
The third single isomer sulfoalkyl P-CD derivative, KSPDE-P-CD, shows a uniquely 
different pattern of chiral recognition compared with the above di-O-methyl derivatives 
as shown in Figure 4.10 for the separation of a series of CBI-amino acids at 0.80 mM 
KSPDE-P-CD in the BGE.
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Figure 4.10. Chiral separation o f 9 CBI-amino acids using KSPDE-P-CD. Conditions: 
25 mM phosphate, pH 2.15 with 0.8 mM (~ 0.20 wt %) KSPDE-p-CD.
KSPDE-P-CD is the best resolving agent of this series of derivatives at 0.8 mM CD for 
CBI-ser and CBI-thr with resolution values of 2.77 and 5.17 respectively. This suggests
that this chiral selector would be a complimentary choice to KSBDM-P-CD for 
development o f bioanalytical separation of CBI-ser enantiomers in this concentration 
range. Since it is a structural analog of KSBDM-(3-CD, it is possible to speculate (see 
Figure 4.6) that CBI-ser and CBI-thr resolution may continue to increase with decreasing 
KSPDE-P-CD concentration though future studies will be required for validate this 
proposed similarity. Interestingly, the selectivity of this chiral selector is quite different 
from other CDs developed here. In fact, resolution of CBI-asp and its amide analog CBI- 
asg, as well as CBI-glu and its amide analog CBI-gln, is significantly diminished with 
KSPDE-P-CD at 0.8 mM compared with KSPDM-P-CD (Figure 4.2) and KSBDM-P-CD 
(Figure 4.5) which were both excellent resolving agents for these derivatives. An 
explanation for the loss of resolution and significant difference in chiral recognition may 
require a combination of molecular modeling and NMR binding studies. One of the 
advantages of this single isomer CD is that such future studies can be carried out which 
would be impossible with heterogeneous CDs such as S-P-CD due to their complex 
isomeric nature. The 2-D ROESY NMR approach using conditions that mimic the 
electrophoresis BGE may be valuable for determining a change in orientation and 
binding o f the CBI-amino acids with KSPDE-P-CD. For example, CBI-glu and CBI-asp 
differ by one methylene unit, and a comparison o f chiral separation o f these amino acids 
using 5.0 mM KSPDE-P-CD presents some striking differences in binding interactions 
with this CD (Figure 4.11).
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Figure 4.11. Comparison of chiral separation of CBI-glu and CBI-asp at pH 2.15 with 
5.0 mM KSPDE-p-CD in the BGE.
For the chiral pair, KSPDE-P-CD interacts more strongly with the D-isomer of CBI-glu 
resulting in faster migration of this enantiomer. This is the typical migration order result 
observed for interactions o f CBI-amino acids with KSBDM-p-CD and KSPDM-p-CD. 
In contrast, however, the D-isomer of CBI-asp has a longer migration time then its L- 
enantiomer, suggesting a weaker interaction. In fact, while CBI-glu resolution increases 
with decreasing KSPDE-P-CD (Rs = 1.23 at 5.0 mM, Rs = 1.65 at 0.8 mM), the opposite 
is true for CBI-asp (Rs = 1.61 at 5.0 mM, Rs = 0.44 at 0.8 mM). Furthermore, this 
suggests that ethyl groups on the secondary rim which possibly alter cavity size play a 
uniquely different functional role in chiral selectivity then methyl derivatives.
The order of elution of the respective enantiomers o f CBI-glu and CBI-asp using 
KSPDE-P-CD, as shown in Figure 4.11, is exactly opposite that observed using S-P-CD 
(Chapter 2). A mechanistic understanding of this is presently lacking, and further 
studies are required. However, recall that S-P-CD is a mixture of many positional and 
regional isomers with a range of substitution due to nonselective synthesis. This 
heterogeneity greatly complicates any mechanistic understanding of the fundamental 
interactions responsible for change in binding order. In contrast, KSBDM-P-CD is well 
characterized and intricate investigations on inclusion complexes and binding potentials 
could more easily reveal information pertinent to understanding these fundamental 
interactions.
A reversal o f enantiomer migration order (EMO) was observed for CBI-ala dependent 
on concentration o f KSPDE-P-CD in the BGE as shown in Figure 4.12.
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Figure 4.12. Reversal o f EMO for 22:78 CBI-ala dependent on concentration of 
KSPDE-P-CD in the BGE.
CBI-ala is partially resolved at 10 mM KSPDE-p-CD with the L-enantiomer migrating 
first. Lowering the concentration to 0.8 mM results in complete reversal of migration 
order with near baseline resolution of CBI-ala. To account for this change in F.MO there 
must be a concentration dependent change in the nature of the inclusion complex 
formed.
Rizzi and Kremser have investigated complexation induced reversal of EMO of 
dansylated amino acids (DNS-amino acids) dependent on the concentration of chiral 
selector (Rizzi and Kremser, 1999). While they suggest this observation to be an 
uncommon event, they provide compelling evidence that when the pH of the BGE 
approaches the pKa range of some analytes (as occurs herein), a possibility exists for 
complex induced alteration of the pKa (and thus charge and net mobility) of the guest 
species simply by altering the chiral selector concentration. Thus, rather then a change in 
strength o f interaction for each enantiomer with the CD host resulting in differential 
migration times o f enantiomers, there can be a change in the ionization o f the guest 
resulting in enhanced electromigration of one enantiomer over the other. Rizzi and 
colleagues demonstrate that enantiomer migration order for DNS-phe and DNS-trp is 
dependent on the concentration of HP-p-CD in the BGE and rationalized this data by 
evidence demonstrating that one weakly acidic enantiomer exhibits a greater 
complexation induced pKa shift then the other, resulting in a change o f electrophoretic 
mobility o f the enantiomer independent of differences in binding affinity.
The data provided by Rizzi et al. would argue that CBI-ala enantiomers studied herein 
exhibit a KSPDE-P-CD concentration dependent alteration in pKa during complexation
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resulting in the observed reversal of migration order. The determination of binding 
affinities of CBI-ala enantiomers with KSPDE-p-CD as well as any complex induced 
pKa alterations under the current separation conditions will be required in future studies 
to verify the proposed mechanism of EMO reversal. Furthermore, the dimethyl CD 
derivatives (KSPDM-p-CD, KSBDM-p-CD) did not exhibit any concentration 
dependent reversal o f EMO when resolving amino acids at the concentrations 
investigated. It is of note that the concentrations of single isomer sulfoalkyl CDs used in 
the experiments above did not exceed 10 mM. An investigation of higher CD 
concentrations in the BGE for all three of these derivatives may reveal complexation 
induced pKa changes for additional amino acids which are not observed in the limited 
range studied here. This will verify whether this effect can be achieved with selectively 
modified sulfoalkyl CDs bearing methyl groups on the secondary rim. Studies by the 
Vigh group with single isomer sulfato CDs at low pH typically investigate sulfato CD 
concentrations as high at 50 mM in the BGE (Cai et al., 1998). Similar high levels 
should be studied in future experiments with single isomer sulfoalkyl CDs.
4.4 Summary of enantioselectivity for KSPDM-p-CD, KSBDM-p-CD, and KSPDE- 
P-CD
Single isomer sulfoalkyl P-CD derivatives form inclusion complexes with CBI-amino 
acids and were found to be excellent new chiral resolving agents for a series of CBI- 
amino acids at low PH reversed polarity. Biologically significant DL-amino acids 
including CBI-ser, CBI-glu, CBI-ala, and CBI-asp could be baseline resolved with these
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chiral selectors. KSPDM-p-CD, KSBDM-p-CD, and KSPDE-p-CD form strong 
inclusion complexes with CBI-amino acids demonstrated by enhanced apparent mobility 
of CBI-amino acids which dramatically surpasses that o f S-P-CD and allows for chiral 
analysis at much lower concentrations. Single isomer sulfoalkyl CDs do not form 
significant electrostatic interactions, either attractive or repulsive, with CBI-amino acids 
as demonstrated by comparison of mobility of cationic and anionic CBI-amino acids, 
and also by comparison of pH effects with these selectors. In addition, different 
selectivity is observed for these CDs with various chiral guests. KSBDM-P-CD and 
KSPDE-P-CD are the best resolving agents for CBI-ser enantiomers. While the dimethyl 
derivatives offer similar selectivity for biologically important amino acids (though 
sulfobutyl derivatives are superior in this respect), the selectivity was found to be quite 
different for KSPDE-P-CD. A KSPDE-P-CD concentration dependent reversal of EMO 
was observed for CBI-ala that may be the result of complex induced alteration in the
Simultaneous efflux of endogenous D-ser and L-glu from single acute 
  hippocampus slices during oxygen glucose deprivation   ......
5.1 Overview of study
Stroke is the third leading cause of death in the United States and the leading cause of 
adult long term disability (Rosamond et al., 2008). Much o f the resulting brain damage 
caused by stroke is due to a cascade of excitotoxic events which occur as a result of 
insufficient blood supply to the brain. Similar excitotoxicity is responsible for much of 
the high morbidity and mortality in patients suffering from post cardiac arrest syndrome 
(Neumar et al., 2008). In the central nervous system (CNS), the excitotoxic cascade is 
initiated by the onset of energy deficit, which forces cell depolarization and subsequent 
neurotransmitter release. High levels of L-glu, the dominant excitatory neurotransmitter 
in the CNS, efflux from neurons and glia, resulting in excitotoxicity (Lipton, 1999). The 
N-methyl-D-aspartate receptor (NMDAR) is a glutamatergic ligand gated 
calcium/sodium ion channel that is responsible for the majority of excitotoxic cell death 
that occurs as a result of L-glu released during cerebral ischemia (Arundine and 
Tymianski, 2004).
The NMDAR is unique among neurotransmitter receptors in its requirement for 
coagonist activation (Kleckner and Dingledine, 1988; Curras and Pallotta, 1996). D-ser, 
an endogenous amino acid, is synthesized and released from neurons (Kartvelishvily et 
al., 2006) and glia (Oliet and Mothet, 2006) and is co-localized in brain regions having
Chapter 5
high concentrations of NMDAR. D-ser binds with high nanomolar affinity to the 
strychnine insensitive binding domain (coagonist site, “glycine site”) on the obligatory 
NR1 subunit of the NMDAR. Recent evidence implicates D-ser as the essential 
coagonist of NMDA receptor-induced neurotoxicity in several brain regions (Katsuki et 
al., 2004; Shleper et al., 2005).
L-glu is released rapidly within the first few minutes o f cerebral ischemia in vivo 
and in vitro suggesting it is an early event in the neuroxic cascade. Simultaneous efflux 
of D-ser would be necessary for excitotoxicity via NMDAR activation but little is known 
about the early time course of D-ser release. Lo and colleagues quantified several 
transmitters including D-ser during 2h focal ischemia with 10 min temporal resolution in 
vivo (Lo et al., 1998). In Chapter 2 of this dissertation the development of a sensitive 
enantioselective capillary electrophoresis laser induced fluorescence (CE-LIF) technique 
to assay D-ser, L-glu, and several other amino acids in biological samples using charged 
chiral selectors is described (Kirschner et al., 2007). The focus of this dissertation 
research was to couple the CE-LIF approach to a newly-designed in vitro microperfusion 
device described herein that would allow for more rapid monitoring of dynamic changes 
in D-ser and L-glu efflux from single acute hippocampus slices in response to modeled 
ischemia. Here we (Kirschner et al., 2009) apply our microperfusion technique to study 
L-glu and D-ser temporal response with 2 min sampling during oxygen glucose 
deprivation (OGD), an in vitro model of cerebral ischemia. Using the 
microperfusion/CE-LIF technique, we demonstrate parallel increases in D-ser and L-glu
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efflux during OGD. To our knowledge, our data represents the fastest temporal 
resolution of endogenous D-ser efflux during modeled cerebral ischemia.
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5.2. Methods
5.2.1 General
All chemicals were purchased from Aldrich Chemical Company unless otherwise noted. 
Sulfated p-cyclodextrin was purchased from Fluka (Lot# 1148973) and is the same lot as 
optimized for separation described in Chapter 2. Naphthalene-2,3-dicarboxaldehyde was 
obtained from Invitrogen. Buffers and reagents were prepared regularly every 1-2 weeks 
and stored at 4°C when not in use. Microchambers were soaked and perfusion tubing 
flushed for lhr with 70% ethanol prior to each experiment.
5.2.2 Microperfusion chamber
Acute slice chambers were constructed in-house at the University of Alaska Fairbanks 
Engineering machine shop (Figure 5.1A-D).
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Figure 5.1. Custom Microperfusion chamber for single acute brain slices. (A) 
polycarbonate microperfusion chamber, (B) schematic diagram of major components of 
microchamber (actual chamber dimensions LxWxH -9x5x0.7mm with additional 0.3 
mm deep microchannel support), (C) magnification of microchamber well illustrating 
microchannel support designed to increase fluid flow around slice, (D) schematic of 
microperfusion setup from syringe pump to fraction collection, (E) actual instrument 
setup showing (from left to right) syringe pump, switching valve manifold, warming 
bath with sealed microchambers, and outlet tubing. The 150 mm thermometer is shown 
to illustrate chamber size and was not used for absolute determination o f temperature
d )
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Treatment
36°C
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during experiments. Temperature was maintained by the proportional integral derivative 
(PID) controller built into the digital water bath (± 0.2 °C at 37 °C).
The chambers were machined from polycarbonate and incorporate a beveled leak-free 
lid and chamber body. The chamber body houses inlet and outlet ports connected via a 
small channel to an oval 2mm deep recessed, microchamber (dimensions ~9x5mm) 
specifically designed to accommodate 400 pm thick acute hippocampus slices from rats. 
The microchambers were engineered with a microchannel support in the well bottom to 
increase fluid exchange around the acute tissue preparation. The microchannels were 
machined -400 pm wide, 300 pm deep in a waffle pattern shown in Figure 5.1c. A 
polycarbonate lid was machined with a 1 mm deep beveled oval flange to form a 
watertight (O-ring free) seal with the chamber body. This design yields a sealed 
chamber 700 pm deep with an additional 300 pm microchannel support. The sealed 
chamber has an estimated volume of -35 pL without tissue in place. The lid is secured 
to the base using 4 stainless screws. Four chambers were mounted in parallel to a 
stainless steel tray submerged in a thermistor-controlled StableTemp water bath (Cole 
Parmer Instrument Company, Vernon Hills, Illinois, USA) kept at a constant 
temperature. All connections were made using 1/16-in O.D. 100 pm I.D. PEEK tubing 
with flanged fittings (outlet port used 150 pm I.D. PEEK tubing). Perfusion medium for 
each chamber was administered via a 10-stage syringe pump (Harvard Apparatus, 
Holliston, MA, USA), with medium passing first through a 4-port diagonal flow 
switching valve (#V101D, Upchurch Scientific, Oak Harbor, WA, USA) for 
administering treatments, before entering the water bath where it was preheated prior to
passing through the microchamber inlets. The chamber outlet tubing exited the water 
bath where samples were manually collected dropwise.
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5.2.3 Acute hippocampus slices
Adult Male Sprague Dawley rats (Simonson labs, Gilroy, CA; age 3-4 months, 250­
400g) were used for all experiments. Procedures were in accordance with The 
Institutional Animal Care and Use Committee of the University of Alaska Fairbanks. 
Transverse 400 pm acute hippocampus slices were prepared as follows. Rapidly 
dissected hippocampi were embedded in agar and sliced using a Vibratome 1000 plus 
sectioning system (The Vibratome Company, St. Louis, Missouri, USA). Slicing was 
performed at ~2°C in oxygenated HEPES buffered artificial cerebral spinal fluid 
(HEPES aCSF containing in mM: 120 NaCl, 20 N aH C03, 6.88 HEPES acid, 3.3 HEPES 
sodium salt, 5 .0  KC1, 2.0 MgS04 (pH 7.30-7.40)). Slices were transferred from HEPES 
buffered aCSF to a Brain Slice Keeper (Scientific Systems Design Inc, Mississauga, 
Ontario, CA) and allowed to recover in oxygenated aCSF (aCSF continuously bubbled 
with 95% O2, 5% CO2 containing in mM: 120 NaCl, 25 N aH C 03, 10 glucose, 3.3 KC1,
1.2 NaH2P04 , 2.4 MgS04 , 1.8 CaCh, pH 7.30-7.40) for 1 h at room temperature prior to 
placement in individual microchambers. Slices were then transferred individually to 
chambers and lids sealed. The apparatus containing 4 parallel chambers was submerged 
in a bath at 36°C (±0.2°C) and acute slices were perfused at a flow rate of 7 pL /min. 
Sampling began 20 min after submerging the sealed chambers to allow adequate time for 
stabilization of neurochemical efflux. Perfusate was collected at 2 min intervals during
pre-treatment (basal), treatment, and the first 20 min o f reperfusion. After 20 min 
reperfusion, samples were collected every 3 min. Treatment consisted o f a 24 min 
exposure to oxygen glucose deprivation (OGD) solution (glucose-free aCSF equilibrated 
with 95% N2 5% CO2 for a minimum of 1 h until pH stabilized in the range of 7.3-7.4). 
The PO2 in OGD solution varied from 0-2.9 mmHg with an average for 6 determinations 
of 1.1 mmHg as measured using a miniature Clark-style electrode (Instech Laboratories, 
Plymouth Meeting, PA, USA). In control slices treatment was administered by switching 
to standard aCSF. Collected fractions were kept at -80 °C until they were analyzed by 
chiral CE-LIF.
5.2.4 CE-LIF analysis
Perfusate was derivatized with slight modification to the procedure described previously 
in Section 2.25 of Chapter 2 to form highly fluorescent CBI-amino acids. Briefly, 1 pL 
thawed perfusate was reacted with 1 pL 2 mM naphthalene-2,3-dicarboxaldehyde 
(NDA) in methanol and 1 pL NaCN (5.5 mM) in 60 mM sodium tetraborate. Cyanide 
solution contained 3 pM D-amino adipic acid as internal standard (IS) which was 
superior to L-homoarginine as IS due to its similar migration time to quantified amino 
acids (vida infra). Samples were reacted at room temperature for 20 min prior to 
analysis. CE-LIF was performed on a custom in-house built instrument as described in 
Section 2.2 o f Chapter 2. Samples were injected onto a bare fused silica capillary of 
dimensions 48 x 45 cm x 25 pm for Is at 380 mbar vacuum, and separated using 
negative polarity (-21 kV). Separation buffer optimized for analysis o f D-ser and L-glu
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is a 25 mM phosphate background electrolyte (BGE) adjusted to pH 2.15 using equal 
molar additions o f H3PO4 and N a^PCL. BGE additionally contained 20 g/L (2 wt %)
S-P-CD as chiral selector. PeakFit® software was used to process raw data and quantify 
peak areas in all experiments based on a Gaussian peak shape for each analyte. Linear 
calibration curves were constructed for analytes as a function of concentration versus the 
peak area ratio (analyte area / Internal Standard area). Efflux of analytes is expressed as 
percent of baseline, where baseline is defined as the average value of 10 samples 
collected prior to onset of treatment, a period of sampling in which analyte levels were 
stable.
5.2.5 Monitoring treatment profile
Monitoring actual treatment exposure is critical for precise timing of transmitter efflux. 
The actual treatment exposure time in perfusion experiments is influenced by multiple of 
factors including flow rate, chamber dimensions, lag time between pump and chamber, 
and lag time between chamber and sample collection and properties o f flow within the 
chamber. Flow profile was monitored using different concentrations of D-glu as a 
marker of aCSF and OGD solutions. D-glu was conveniently quantified with 
endogenous amino acids in our chiral CE-LIF preparation which utilizes the remarkable 
chiral resolving properties of S-P-CD. D-glu does not have any known biological roles in 
the CNS, and is reportedly found in only trace levels in a few brain regions (Quan and 
Liu, 2003; Mangas et al., 2007). In our preparations, we detected no D-glu in
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hippocampus slice perfusates. We therefore used 0.5 pM D-glu in aCSF solutions and 
3.0 pM D-glu in treatment solutions.
Ill
5.2.6 Statistics
Data was analyzed using SAS® v9.1 software (SAS Institute Inc., Cary, NC, USA) by 2­
way ANOVA with treatment analyzed as a between subjects variable and time analyzed 
as a repeated measures variable. Tukey post-hoc comparisons were used to compare 
OGD and control groups at specific time points. Significance was indicated by p < 0.05. 
Data are shown as mean ± standard error mean (SEM).
5.3 Results
An optimized narrow pH range of 2.15-2.20 for the CE-LIF run buffer with 2 wt % S-P- 
CD allowed for baseline separation of D-ser, L-glu, L-asp, and L-gln CBI-amino acids 
as shown in Figure 5.2 in addition to an internal standard D-amino adipic acid.
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Figure 5.2. Impact of narrow pH range on migration order and run time for CBI-amino 
acids for bioanalysis with S-P-CD. Peak identities for CBI-amino acid standards: (1) 
CBI-L-gln; (2) CBI-D-ser; (3) CBI-L-asp; (4) CBI-D-amino adipic acid; (5) CBI-L-asp; 
(6) CBI-L-glu; (6) CBI-L-thr. Conditions: 25 mM phosphate with 2 wt % S-P-CD.
Exogenously applied D-glu partially overlapped with L-thr. The partial overlap of L-thr 
and D-glu was resolved using Gaussian peak fitting software (PeakFit® v4.12, SeaSolve 
Software Inc., Framingham, MA, USA).
Calibration curves using a weighted least squares linear regression for CBI-
■y
amino acids were obtained and the equations, R values, linear dynamic range
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investigated, and estimated concentration limits of detection (CLOD) for each analyte 
are given in Table 5.1. Larger dynamic ranges were calibrated for L-glu, L-asp and L- 
gln compared to other CBI-amino acids since preliminary results suggested these 
transmitters could fluctuate markedly during treatment with OGD.
Table 5.1. Linear regression results for concentration determinations of amino acids in 
perfusate medium. Shown are weighted standard curve equations (y = mx + b; CBI- 
AA/intemal standard = m[CBI-AA] + b), square of correlation coefficient (R2), 
calibrated range, and estimated CLOD. Curves were generated from weighted linear 
regression of > 6 standard solutions with N=5 for each standard. *CLOD calculated from 
response of a low-concentration standard (N=5) assuming S/N = 3.
Analyte Equation R2 Calibrated range, pM CLOD*, nM
L-glu y = 0.388x - 0.032 0.997 0-63.0 14.7 ±3.8
L-asp y = 0.308x± 0.002 0.999 0-25.2 16.0 ±2.1
D-ser y = 0.260x - 0.001 0.9% 1 0-1.80 19.3 ±4.4
L-lhr y = 0.247x- 0.005 0.9995 0-7.20 26.2 ±8.8
L-gln y = 0.357x-0.031 0.9968 0-36.0 12.5 ±1.5
A stepwise change in D-glu produced a 6-fold higher concentration of D-glu in treatment 
compared to aCSF. The resultant profile was used to establish the timing of OGD 
treatment (Figure 5.3). D-glu profiles were conveniently quantified by CE-LIF which 
chirally resolves exogenous D-glu from endogenous L-glu in perfusate samples.
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Figure 5.3. OGD treatment profile determined using trace D-glu perfusion across slices. 
A stepwise change in D-glu levels (0.5 pM switched to 3.0 pM) occurs in -4.5 min 
which establishes the turnover rate of the microchamber and allows for precise 
monitoring of the treatment profile. A 24 min OGD exposure is equivalent at the 
reported perfusion flow rate to ~20 min of 100% OGD (based on time D-glu response is 
at maximal level) and 24 min of >80% OGD solution, n = 8 slices.
OGD induced a significant increase in all amino acids investigated except L-gln as 
demonstrated by a comparison of CE electropherograms of basal and OGD perfusates 
(Figure 5.4). Average basal concentrations of analytes in slice perfusates, including both 
control (n= 5) and OGD (n=8) slices, are as follows: D-ser (0.34 ± 0.03 pM OGD, 0.34
D-glu as Indicator of OGD
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± 0.03 pM CTL), L-glu (0.93 ± 0.19 pM OGD, 1.07 ± 0.18 pM CTL), L-asp (0.66 ± 
0.20 pM OGD, 0.80 ± 0.15 pM CTL), L-gln (10.68 ± 1.20 pM OGD, 9.83 ± 0.74 pM 
CTL), L-thr (1.64 ± 0.14 pM OGD, 2.00 ± 0.21 pM CTL).
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Figure 5.4. Comparison of typical electropherograms from basal and OGD perfusate 
samples. A change in analyte peak height relative to internal standard, IS, is observed 
for labeled amino acid peaks. Basal sample shown is from perfusate collected 10 min 
prior to OGD treatment whereas OGD sample shown was collected 24 min into OGD 
treatment. Both basal and OGD samples were obtained from the same acute slice 
experiment.
Within a few minutes after the onset of OGD treatment, there is a significant, rapid 
increase in all amino acids except L-gln (Figure 5.5a-e).
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Figure 5.5. Efflux profiles for amino acids from single acute hippocampus slices in 
response to OGD. Efflux o f D-ser occurs in parallel with efflux o f L-glu during OGD in 
acute hippocampal slices. Percent change in endogenous amino acid concentrations
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relative to average o f last 10 pre-treatment samples are shown: a) D-ser, b) L-glu, c) L- 
asp, d) L-thr, and e) L-gln. Sampling and analysis was carried out using the newly 
developed microperfusion/CE-LIF strategy. Temperature was maintained at 36°C 
throughout perfusion. In control experiments, perfusate treatment was administered by 
switching to standard oxygenated aCSF medium. Data points represent average ± SEM 
of n slices as indicated. *p<0.05, OGD vs. CTL (Tukey post-hoc comparison).
Stable, pretreatment D-ser efflux rapidly increases during OGD and is significantly 
different from CTL values within 14 min of onset of OGD (p<0.05; Tukey post-hoc 
comparison). D-ser efflux increases to 254 ± 24% of baseline levels then decreases 
within the first few minutes of reperfusion (reintroduction o f oxygenated aCSF) 
returning to near pre-treatment values within 12 min. D-ser remains at pre-treatment 
levels throughout the remainder of the reperfusion phase (Figure 5.5a).
Likewise, efflux of L-glu is rapid and the timing of efflux is similar to D-ser. 
Stable, pretreatment, L-glu efflux increases and is statistically different from CTL levels 
within 16 min of onset of OGD (p<0.05; Tukey post-hoc comparison) and reaches a 
maximum of 1675 ± 259% of baseline 24 min after onset of OGD. Within the first 2-4 
min of reperfusion L-glu begins to slowly decline and this decline continues over the 
course of the 50 min reperfusion. The magnitude of L-glu efflux is larger than D-ser and 
unlike D-ser, L-glu remains significantly higher (244 ± 56% of baseline values) for up to 
46 min after onset of reperfusion (p <0.05; Figure 5.5b).
Stable, baseline L-asp efflux increases rapidly and is statistically different from 
CTL levels within 18 min of onset o f OGD (p<0.05; Tukey post-hoc comparison). L-asp 
levels increase significantly to 519 ± 128 % of baseline shortly after OGD with maximal
efflux corresponding to that of L-glu at 24 min from onset of OGD. L-asp returns to 
basal values within 10-12 min of reperfusion (Figure 5.5c). Stable, pretreatment, L-thr 
efflux initially increases from CTL levels modestly and is statistically significant by 4 
min after onset o f OGD (p<0.05; Tukey post-hoc comparison). After 12-14 min 
treatment, L-thr efflux rises more rapidly with maximum efflux at 24 min from onset 
with magnitude of 313 ± 33% basal values. L-thr returns to near baseline within 12 min 
of reperfusion (Figure 5.5d).
Interestingly, the effect of OGD on L-gln efflux is markedly different from the 
other amino acids investigated here (Figure 5.5e). Firstly, in control slices, L-gln efflux 
slowly decreases throughout the entire experiment (46.3 ± 4.6 % basal values after 94 
min of perfusion). Initially it appears that L-gln efflux increases briefly and early on 
during OGD however statistical analysis of these early events does not support this 
conclusion (p > 0.05; Tukey post-hoc comparison, time periods 6, 8, and 10 min). OGD 
then produces a further significant drop in L-gln efflux that reaches statistical 
significance compared to CTL at 24 min from onset (p<0.05; Tukey post-hoc 
comparison). Ultimately, L-gln efflux reaches a minimum of 30.7 ± 6.0 % baseline after 
4 min reperfusion (versus 62.3 ± 5.8 % at the same time point in control slices). L-gln 
does not significantly recover to baseline levels over the next 30 min of reperfusion.
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5.4 Discussion
5.4.1 D-ser efflux from hippocampal slices during OGD
We demonstrate that D-ser, the endogenous coagonist of NMDAR, increases 2.5-fold 
during 24 min of in vitro modeled ischemia in hippocampus and, for the first time with 2 
min temporal resolution, show that the timing of the rise and fall o f D-ser precedes or 
parallels that o f L-glu. These results therefore demonstrate that both co-agonists are 
available to activate NMDAR and contribute to excitotoxicity. Endogenous D-ser is 
essential for NMDA-induced excitotoxicity while endogenous levels of glycine are not 
sufficient to support excitotoxicity (Shleper et al., 2005). D-ser release is therefore 
expected to enhance excitotoxicity and, indeed, antagonists o f the D-ser (“gly”) binding 
site are neuroprotective in animal models o f stroke (Wasterlain et al., 1996; Ohtani et al., 
2000; Ohtani et al., 2003).
To our knowledge, there is only one other report o f a temporal response of D-ser 
to model ischemia. Lo and colleagues using in vivo microdialysis with HPLC and 
fluorescence detection investigated efflux of D-ser with 10 min temporal resolution in 
response to 2 hr focal ischemia in rabbit cortex (Lo et al., 1998). As supported by our 
study, they found D-ser efflux was significantly elevated throughout the ischemic period 
but did not have sufficient time resolution to address if D-ser and L-glu release occurred 
within the same functional time window. Additionally, this is the first report of D-ser 
efflux from hippocampus during modeled ischemia. Hippocampus is highly susceptible 
to global cerebral ischemia experienced during cardiac arrest (Schmidt-Kastner and
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Freund, 1991; Kirino, 2000) and hippocampal tissue is shown to have particularly high 
concentrations o f both D-ser and NMDAR (Hashimoto and Oka, 1997).
5.4.2 Validity of microperfusion chamber
Similarities between results reported here in acute hippocampal slices and results 
reported during cerebral ischemia in vivo support the validity of the microperfusion 
technique. We demonstrate that L-glu increases ~17-fold from baseline during 24 min in 
vitro ischemia (Figure 5.5b). In support of our data, Mitani and Tanaka show that during 
20 min of bilateral occlusion of the common carotid artery in mouse hippocampus glu 
levels, sampled by microdialysis from probes placed in the CA1 region, rose ~ 14-fold 
and did not return to basal values after 40 min of reperfusion (Mitani and Tanaka, 2003). 
Using the microperfusion chamber in the present study L-asp increases ~6-fold during 
24 min OGD and returns to basal values soon after reperfusion. Similarly, L-asp 
increases in response to ischemia in vivo (Benveniste et al., 1984; Dawson et al., 2000).
Three points of evidence in our current data support slice viability despite low 
flow rates. First, we demonstrate stable basal levels of glutamate and other transmitters 
over the course of 2 hours in the microchamber. Second, treatment o f stable basal slices 
with OGD results in robust efflux of L-glu which is compelling evidence that slices are 
viable prior to switching to treatment since it demonstrates that cells maintain Na+ 
gradients and that these are reversed during OGD. The capacity for slices to recover 
basal levels of glu that persist at a slightly higher level than basal levels as demonstrated 
following in vivo ischemia further demonstrate that slices are able to recover ion
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homeostasis post-OGD. Furthermore, the magnitude of maximal evoked L-glu release 
and levels during recovery demonstrated here is similar to reported magnitudes for 
hippocampus in vivo during cerebral ischemia. Taken together, these results suggest that 
slices are viable in this microperfusion preparation. This validates the microperfusion 
device for hippocampal slice OGD experiments.
In our 24 min OGD exposure several factors likely contribute to the delayed glu 
response seen in these hippocampal slices. Firstly, several minutes are likely required for 
significant depletion of ATP from the slice preparation. Mitani et al. demonstrated that 
over 3 min were required for ~80 % ATP depletion in acute hippocampal slices exposed 
to OGD in a flow through chamber at 33 °C (Mitani et al., 1994). Secondly, the temporal 
response of our slice chamber is around 4.5 min for a complete turnover. This response 
may have the effect of further delaying total ATP depletion and initial chemical 
response, since it takes longer for tissue to be exposed to the full 100 % OGD solution. 
Thirdly, we expect that chemical diffusion from synaptic regions in the tissue matrix to 
the bulk medium may limit overall temporal response in 400 pm thick slices during 
perfusion experiments.
5.4.3 Significance of L-thr efflux
L-thr increases significantly in response to OGD in a manner similar to that of D- 
ser with the exception that we note a small but significant elevation o f L-thr earlier on in 
the OGD time course as compared to D-ser. The chemical similarity between L-thr and 
D-ser suggests that these two amino acids use similar transport mechanisms. The sodium
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dependent neutral amino acid transporter alanine serine cysteine transporter-2 (ASCT-2) 
has indeed been demonstrated to show high micromolar affinity for both L-thr and D-ser 
(Ribeiro et al., 2002; Rutter et al., 2007). ASCT-2 is therefore an attractive candidate for 
efflux of these amino acids during OGD when transmembrane sodium ion gradients are 
reversed. Unfortunately selective inhibitors of ASCT-2 have not yet been developed thus 
the relative contribution o f this Na+ dependent mechanism to L-thr and D-ser efflux 
during OGD remains to be determined.
5.4.4 Significance of L-gln efflux
L-gln response to 24 min OGD treatment is different from other amino acids 
investigated here. The basal level of L-gln steadily decreases in control slices. This 
result is similar to that o f Kapetanovic and colleagues who demonstrated a dramatic, 
time-dependent loss of L-gln in mouse and rat acute hippocampal slices under static (no 
flow) and superfused (3 mL/min, constant flow) conditions (Kapetanovic et al., 1993). 
Several studies have demonstrated a similar drop in L-gln during cerebral ischemia in 
vivo, though never with the same temporal resolution as shown here during OGD 
(Benveniste et al., 1984; Silverstein et al., 1991; Uchiyama-Tsuyuki et al., 1994; Van 
Hemelrijck et al., 2005). Many studies have postulated that the decrease of L-gln during 
ischemia may be due to loss as L-glu via the Gln-Glu cycle (Silverstein et al., 1991; 
Uchiyama-Tsuyuki et al., 1994; Huang and Hertz, 1995a, b; Phillis et al., 2001; Shen et 
al., 2009). The particular role of L-gln in excitotoxicity has not been investigated; 
however, L-gln may enhance excitotoxicity by serving as a source for L-glu.
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5.4.5 Advantages of microperfusion/CE-LIF technique
The importance of D-ser in the mammalian brain and its relationship to L-glu via 
NMDA receptor coactivation has led to the need for robust and sensitive approaches for 
quantifying this transmitter with L-glu in various brain preparations. Chiral HPLC 
assays have been extensively utilized for D-ser quantification from brain homogenates 
and in vivo microdialysis samples (Hashimoto et al., 1995; Fukushima et al., 2004; Grant 
et al., 2006). HPLC assays typically suffer from long migration times (30-60min) and 
expensive chiral columns and column switching protocols. Recently, Bowser and 
colleagues developed powerful online capillary electrophoresis microdialysis assays for 
monitoring D-ser, L-glu, and other amines in vivo (Ciriacks and Bowser, 2006; Klinker 
and Bowser, 2007) and in vitro (O'Brien et al., 2004; O'Brien and Bowser, 2006). The 
latter studies involved assaying D-ser and L-glu in single excised retina and acute 
cortical tissue using a microliter sized retinal perfusion chamber coupled online to 
microdialysis CE-LIF. To our knowledge these were the first reports of monitoring 
rapid dynamic release of endogenous D-ser from an in vitro preparation. Their unique 
system was capable of monitoring efflux of D-ser and L-glu every 15 s, although 
temporal resolution (time required to detect an instantaneous stepwise change in analyte 
concentration) of the transmitter response was limited by the turnover rate of the 
chamber (turnover every 4 min), not by sampling rate. Furthermore the practical 
limitation of this online CE-LIF approach for routine studies in vitro relates to the fact 
that multiple CE-LIF platforms would be required for each chamber run in parallel, thus
limiting throughput. In addition, the prerequisite for microdialysis sampling of the 
perfusion medium as it exits the chamber adds unwanted complexity and costs for in 
vitro studies, and compromises quantitative recovery of analyte. Overall, we demonstrate 
that the microperfusion/CE-LIF technique described here offers several inherent 
advantages including (1) the ability to simultaneously sample from multiple brain slices 
from a single animal, (2) complete recovery of neurotransmitter since microdialysis is 
not required, (3) high temporal in vitro response of neurotransmitter efflux and (4) 
ability to simultaneously monitor multiple analytes by CE-LIF with high sensitivity. 
Temporal response using the microperfusion approach could be increased further than 
reported here in future work by increasing perfusion flow rate and sampling frequency. 
Indeed one of the advantages of the microperfusion approach in combination with 
sensitive CE-LIF is the potential to realize these improvements. Our CE-LIF technique 
utilizes minute volumes of perfusion media and based on S/N shown in Figure 5.4 for 
CBI-amino acids, would likely allow for doubling of flow rate without loss in capacity to 
detect the amino acids o f interest.
5.5 Summary on microperfusion sampling with CE-LIF
In summary, we show that OGD-induces D-ser and L-glu efflux from acute slices 
with similar timing of release which is important when considering that both are required 
for NMDAR excitotoxicity. In addition, our data represents the first temporal monitoring 
of both excitotoxic chemicals D-ser and L-glu in hippocampus. We describe a new 
microperfusion technique that is coupled to offline chiral CE-LIF to investigate ischemia
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evoked efflux of neurochemicals. The use o f CE-LIF utilizing S-P-CD as described in 
Chapter 2 allowed for monitoring efflux profiles of L-asp, L-thr, and L-gln in addition to 
the targeted excitotoxic chemicals D-ser and L-glu with 2 min temporal resolution. We 
speculate that this new approach will be valuable for future studies investigating 
mechanisms o f neurochemical regulation.
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Chapter 6 
Conclusions
6.1 Overview
Several D-amino acids including D-ser and D-asp are important metabolites in the 
mammalian brain; studies on function and distribution o f D-amino acids require the 
development of bioanalytical tools capable of sensitive enantioselective analysis in 
complex biological matrices. Capillary electrokinetic chromatography has emerged as a 
powerful, yet simple tool for chiral recognition; the approach is well validated for 
bioanalysis and offers many advantages for analyzing trace samples in complex 
biological matrices.
The primary focus of this dissertation was to demonstrate the capabilities of anionic CDs 
in cEKC for bioanalysis o f amino acids for the first time and take advantage of sensitive 
bioanalytical approaches with these chiral selectors for quantifying D-amino acids in the 
CNS. This research represents the first application o f an ionic CD for bioanalysis of a 
chiral amino acid. Selective separation and sensitive detection of D-ser, the dominant 
coagonist of the NMDAR, in CNS samples, was a central focus of this work. Studies 
over the past few years stress the importance of single isomer CDs for robust chiral 
separations; this thesis research also focuses on design and synthesis of a new family of 
single isomer selectively modified sulfoalkyl anionic CDs and investigations on their 
application for D-amino acid analysis. Sensitive separation and quantification is only 
one aspect of bioanalytical chemistry. This dissertation also focused on the development
of a novel microperfusion brain slice chamber for rapid sampling of neurochemical 
efflux dynamics including D-ser and L-glu from single acute hippocampus slices. 
Studies with this approach coupled to anionic CD based chiral separations were carried 
out for investigating timing and magnitude of D-ser and L-glu efflux in response to 
modeled cerebral ischemia.
6.2 Conclusions on reverse polarity CD-cEKC with S-p-CD
Anionic commercially available S-p-CD was shown for the first time to be a powerful 
chiral selector for CBI-amino acids and was capable of resolving as many as 14 CBI- 
amino acids with a single buffer formulation. The anionic CD derivative was found to 
be highly sensitive to the ionic nature of the CBI-amino acid; significant electrostatic 
interactions drastically altered resolution using reverse polarity CD-cEKC. BGE pH was 
established as the most important factor for chiral resolution of CBI-ser as well as other 
weakly acidic CBI-derivatives due to this electrostatic interaction. Data was provided 
demonstrating significant ionization of CBI-amino acids around pH 3 which results in 
significant electrostatic repulsion between anionic CD and anionic amino acid derivative 
and also significant electrostatic attraction at low pH between cationic CBI-amino acids 
and anionic CDs. RP-CD-cEKC with S-P-CD was applied to dilute samples of CBI- 
amino acids to investigate an observed stacking phenomenon. We found that S-p-CD 
could be used for pH mediated stacking and sweeping of dilute enantiomers of CBI- 
amino acids resulting in ~ 100-fold improvements in S/N without loss in chiral 
resolution. S-p-CD was developed for the first time as a bioanalytical method for amino
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acids. The approach was used for analysis of D-ser, D-asp, L-asp, D-glu, and L-glu in 
microdialysates from hippocampus of arctic ground squirrel. The bioanalytical method 
offered sufficient sensitivity for biological samples and was the first CE-LIF method for 
analysis of all three o f these D-isomers simultaneously.
6.3 Conclusions on synthesis of selectively modified sulfoalkyl CDs
The poor batch to batch reproducibility of most commercially available anionic CDs 
(including S-P-CD) stimulated interests to develop a new class of selectively modified 
single isomer sulfoalkyl cyclodextrins. These CDs were expected to have increased 
binding affinity with hydrophobic guest species compared to S-p-CD due to an increase 
in the separation o f the charged sulfonate from the CD torus.
Six new members o f the first family o f selectively modified sulfoalkyl CDs, including a- 
and P-CD derivatives, were fully synthesized and characterized. The CDs were designed 
to incorporate hydrophobic methyl or ethyl groups on the wider secondary hydroxyl rim 
of the CD torus. The primary hydroxyl rim was selectively modified with either 
sulfopropyl or sulfobutyl groups. A 4-step synthesis for each single isomer was required 
in order to selectively react both primary and secondary hydroxyls of the native CDs. 
The first 3-steps were primary hydroxyl protection, secondary hydroxyl alkylation, and 
primary hydroxyl deprotection reactions, and were reproduced from literature with only 
minor modifications. The sulfoalkylation step had to be developed within this thesis 
using nonaqueous reaction chemistry.
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We found that hexakis- and heptakis(2,3-di-0-alkyl)cyclodextrins could be reacted to 
produce single isomer 6-O-sulfoalkyl derivatives using 1,3-propanesultone or 1,4- 
butanesultone in THF in the presence of 18-crown-6/KH as base. Without crown ether, 
the reaction produced only poorly substituted product mixtures characterized by a low 
average DS. Full substitution was accomplished using high molar excess of crown ether 
compared to CD. After purification to remove various byproducts, reactants, and 
catalyst, CDs were characterized by NMR, elemental analysis, inverse detection 
capillary electrophoresis and MALDI-MS. All CDs were highly substituted with a 
composition of at least 95 % of the single isomer heptasulfalkyl (P-CDs) or 
hexasulfoalkyl (a-CDs) products. KSPDM-P-CD was additionally demonstrated to form 
an inclusion complex in solution using ROESY NMR with CBI-D-ser.
6.4 Conclusion on single isomer CDs as resolving agents for CBI-amino acids
Single isomer CDs are structurally superior buffer additives for robust chiral analytical 
assays compared to commercially available randomly substituted CDs. The initial study 
on single isomer sulfoalkyl CDs developed here for CBI-DL-amino acid analysis using 
RP-CD-cEKC was promising and suggests that KSPDM-P-CD, KSBDM-P-CD, and 
KSBDE-P-CD are excellent new resolving agents for chiral capillary electrophoresis. 
Additionally these CDs may be valuable for bioanalysis of chiral amino acids. Single 
isomer sulfoalkyl CDs form much stronger interactions with CBI-amino acids then S-P- 
CD and are not as sensitive to the ionic nature of the guest molecule. This latter 
observation was in accordance with the structure of these selectively modified
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derivatives compared to S-P-CD in that the extended alkyl spacer group separates the 
charged sulfonates too far from the CD torus to allow for significant electrostatic 
interaction with guest species for sulfoalkyl CDs. Thus the significant pH effects on 
resolution o f CBI-amino acids with S-P-CD are not observed to anywhere near the same 
magnitude with KSBDM-P-CD suggesting for the latter that the complexation potential 
is not as greatly affected by increased ionization of CBI-amino acid. Further, CBI-his 
migration was actually ~2-fold longer then weakly acidic amino acids at low KSBDM-P- 
CD concentration illustrating that CBI-his migration is not greatly influenced by any 
significant electrostatic attraction to this CD. The strong interaction between weakly 
acidic CBI-derivatives and single isomer sulfoalkyl CDs allowed for chiral resolution at 
remarkably lower concentrations of selector while maintaining high separation 
efficiencies. Thus CBI-DL-ser, CBI-DL-asp, CBI-DL-glu, CBI-DL-ala, and CBI-DL-thr 
were all baseline resolved in less then <17 min using 50 pM of KSBDM-P-CD as the 
only chiral selector in the BGE. The diethyl derivative, KSPDE-P-CD, offered unique 
selectivity compared to the similar chiral recognition behavior o f dimethyl derivatives. 
KSPDE-P-CD was the best resolving agent o f the series investigated for CBI-ser 
enantiomers at low CD concentrations though it displayed poorer selectivity at these 
levels for several other CBI-derivatives. A notable observation was a KSPDE-P-CD 
concentration dependent change in enantiomer migration order which may be the result 
of complex induced alterations in CBI-amino acid pKa values.
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6.5 Conclusions on microperfusion/CE-LIF for D-ser and L-glu analysis during 
oxygen glucose deprivation.
D-ser and L-glu play crucial roles in excitotoxicity through N-methyl-D-aspartate 
receptor coactivation but little is known about the temporal profile o f efflux during 
cerebral ischemia. To investigate, this dissertation describes a newly designed brain 
slice microperfusion device coupled offline to chiral CE-LIF with S-p-CD as chiral 
selector to monitor dynamic efflux of endogenous D-ser and L-glu in response to oxygen 
glucose deprivation in single acute hippocampus slices. Efflux profiles with 2 min 
temporal resolution in response to 24 min OGD show that efflux o f D-ser slightly 
precedes efflux of L-glu by one, 2-min sampling interval. Thus both coagonists are 
available to activate NMDA receptors by the time glu is released. The magnitude of D- 
ser efflux relative to baseline values is, however, less than for L-glu. This 
microperfusion approach coupled with CE-LIF represents the fastest temporal 
monitoring o f D-ser during modeled ischemia to date, and was the first study to 
investigate D-ser and L-glu efflux simultaneously in acute hippocampus. Several other 
endogenous amino acids were also simultaneously analyzed in perfusate media using 
CE-LIF including L-thr, L-gln, and L-asp. Advantages o f the microperfusion device 
included (1) the ability to simultaneously sample from multiple brain slices from a single 
animal, (2) complete recovery of neurotransmitter since microdialysis is not required, (3) 
high temporal in vitro response of neurotransmitter efflux, and (4) ability to 
simultaneously monitor multiple analytes by CE-LIF with high sensitivity. We
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speculate that this new approach will be valuable for future studies investigating 
mechanisms of neurochemical regulation.
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6.6 Final remarks
To summarize, this dissertation argues that anionic CDs are powerful chiral selectors for 
fluorescently labeled amino acids and can be applied for sensitive bioanalysis of D- 
amino acids including D-ser, D-glu, and D-asp in brain samples. It is anticipated that the 
single isomer sulfoalkyl CD derivatives which were synthesized and characterized here 
for the first time, and initially studied for separation o f CBI-amino acids, will be 
valuable reagents for future bioanalytical separations o f these important metabolites. 
Due to excellent batch-to-batch reproducibility, these CDs will likely replace 
bioanalytical methods using heterogeneous CD mixtures despite excellent resolving 
power demonstrated for these latter CDs. These new single isomer sulfoalkyl CDs are 
powerful chiral selectors capable of chiral recognition at very low concentrations of 
selector. Their unique structure allows for significant interaction between the CD torus 
and the hydrophobic guest of both weakly acidic and cationic CBI-amino acid 
derivatives which is a rather unique feature of anionic CD selectors reported thus far. 
The single isomer sulfoalkyl a-CD derivatives await further application to analytical 
chemistry. It is anticipated that they will additionally show similar unique inclusion 
complexing behavior which may be characteristic o f this broader family of sulfoalkyl 
CDs. This dissertation describes a new in vitro tissue perfusion approach which allows 
for rapid dynamic changes in neurochemicals from acute tissue to be evaluated. The
approach was applied to investigate magnitude and timing of D-ser and L-glu efflux 
during modeled ischemia in hippocampus and evidence suggests that these 
neurochemicals are released with similar timing but differing magnitudes. Future studies 
with this new in vitro approach are expected which may reflect investigative studies on 
mechanisms of neurochemical regulation in the CNS.
Future studies in molecular recognition with single isomer CDs will seek to understand 
more clearly the mechanisms of chiral interaction of selectively modified sulfoalkyl CDs 
with guest molecules and especially verify the novel data presented here suggesting 
weak to nonexistent electrostatic interaction with acidic and basic guest species despite 
the heptasulfato nature of these new single isomer CD derivatives. The development of 
robust bioanalytical separations of CBI-ser and additional CBI-amino acid enantiomers 
is expected in future studies with these powerful new chiral resolving agents. These CDs 
may prove valuable for additional chiral separations; perhaps including analysis of 
pharmaceutical weak bases, acids, and neutral chiral drugs and intermediates. Their 
ability to offer excellent enantiorecognition, high batch to batch reproducibility, narrow 
peak widths, and high separation efficiencies at reduced concentrations are all features 
that will be utilized in future robust analytical separations.
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